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ABSTRACT 
Liver on a Chip: Engineering a Liver Sinusoid Functional Unit 
Young Bok (Abraham) Kang 
Moses Noh, Ph.D. 
 
The liver is the largest internal organ in our body that conducts numerous 
metabolic activities and detoxification. Currently, liver biology, liver-related disease 
studies, and drug screening research are facilitated predominantly by in vitro liver-cell 
culture models. However, primary liver cells cultured on conventional tissue culture 
platforms do not maintain their viability and functions for more than a week and do not 
recapitulate the in vivo architecture of the liver. In order to overcome these limitations 
and develop an authentic and long-term liver model, we applied microfabrication and 
microfluidics technologies to mimic the architecture and function of a liver sinusoid 
where most liver activities take place. The liver sinusoid is a blood-carrying microscale 
channel lined with liver sinusoidal endothelial cells (LSECs).  The liver cells 
(hepatocytes) are located outside the LSECs separated from them by the Space of Disse. 
Bile is secreted from the hepatocytes and transported to the intestines through bile ducts.  
In short, the liver sinusoid is a dual channel structure with LSECs and hepatocytes in 
between them. In order to engineer the liver sinusoid we conducted a stepwise study from 
a macroscale culture system to a microfluidic culture system and from a rat liver model to 
a human liver model. First, primary rat hepatocytes (PRHs) were co-cultured with 
endothelial cells in layers in conventional Transwell plates with the two cell layers 
cultured on the opposite sides of the porous membrane. Second, the layered co-culture 
was then transferred to a dual microchannel platform and cultured the cells with a 
 xv 
 
continuous perfusion to simulate the blood sinusoid and bile duct. Finally, primary 
human liver cells were cultured in the dual microchannel platform realizing human liver 
on a chip. Morphological and biochemical analyses data support that our liver models 
maintain the viability and functions of hepatocytes for a long-term. We also demonstrated 
the utility of our human liver model via HBV replication study. Thus, we believe that our 
liver on a chip can find numerous applications in liver biology, liver-related disease 
studies, and drug screening research. 
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CHAPTER 1.  INTRODUCTION & BACKGROUND 
1.1. In vivo liver 
The liver is the largest internal organ in the body, constituting approximately 2-5 % 
of the weight of an adult and about 5% of weight in the neonate [1]. The liver is a 
collection of numerous hepatic lobules. The various, remarkable functions of the liver are 
reflected by the structural organization of the liver, the functions of each of the cell types 
consisting of the liver, and numerous interactions between cell types and blood flow in 
the microenvironment of the liver [1]. 
 
1.1.1. The structural organization of the liver 
The liver is an eight-segmented organ that is endowed with specific hepatic 
functions in the body [1]. The basic structural unit of liver tissue is the hepatic lobule 
with portal tracts in its periphery and the hepatic vein tributary in its center [1]. The 
fundamental functional unit (the liver sinusoid function unit) of the hepatic lobule 
consists of a hepatic sinusoid, the surrounding cells, bile duct, and lymphatic and neural 
connection (Figure 1-1). The hepatic sinusoid is an approximately 10-micron wide 
capillary that is between 225 and 475 microns long, and it receives blood from the 
intestines, pancreas, spleen, and gallbladder [2-4]. The flow of blood through the sinusoid 
has a linear flow rate of approximately 0.1-1 μm/s [5]. The liver sinusoid is a capillary 
lined by LSECs. Stellate cells that help to maintain the extracellular matrix and Kupffer 
cells, which are liver macrophages, are also present in the liver sinusoid (Figure 1-1). 
There is a small space of around 50-200 nm thickness called the Space of Disse that 
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separates LSECs from hepatocytes [6-8]. Hepatocytes (typically about 20-22 µm 
diameter) are the major cells within the liver and are responsible for many activities that 
are attributed to the liver [9]. The hepatocytes naturally secrete bile that is collected in the 
bile duct. The bile secreted from the hepatocytes is transported to the intestines or stored 
in the gall bladder from the liver through bile ducts [9, 10]. Bile canaliculi are small 
channels that form between adjacent hepatocytes. 
 
 
Figure 1-1. The liver sinusoid functional unit. 
 
  
 
1.1.2. Cell types of the liver 
1.1.2.1. Hepatocytes 
The essential or functional element of the liver is known as the parenchyma that 
constitutes approximately 60-65% of the cells of the liver [10]. The parenchyma is 
composed of hepatocytes that are a highly differentiated, epithelial cell type that are lined 
in radial direction from a portal tract to a central vein. Hepatocytes primarily carry out 
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most of the liver’s various metabolic functions including metabolism of xenobiotic and 
detoxification of systemic and portal blood; secretion of plasma proteins, growth factors, 
urea, and bile; regulation of blood glucose; uptake and metabolism of proteins, and fat; 
and storage of vitamins, and glycogen [1, 9-11].  
The other cell types in the liver are known as the non-parenchymal cells that 
account for 35-40% of cells in the liver [1, 9, 10]. The non-parenchymal cells include 
LSECs (19-21%), bile duct epithelial cells (3-5%), stellate cells (5-8%), Kupffer cells (8-
12%), and liver stem cells (<<1%) [1, 9, 10].  
 
1.1.2.2.  Liver sinusoidal endothelial cells 
The structure of liver sinusoids is created by lining the specialized microvascular 
with endothelial cells. The LSECs are separated from the hepatocyte layer by the Space 
of Disse. LSECs are responsible for important activities in lipid metabolism, coagulation, 
cellular growth, differentiation, immune, and inflammatory response [12]. LSECs have 
numerous fenestraes that are open small pores with approximate 100 nm diameter in their 
membrane [12]. The fenestrations of the LSEC plays a role in selective control and 
filtration of the blood flow from the sinusoidal lumen into the Space of Disse [13].  
 
1.1.2.3. Kupffer cells 
Kupffer cells are the liver resident macrophages that are found anchored to or 
inserted into the endothelial cells lining [12]. Kupffer cells are exposed to gut-derived 
bacteria, microbial debris and bacterial endotoxins that may be included in nutrient rich 
blood of the portal vein that comes from the gut. Kupffer cells are responsible for the 
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liver's immune response to infection, toxins, ischemia, resection, and other stresses [12]. 
Furthermore, the role of Kupffer cells is involved in the pathogenesis of various liver 
diseases mediated by chemical substances and toxins.   
 
1.1.2.4. Hepatic stellate cells 
Hepatic stellate cells (HSCs) are the main mesenchymal cell type with a 
myofibroblast-like phenotype; HSCs are found in the Space of Disse in the liver. HSCs 
play a role in extracellular matrix production, secretion of growth factors (i.e. HGF and 
TGF), and storage of vitamin A and fat [12]. The activities of HSCs are involved in liver 
regeneration, differentiation, and inflammation [12]. HSCs also help regulate vascular 
tone and hepatic blood pressure, and they become activated during liver fibrosis, which is 
the formation of scar tissue in reaction to liver damage [12]. 
 
1.1.3. In vivo microenvironment of the liver 
The in vivo microenvironment of the liver consists of a complicated biochemical 
network of physical factors, both insoluble and soluble, and also cell-cell interaction that 
can influence cell functions [14]. Liver cells, including hepatocytes, are sensitive to the in 
vivo microenvironment of the liver, and their phenotypes and functions are affected by it. 
Therefore, it is important to consider the in vivo microenvironment related to the 
biochemical and physical influential factors, which can determine the phenotype of cells 
in vivo,  in any attempt to recreate in vivo liver sinusoid [14].   
 
1.1.3.1. Biochemical environment 
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Biochemical environment includes soluble factors, and its signaling, gas transport, 
and cell to ECM interaction. Soluble factors are various biomolecules that are presented 
in blood and intracellular compartments [14].  
Importantly, the blood flow delivered from the intestines, pancreas, and gallbladder 
includes various soluble components such as nutrients, growth factor, toxins, oxygen, and 
carbon dioxide [2, 15]. Hepatocytes uptake necessary oxygen and nutrients from the 
hepatic sinusoid and secrete bile into canaliculi [14]. These soluble compounds are 
continuously transported away from the source via diffusion and the blood. Many soluble 
factor signals also present as gradients generated by the concentration difference caused 
by the blood stream line in vivo. For example, the gradient of oxygen concentration is 
formed because the dissolved oxygen is consumed by the cells along the sinusoid line 
within the liver. Soluble factors that are carried out via diffusion or the blood flow can 
interact with ECM. 
The ECM of the liver is a biochemical environment made up of a very thin layer of 
collagen, laminin, fibronectin, and other proteins which are present in the Space of Disse 
[14]. The ECM provides cells with mechanical anchors for cell attachment as well as 
receptors for sensing the biochemical and physical change of microenvironment [14]. The 
geometry of the ECM and hepatocyte to ECM interaction affects the cellular function of 
hepatocytes, the cell structure, and signaling related to cell adhesion [14]. Furthermore, 
cell to ECM interaction is important in understanding the mass transport phenomenon in 
the in vivo microenvironment. 
 
1.1.3.2. Physical environment 
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The physical environment includes the geometry of capillary network, fluid flow in 
the vascular system, and force/temperature that can be sensed by cells [14]. Fluid flow in 
blood vessels leads to shear stress as well as mass transport and compound distribution. 
The flow of blood from the vascular system to the lymphatic system has a linear flow rate 
that ranges approximately from 0.1 to 1 μm/s [16]. Also, cell behavior is affected by the 
change of temperature in the cell environment.  
 
1.1.4. Liver function 
The liver is involved in various metabolic processes that influence body 
homeostasis. Liver activities include modulation of blood-glucose levels, bile synthesis, 
and the production of plasma proteins such as albumin, acute phase proteins, and 
coagulation factors [12, 17] (Figure 1-2).  The liver receives oxygen-rich blood from the 
hepatic artery and nutrient-rich blood from the portal vein; the portal vein carries 
nutrients derived from the intestinal tract, exposing the liver to ingested nutrients as well 
as toxins and infectious agents.  Consequently, another major function of the liver is 
detoxification.  The liver can also modulate immune responses by inducing antigen 
tolerance and by removing activated immune cells from circulation [12, 17]. 
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Figure 1-2. The liver function. 
Image from http://www.foxriverwatch.com/liver_hepatic_damage_pcbs_1a.html 
 
 
Because of its overall importance to drug metabolism, detoxification, and other 
metabolic activities of the body, the liver is one of the main target organs of 
pharmaceutical research [12, 18].  
 
1.1.5. In vivo liver studies 
In pharmaceutical research, animal testing has been widely used for drug safety and 
efficacy in drug discovery and screening research. However, drug development usually 
requires about 10-15 years from the initial development of one new drug to commercial 
use for patients after the approval of Food and Drug Administration (FDA) [19]. In 
addition, in vivo studies have an inherent difficulty in distinguishing the primary effects 
of certain chemical compounds from those that are induced secondarily, because normal 
liver function involves processing various endogenous and exogenous through 
detoxification [20]. This is because the numerous interactions of a series of complex 
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cellular processes that are involved in the uptake, biotransformation, and elimination of 
potentially toxic compounds occur in vivo [20]. Furthermore, drug studies using animal 
such as non-human primates, mice, and rat model systems often fail to predict results 
related to drug efficacy and safety in humans [21]. 
Due to the limitation of in vivo studies for drug development and liver related disease, 
in vitro liver-cell culture systems have been widely used in the liver biology, liver-related 
disease studies, and drug screening research.  
 
1.2. In vitro liver 
1.2.1. In vitro cell culture studies  
Liver biology, liver-related disease studies, and drug screening research are facilitated 
predominantly by in vitro liver-cell culture systems. In conventional in vitro culture 
systems, primary liver cells are cultured on tissue culture platforms. Generally, primary 
liver cells do not maintain their differentiation for more than a week, and monolayer 
culture of hepatocytes does not recapitulate the in vivo architecture of the liver [12, 20]. 
In addition, it is hard to interpret the surrounding biological context of cellular responses 
for cell biological response testing. Moreover, it is difficult to control biological 
conditions, and there is a restriction of cell growth in the conventional culture method.  
On the other hand, newly developed in vitro liver models that mimic the in vivo liver 
microenvironment can simulate the physiology and pathophysiology of the human body 
and provide patient-specific-in vitro test environment and therapy (Figure 1-3). These 
models have high measurement accessibility and can be substituted for animal testing. 
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Therefore, in vitro liver models can compensate for the problems of drug testing in in 
vivo animal studies and cell biological response testing in conventional culture method. 
Also, it is important to develop accurate and experimentally tractable in vitro liver model 
systems that facilitate long-term viability of cells and maintenance of liver-specific 
functions. Eventually, in vitro liver models can be widely used in the area of liver biology 
studies, cancer research, and toxicology studies.  
Here in this section, we will analyze the advantages and disadvantages of newly 
developed in vitro liver models by comparing the conventional in vitro cell culture 
system to the newly developed in vitro cell culture system.  
 
 
Figure 1-3. The development of in vitro liver model to mimic in vivo liver architecture. 
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1.2.2. In vitro liver-cell culture system  
1.2.2.1. Macroscale culture vs microscale culture 
Conventional culture of hepatocytes has traditionally been conducted in tissue culture 
plates such as 6-well plates, 12 well plates and 24 well plates until microtechnologies and 
microfabrication technologies were developed as alternative technologies for culturing of 
cells. This conventional culture system is the macro scale, simplest and most popular way. 
Considering that the number of cells to be cultured are dependent on culture area of the 
culture platform, approximately more than 10
5
 cells per well may be required for cell 
seeding. Moreover, medium including reagents is required in proportion to the culture 
volume of the culture platform. On the other hand, microtechnologies and 
microfabrication technologies enable many researchers to culture cells in a 
microenvironment culture platform that is scaled down from a macroscale culture 
platform. Because of this, a smaller number of cells (less than 10
5
) and less amount of 
medium are required in contrast to the conventional macroscale culture system. 
Additionally, such a physiological microenvironment enables the cells to experience an in 
vivo like environment and to maintain hepatocyte function for a longer period of time 
versus traditional culturing methods. Furthermore, the physiological environments 
mimicking human tissue and organ structure enable more accurate assessment of a drug’s 
performance at a much lower cost.  
 
1.2.2.2. Two dimensional culture vs three dimensional culture 
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The most commonly used culture system is a two dimensional (2D) culture system in 
which cells form a monolayer on a collagen-coated substrate. In a flat and rigid culture 
dish, cells stretch longitudinally and form a flat shape. This shape is not comparable to 
the in vivo three dimensional (3D) cell shape and has a certain intrinsic limitation such 
that cells lose their function rapidly after plating.  
In contrast, three dimensional culture systems provide a physiological 
microenvironment that mimics the in vivo cellular architecture observed in native tissue. 
Three dimensional culture models are achieved with the help of the construction of 
extracellular matrix such as collagen, matrigel, and hydrogel around cells or three 
dimensional scaffolder using microtechnologies. Cells cultured in the three dimensional 
culture system often show improvement in cellular function compared to hepatocytes 
cultured in the conventional culture system [22]. Furthermore, relevant to a drug delivery 
study, the extracellular matrix surrounding cells plays a role as physiological barriers for 
drug delivery in vivo by hindering transport of drugs and genes to target cells [23]. Due to 
useful strengths of three dimensional culture, the development of in vitro liver model 
using three dimensional culture has been increased for the past decade.  
 
1.2.2.3. Static culture vs perfusion culture 
A widely used conventional in vitro cell culture is a static culture where medium is 
periodically exchanged manually without perfused medium flow. In this culture system, 
cells are often cultured in open wells, and certain materials secreted from cells can 
accumulate in the medium until replacement and may adversely affect the cell viability.  
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Moreover, there are high variations between static periods of incubation, and cells 
experience high shear stress during medium replacement by pipette.  
In contrast to traditional cell culture, a perfusion cell culture system that cultures cells 
with the introduction of continuous medium flow to the cell culture platform not only 
provides cells with nutrients and oxygen continuously, but also removes wastes. Also, the 
perfusion culture system which operates under a closed environment is kept under sterile 
conditions during the course of the culture time. In addition, this system can control the 
level of flow and minimize shear stress exerted on cells by flow. Moreover, it is possible 
to recreate the physiological microfluidic environment, where cells can experience in vivo 
like environment and maintain cell viability and function for extended periods. With 
these advantages, the perfusion microfluidic culture system is often used for drug 
research, even though the perfusion system is more complicated than static culture. 
 
1.2.2.4. Monoculture vs co-culture 
The cell culture method commonly used in many laboratories is a monoculture of 
hepatocytes where hepatocytes are cultured on the collagen-coated substrate in medium 
and form a monolayer. This is the simplest way of cell cultivation and the most popular 
one. Even though cell function is improved by culturing a single cell type in three 
dimensional culture system, there is still a certain limitation in that primary hepatocytes 
in two dimensional monoculture rapidly de-differentiate. In addition, a monoculture 
system of hepatocytes may generate misleading results in drug testing because not only is 
the monoculture environment different from the in vivo liver environment, where 
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hepatocytes live with different cell types, but hepatocytes in the monoculture respond 
without the influence of other cell types on hepatocytes function after uptake of the 
drugs.  
Comparing to hepatocytes monoculture, co-culture where hepatocytes are cultured 
with other cell types such as endothelial cells is enabled to recreate in vivo-like liver 
architecture where parenchymal cells and non-parenchymal cells co-exist. Co-culture of 
hepatocytes and fibroblast/endothelial cells has been shown to improve hepatocyte-
specific function and a long term cell viability [20]. Moreover, co-culture system 
enhances cell to cell interaction via cell to cell direct or indirect contact. Furthermore, it 
provides a better test environment for drug research by considering the effect of other cell 
types on hepatocyte functions after uptaking drugs compared to hepatocyte-only culture.  
  
1.2.2.5. The immortalized cell line vs primary hepatocytes 
Liver studies have often been conducted in vitro culture model using immortalized or 
transformed hepatocyte cell lines which are dedifferentiated to varying degrees. The 
prevalence of these types of studies is due to the fact that cell lines are easy to 
manipulate, are readily available, and easy to culture cells for long term, unlike the 
culture of primary hepatocytes. However, these cells often have altered signaling 
pathways. Consequently, the results obtained using transformed cell lines can provide 
misleading information in studies analyzing drug testing on normal differentiated 
hepatocytes [24, 25]. 
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In contrast, liver biological studies using primary cells can bring meaningful results 
because primary hepatocytes retain responsiveness to signals to which they reacted in 
vivo. In most experiments using primary cells, animal liver cells such as a rat and a 
mouse are widely used due to a limited availability of human hepatocytes. However, liver 
studies conducted in vitro culture model using animal cells have often been variable, and 
the obtained data using animal cells cannot always be extrapolated with certainty to the 
human situation [20]. Thus, it is most desirable to use primary human hepatocytes 
(PHHs) for drug testing and liver disease studies.  
 
1.2.3. Review of in vitro liver models 
In the previous section, we explored various in vitro culture systems that are widely 
used. Also, we briefly analyzed characteristics, strengths and drawbacks of each culture 
system. In vitro cell culture methods have been evolved gradually from conventional, 
simple, mono-, two-dimensional culture system under static condition to microscale, 
complex, co-, three dimensional culture system under perfusion condition with the advent 
of microtechnologies and microfabrication technologies. Moreover, many research 
groups have presented new developments in in vitro culture systems which are much 
better than conventional culture systems by demonstrating improved liver specific 
function and the long term cell viability. Therefore, in this section, we will go over 
examples of the current in vitro liver models that have been developed by other research 
groups with the basic knowledge of various culture systems.  
 
 15 
 
1.2.3.1. In vitro liver models using conventional culture platform 
Many studies have been conducted to develop an in vitro liver model that sustains 
liver specific function and viability for a long term. In vitro liver models and bio-artificial 
livers using macroscale culture platform conventional culture platform such as a tissue 
culture dish have been developed for studying liver biology, liver toxicity, and drug 
metabolism as they offer comparatively simpler and more tractable model systems and 
reduce the cost of conducting such studies in animal model systems. For example, one 
report showed improved long-term culture of PRHs that were entrapped in Arg-Gly-Asp 
(RGD)-incorporated hydrogel; the hydrogel was used as a synthetic extracellular matrix 
of hepatocytes [26]. However, this hepatocyte single culture in tissue culture plate does 
not accurately mimic in vivo liver sinusoid architecture that consists of hepatocytes 
(parenchymal cells) and the non-parenchymal cells such as LSECs, Kupffer cells, and 
hepatic stellate cells; The interactions between the parenchymal and non-parenchymal 
cells of the liver plays an important role in maintaining hepatocyte function [27-31]. 
Recently, liver organotypic co-culture systems were developed using synthetic and 
biodegradable membranes to culture primary human hepatocytes and human umbilical 
vein endothelial cells [32]. In another study, a layered three-dimensional co-culture of 
PRHs and human LSECs with an intermediate chitosan-hyaluronic acid polyelectrolyte 
multilayer (PEM) was developed on 6-well tissue culture plates. The chitosan-hyaluronic 
acid polyelectrolyte multilayer (PEM) was introduced in order to mimic the Space of 
Disse [31]. A layered tri-culture model of the hepatocyte, hepatic stellate cells, and 
sinusoidal endothelial cells using different size microporous membranes was used to 
investigate cell-to-cell communications [33]. In addition, Chen et al. synthesized a weak 
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polyelectrolyte multilayers (PEMs) to investigate the effect of the mechanical compliance 
and ligand presentation of synthetic PEMs on the adhesion and liver-specific function of 
PRHs in 12-well plate [34].  PRHs cultured on highly compliant substrates showed 
improved phenotypic function for two weeks. However, these reports did not show the 
long-term co-culture of primary hepatocytes; hepatocytes typically lose hepatocyte-
specific functions and de-differentiate shortly after they are isolated from the liver [12, 
35].  
Together, many studies using conventional macroscale culture platforms have shown 
the feasibility of long-term co-culture of hepatocytes with either endothelial cells (ECs) 
[36] or stellate cells[37], and were able to demonstrate that hepatocytes maintained their 
functions in these systems, however, there is a limitation to mimic the in vivo 
microfluidic environment using conventional macroscale culture platforms.   
 
1.2.3.2. In vitro liver models using microfabricated platform 
With the help of microtechnology and microfabrication, various in vitro liver models 
using microtechnolgies have been presented and some of them are shown in the Table 1-
1. These in vitro culture models using microtechnologies and microfluidic technologies 
demonstrated improved hepatocytes-specific function compared to conventional culture 
of primary hepatocytes. In addition, some of these models are biomimetic culture systems 
which mimic the in vivo liver organization or recreate physiological microenvironment 
where cells can experience like in vivo conditions. Examples of current in vitro liver 
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models include micropatterned cultures, three dimensional cultures, co-cultures, and 
perfusion cultures, which are summarized in the Table1-1.   
 
Table 1-1. Examples for current in vitro liver-cell culture systems using 
microtechnologies and microfluidics. 
Culture 
system 
Applied 
technologies 
Cell type Function analysis Advantage Disadvantage Ref. 
Static-
2D-
monocult
ure 
 
Single 
microchannel 
PRH/ 
HepG 2 
HBV replication 
study  
Differentiation 
Simple method 
Non-biomimetic 
Short term 
viability 
Lack of non-
parenchymal cells 
Inefficient mass 
transfer 
[38] 
Synthetic 
polymeric 
substrate 
PRH Urea/Alb [39] 
Static-
2D-Co-
culture 
Micropatterned 
co-culture 
PHH/PRH
/fibroblast/ 
LSEC/ 
Kupffer 
cells 
Urea/Alb/CYP450/ 
Toxicity test (Activity 
Phase I/II 
Gene expression)/ 
HCV replication 
study 
Heterotypic junction 
increase 
Improved function 
Non-biomimetic 
Long term 
viability 
Inefficient mass 
transfer 
[40] 
[41, 
42] 
[43] 
[44] 
Micropatterned 
layered co-culture 
PRH/ 
fibroblast 
Urea/Alb [42] 
Static-
3D-
Monocult
rue 
Bio-artificial liver 
support 
(Microcarriers 
(bead)) 
PHH 
Urea/Alb/ 
CYP activities 
Cell-ECM 
interaction 
Improved function 
Non biomimetic 
Lack of non-
parenchymal cells 
Inefficient mass 
transfer 
[45] 
 Hollow fibers. PRH Urea/Alb [46] 
Static-
3D-Co-
culture 
Micropatterned 
array chip 
(PEG gel) 
PMH/PRH
/non-
parenchym
al cells 
/fibroblast 
Urea/Alb/CYP450 
Cell-cell and cell-
ECM interaction 
Improved function 
Biomimetic 
Long term 
viability 
Inefficient mass 
transfer 
[47] 
[48] 
 
Encapsulation in 
PEG polymer 
scaffolds 
PHH/ 
Fibroblast 
Urea/Alb/CYP450/Ph
armacokinetic 
analysis (Phase II 
metabolites). 
[49] 
Perfusion
-2D-
Monocult
ure 
Microfluidic chip 
(collagen overlay 
or ‘sandwich 
configuration’) 
PRH 
Urea/Alb/CYP 
activity 
High throughput 
system 
Improved function 
Efficient mass 
transfer 
Useful for drug 
testing 
Loss of cell-cell 
interaction 
Lack of non-
parenchymal cells 
[50] 
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Perfusion
-2D-Co-
culture  
A flat-plate 
bioreactor  
(Grooved 
microchannel) 
PRH/ 
Fibroblast 
 
 
Urea/Alb/ 
Oxygen concentration 
High throughput 
system 
Improved function 
Inefficient mass 
transfer 
Useful for drug 
testing 
Long term 
viability 
 
[51] 
[52] 
[53] 
Perfusion
-3D-
Monocult
ure 
Micro fluidic 
channel with 
micropillar array  
3D-µ FCCS 
PRH/ 
HepG 2/ 
MCF7 
Alb/UDP glucuronyl 
transferase (UGT) 
activity 
Biomimetic 
High throughput 
system 
Cell-cell and cell-
ECM interaction 
Improved function 
Inefficient mass 
transfer 
Useful for drug 
testing 
Lack of non-
parenchymal cells 
[54] 
 
Multichamber 
modular 
bioreactor 
PHH 
Urea/Alb/CYP 450/ 
Detoxification gene 
expression 
[55] 
 
Multicompartment 
hollow fiber liver 
bioreactor 
PHH 
Urea/Alb/CYP 
activities 
[56] 
Perfusion
-3D-Co-
culture 
A bioreactor 
(3D hepatocellular 
aggregates) 
PRH/ 
LSEC 
Alb/Oxygen 
concentration/SE-1 
High throughput 
system 
Biomimetic 
Cell-cell and cell-
ECM interaction 
Improved function 
Inefficient mass 
transfer 
Useful for drug 
testing 
Short term 
viability 
Expensive and 
challenging to 
fabricate 
[57] 
 
Microreactor 
(polycarbonate 
scaffolds) 
PRH/ 
LSEC 
SE-1/ GFAP for 
LSEC 
[58] 
 
Biochip 
(microchambers) 
Rat liver 
slice 
Metabolite analysis/ 
Bile acid  
[59] 
 
 
1.2.3.2.1. Static-2D-monoculture vs co-culture 
Similar to macroscale culture to form two dimensional monolayer of hepatocytes on a 
substrate, the simplest way in a microscale culture is to culture two dimensional mono-
layered hepatocytes in a single microchannel under static condition. Sodunke et al. 
fabricated a culture platform for HBV replication study that is a single microchannel 
without pattern [38]. This channel is bonded to a glass slide or tissue culture dish that is 
coated with extracellular matrix. PRHs cultured in this microchannel with one inlet and 
outlet under static condition were able to survive a few days. Bettinger et al. cultured 
PRHs on elastomic poly-esteramide substrates modified with replica-molded 
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nanotopographic features [39]. PRHs cultured on a synthetic polymeric substrate reduced 
albumin secretion and urea synthesis. However, this study showed improved attachment, 
spreading, and adhesion of PRHs.  
The most popular static two dimensional co-culture model is a micropatterned co-
culture of hepatocytes and fibroblast under static condition (Figure 1-4). Micropatterned 
co-cultures of hepatocytes and fibroblasts without the introduction of medium flow have 
also been created to establish a system that facilitated control of cell-cell interactions, 
which play an important role in maintenance of hepatocyte function [41, 42]. The results 
of these studies showed that increasing the heterotypic contact area between hepatocytes 
and fibroblasts improved hepatocytes-specific functions for at least 4 weeks [41]. 
Zinchenko et al. generated a micropatterned co-culture of hepatocytes and Kupffer cells 
to evaluate the effect of co-culture on hepatocyte specific function [44]. Hepatocytes co-
cultured with Kupffer cells on a micropatterned substrate showed improved function by 
maintaining morphological and functional changes for ten days. In another study, Cho et 
al. presented the layered patterning of hepatocytes on micropatterned fibroblast layers 
using microfabricated PDMS stencils [42]. Co-culture of hepatocytes with fibroblasts in 
layered micro-patterns supported the improvement of liver-specific functions and active 
glycogen synthesis by increasing the heterotypic interface between hepatocytes and 
fibroblasts for 7 days.  
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(a) 
 
 (b) 
 
(c) 
 
(d) 
Figure 1-4. The current in vitro liver models. (a) the bioreactor with microgrooved 
substrate [53], (b) micropatterned co-culture [60], (c) a layered culture of hepatocytes in 
collagen gel in microfluidic channel [50], (d) the micro-array for three dimensional cell 
culture [12]. 
 
 
1.2.3.2.2. Static-3D-monocultrue vs co-culture 
One common way to create the three-dimensional microenvironment is to fabricate a 
three dimensional scaffold with proper pore size and distance between pores by 
synthesizing polymer gel such as hydrogel. Hepatocytes in these scaffolds can be cultured 
maintaining a three dimensional cells structure similar to a three dimensional condition in 
vivo.  
Williams et.al. developed a micropatterned hydrogel scaffold using semisynthetic 
polyethylene glycol-fibrinogen hydrogels to investigate the role of growth factor and 
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ECM-modulated autocrine signaling in culture of hepatocytes [61]. In this study, PRHs 
cultured in a micropatterned scaffold retained high levels of liver-specific functions over 
the 10-day culture period. In addition, Bierwolf et al. presented that primary hepatocytes 
cultured on collagen-coated nanofibrous scaffolds maintained their specific function for 7 
days [62]. Fukuda et al. developed a spherical organoid microarray culture system that 
enables hepatocytes to form spheroids using a microfabrication and 
collagen/polyethylene glycol microcontact printing [63, 64]. PRHs formed a cuboidal cell 
shape in a microarray culture and maintained improved liver-specific function for 14 
days. These scaffolds with interconnected spherical macro- or micro-pores provide a 
good microenvironment for viability and function of PRHs. As another example, Zhang 
et al. developed a hepatocyte sandwich culture configuration using an ultra-thin 
microfabricated porous silicon nitride membrane [65]. Hepatocytes cultured in the 
microfabricated porous membrane showed improved differentiated functions and 
enhanced drug sensitivity compared to hepatocytes cultured in conventional sandwich 
culture using a collagen gel. The microfabricated membrane with well-defined pore size 
and inter pore distance led the improvement of hepatocytes attachment and function in 
the sandwich culture by a systematic optimization of the mass transport properties of 
hepatocyte culture.  
Another three dimensional culture model is a culture of hepatocytes using hollow 
fibers that support the form of an organoid. PRHs formed a cylindrical organoid inside 
hollow fibers and maintained their morphology and liver-specific functions for 2-5 
months [46]. 
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In three dimensional co-culture systems, the three dimensional multicellular structure 
closely resembles in vivo liver architecture which promotes homotypic/heterotypic cell to 
cell contacts due to the high density hepatocytes present. In addition, it provides a culture 
environment that provides nutrients and oxygen to cells at high densities. Both the 
promoted cell to cell interaction and the enhanced cell to medium interaction support the 
hypothesis that hepatocytes can maintain the expression of the differentiated hepatic 
functions at high levels for an extended period.  
Three dimensional co-culture of hepatocytes was achieved by co-culturing 
hepatocytes and non-parenchymal cell types in polymer scaffolds. Ikeda et al. presented 
the long term viability and function of hepatocytes using a microfabricated cell array 
[48]. Hepatocytes formed spheroid on a poly-styrene based plate surface that was 
microfabricated from a PEG block copolymer. Hepatocytes co-cultured with fibroblasts 
in microfabricated cell array retained liver-specific function for 42 days. Chen et al. 
cooperated that co-cultivation of primary human hepatocytes and fibroblasts by 
encapsulating cells in PEG diacrylated polymer scaffolds led to sustained albumin 
secretion and urea synthesis for one week [49]. Similarly, Kojima et al. demonstrated that 
primary mouse hepatocyte spheroids co-cultured with non-parenchymal cell types on a 
PEG-gel micropatterned surface retained upregulated hepatic function for 21 days [66].  
As another example of three dimensional co-culture under static condition, a stable 
three dimensional multilayer culture was reported by Evenou et al. PRHs and fibroblasts 
were co-cultured on a gas permeable, collagen-conjugated PDMS membrane in a micro-
plate-based format [67]. Hepatocytes co-cultured with fibroblasts in a three dimensional 
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multilayered system sustained their specific function at higher level for 7 days than two 
dimensional hepatocytes only culture. Wong et al. described a size-controllable 
spheroidal hepatosphere and heterosphere model within concave microwell arrays [68]. 
Heterospheres that are self-aggregates and formation of PRHs and hepatic stellate cells 
showed higher albumin synthesis function and cytochrome P450 activities for 9 days 
compared to primary hepatospheres. These size-controllable heterospheres could be 
available for artificial three-dimensional hepatic tissue constructs and regeneration of 
failed liver. 
 
1.2.3.2.3. Perfusion-2D-monoculture vs co-culture 
Perfusion culture systems have been effectively generated in microfluidic systems. 
Perfusion microfluidic systems form laminar flow in miniaturized channels that expose 
cells to consistent levels of nutrient and remove the secretion from cells. Thus, perfusion 
microfluidic system is a culture system that closely mimics the in vivo microfluidic 
environment.  
A simple two dimensional perfusion monoculture system was described by Vinci et al. In 
this study, primary human hepatocytes that were cultured on coverslips in multi-chamber 
modular bioreactor with a flow rate showed the up-regulated expression and activity of 
detoxification genes for 20 days as compared with cells cultured under static condition 
[69, 70]. Microfluidic biochip to provide the microfluidic environment to form a 
multilayer tissue was developed by Prot et al. Ttranscriptomic, proteomic and 
metabolomics profiles of hepatoma cells (HepG2) cultivated inside a microfluidic PDMS 
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biochip with drug such as acetaminophen was analyzed [71]. More recently, a 
microfluidic platform was used to study the interplay of the medium flow, production of 
collagen mRNA, and hepatocyte function (Figure 1-4). Hepatocytes were cultured under 
consistent culture medium flow conditions with a collagen overlay to mimic in vivo-like 
condition for hepatocytes, which are not directly exposed to flow [50]. These studies 
demonstrated that the dynamic interplay of the medium flow and collagen type IV 
secreted by hepatocytes plays an important role in the maintenance of primary hepatocyte 
function. During a culture period of two weeks, hepatocytes cultured under flow showed 
better maintenance of hepatocyte function as compared to static cultures without the 
introduction of medium flow. However, these models did not simulate the complex multi-
cellular in vivo microenvironment. 
As examples of perfusion two dimensional co-culture, a flat-plate bioreactor was 
developed in one early study to investigate the effect of medium flow and oxygenation on 
the viability and function of rat hepatocytes co-cultured with fibroblasts [53, 72] (Figure 
1-4). A similar bioreactor with an in-line oxygenator was also generated and used to 
provide physiologic oxygen gradients over a period of five days, producing an in vitro 
model of liver zonation [52]. It is important to note that these two bioreactor systems 
were based on a mixed co-culture of hepatocytes and fibroblasts, and did not result in 
successful long-term culture of the hepatocytes. 
 
1.2.3.2.4. Perfusion-3D-monoculture vs co-culture 
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The three dimensional perfusion culture system is a recently developed microfluidic 
culture model with a better bio-mimetic system compared to conventional culture system 
such as a static two dimensional culture. Recently, various perfusion three dimensional 
culture models that mimic in vivo conditions better have been presented.   
Among them, some perfusion three dimensional monocultures were used in the 
development of bio-artificial liver systems. Wurm et al. demonstrated a bio-artificial liver 
support that is a stand-alone, perfused, rotary cell culture system [45]. Human 
hepatocytes cultured in a perfused rotary culture system aggregated into a three 
dimensional shape on microbeads and maintained liver-specific functions for 12 days. 
Similarly, the bio-artificial liver system that is a bioreactor with stacked sandwich culture 
plates was demonstrated by Xia et al. [73]. This system had an effective mass exchange 
by increasing cell-fluid contact area through serial flow perfusion in a bioreactor and 
minimized the shear stress exerted on cells by flow. PRHs cultured in the bio-artificial 
liver system retained liver-specific functions for 7 days. Also, Meng et al. demonstrated 
bio-artificial livers that consist of three polysulfone, hollow-fiber cartridges including 
membranes with different pore sizes [74]. PRHs entrapped in a micro-filtration cartridge 
with the membrane pore retained higher liver-specific function compared to the control 
cartridge for 5 days. Sun et al. reported the culture of the microencapsulated primary rat 
hepatocyte in a bio-artificial liver-assisted device [75]. The PRHs encapsulated in 
ultrathin shell microcapsules using an electrostatic droplet generator showed higher 
differentiated functions than cells cultured in monolayer for 3 days. Jeffries et al. 
presented a fluidized-bed bioreactor for a bio-artificial liver encapsulation type [76]. 
Viability and metabolism as a function of time and oxygen concentration of PRHs 
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encapsulated in alginate and cultured in perfusion were analyzed for 24 hours. A range of 
oxygen concentrations for viable cultures was determined from 35% to 95% oxygen 
concentration for the duration of the experiment in the bio-artificial liver.  
Another type of perfusion three dimensional monoculture is a microfluidic device 
using three dimensional scaffolds. Ostrovidov et al. presented the microfabricated PDMS 
membrane as a scaffold to attach cells [77]. PRHs cultured in microbioreactors containing 
a PDMS membrane that mimics the in vivo liver architecture showed good cell 
attachment, cell reorganization, and improved liver-specific function for 15 days under 
perfusion condition. Mao et al. presented the integrated microfluidic device for cell 
culture, metabolite analysis, and cytotoxicity assay [78]. Microchannels contained poly 
ethylene glycol (PEG) hydrogel encapsulated human liver microsomes (Figure 1-5). This 
integrated microfluidic device coupled with ESI-Q-TOF MS simulates drug metabolism 
in human liver and toxicity in HepG 2 cells. Also, it was used to study metabolism of 
acetaminophen and the cytotoxicity of products on HepG2 cells.  
 
Figure 1-5. Microfluidic device for cell culture, metabolite analysis and cytotoxicity 
assay [78]. 
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Similarly, Ma et al. developed an integrated microfluidic device that involved a cell 
culture chamber array and a sol-gel human liver microsome bioreactor array [79]. HepG 
2 cells were cultured in a perforated microwell array containing human liver microsome 
in a sol-gel bioreactor. The metabolism based drug-drug interaction between 
acetaminophen and phenytoin increased the cytotoxicity of HepG 2 for 24 hour in the 
device. Furthermore, Zhang et al. presented a three dimensional-microfluidic cell culture 
system (3D-µFCCSs) that is based on a microfluidic channel with culture methods 
including encapsulation of cells by gelatin microspheres carriers [80]. PRHs encapsulated 
by a layer of in situ formed matrix in 3D-µFCCSs retained higher cell-specific function 
and Phase I/II enzymatic activities for 7 days. Powers et al. presented a three dimensional 
micro-array. PRHs that were aggregated to form tissue-like structure under perfusion 
media flow in the three-dimensional scaffolds retained liver-specific function up to 14 
days (Figure 1-4)  [35].  
Microfluidic device using three dimensional microstructures were presented by Goral 
et al. Primary human hepatocytes were cultured in a microfluidic device with the micro-
patterned and micro-structured supports. Although the microfluidic platform promotes 
the 3-D organization of hepatocytes into cord-like structures, hepatocytes monocultured 
in a microfluidic device were not maintained for over one week [81]. Toh et al. developed 
a microfluidic channel based system that includes an array of micro-pillars (Figure 1-6) 
[54]. Three dimensional cell to cell interaction and cell-matrix interactions in three 
dimensional perfusion culture were supported by a polyelectrolyte complex coacervation 
process to form a thin layer of matrix. Primary hepatocytes in the microfluidic channel 
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were cultured for 7 days with maintenance of three dimensional cyto-architecture and 
cell-specific function. In addition, Toh et al. developed the three dimensional Hepa-Tox-
chip as a modular system that consists of a multiplexed cell culture chip with 8 parallel 
single channel coupled to a linear concentration gradient generator [82]. Hepatocytes 
cultured in multiplexed microfluidic channel with a three dimensional microenvironment 
maintained hepatocyte synthetic and metabolic functions for 3 days. 
 
 
Figure 1-6. Three dimensional perfusion culture system - HepaTox Chip [82]. 
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A microfluidic device based pure chitosan-based microfiber system was developed by 
Lee et al. [83]. HepG 2 cells cultured on the chitosan microfibers in microfluidic device 
were self-aggregated, forming spheroids. Hepatocytes retained improved liver-specific 
function for 5 days. Chao et al. presented the patented HmREL microfluidic device that 
consists of multiple compartments with physiological architectures and perfusion system 
(Figure 1-7) [84]. The functionality, utility and hepatic clearance for reference 
compounds of the HmREL device culturing cryopreserved human hepatocytes for 24 
hours were verified.  
 
 
Figure 1-7. Three dimensional perfusion culture system. The complete setup of a 
HmREL1 prototype instrument [84]. 
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Some examples of perfusion three dimensional co-culture were achieved in the 
microfluidic systems using hollow fibers or bed bioreactors. Zeilinger et al. presented a 
three-dimensional multicompartment hollow fiber bioreactor that is an in vitro culture 
model for pharmaceutical research on human liver functions [56]. Primary human liver 
cells cultured with non-parenchymal cells in the bioreactor formed tissue-like structures 
and retained liver-specific function for 14 days. Similarly, Yang et al. presented a 
fluidized bed bioreactor for a bio-artificial liver [85]. Hepatoma-derived C3A cells were 
encapsulated in alginate microspheres and co-cultured with human placental 
mesenchymal stem cells under perfusion condition in this system. Cells showed improved 
liver-specific function and cytochrome activities in this system.  
In other studies, Schütte et al. developed a microfluidic test system that is a 
microfluidic cell culture chamber with integrated electrodes for the assembly of liver 
sinusoids by dielectrophoresis [86]. This test system was based on an organ-like liver 
three dimensional co-culture of primary human hepatocytes and endothelial cells. Novik 
et al. developed an integrated, microfluidic, in vitro platform that is a hepatic co-culture 
system in the patented HµREL micro-device [87]. Co-culture perfusion systems of 
primary human hepatocytes and non-parenchymal cells supported higher metabolite 
production rate of cells than static systems.  
 Another study in a bioreactor that facilitated the formation of three-dimensional 
hepatocellular aggregates was also reported; PRHs co-cultured with LSECs under 
continuous perfusion in this bioreactor were viable for one week [57]. Similarly, Hwa et 
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al. presented a co-culture of PRHs and LSECs in a three dimensional culture system that 
provides controlled microscale perfusion through the tissue mass [58]. The structure of 
the three-dimensional aggregate in this bioreactor, however, was a randomized cellular 
mass and not comparable to the organized sinusoidal structure of the liver in vivo.  
Most recently, an organotypic microfluidic liver model to mimic the liver sinusoid 
was presented. Primary human hepatocytes were multi-cultured with immortalized non-
parenchymal cells in a microfluidic dual-channel and maintained liver-specific function 
for four weeks [88]. However, this model did not accurately recapitulate the liver 
sinusoid because several hundred µm gap between hepatocytes and endothelial cell layer 
exists.   
While microfabrication and microfluidics have great potential to create more in vivo-
like liver models, there still remains a need to improve hepatocyte longevity and function 
in co-culture with liver relevant endothelial cells in microfluidic devices [41, 89]. 
 
1.2.4. The proposed liver model 
 One of the ways to achieve the in vitro liver model would be to mimic the in vivo 
liver sinusoid architecture, the most basic functional unit of the liver (Figure 1-1). The 
liver sinusoid is a capillary lined by LSECs. Stellate cells that help to maintain the 
extracellular matrix and Kupffer cells, which are liver macrophages, are also present. 
There is a small space called the Space of Disse that separates LSECs from hepatocytes. 
Bile canaliculi are small channels that form between adjacent hepatocytes. Hepatocytes 
secrete bile that is collected in bile ducts and transported to the intestines or stored in the 
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gall bladder [1, 90-92]. Thus, our liver model system mimics the layered organization of 
the liver sinusoid, and hepatocytes are able to maintain their functions and differentiation 
status for a long term. To mimic the in vivo liver sinusoid, three different configurations 
were tested (Figure 1-8) [93]. The first configuration was the simplest design where 
hepatocytes and endothelial cells were co-cultured in a culture platform; a thin layer of 
matrigel was placed between hepatocytes and endothelial cells to mimic the Space of 
Disse. In the second configuration, the cells were co-cultured similar to the first 
configuration on a microporous membrane (0.4 μm pore size). This configuration was 
designed so that the bile can be removed at the bottom of the channel. In case that it 
would be difficult to achieve completely visualized separated LSECs and PRHs in 
configurations 1 and 2, a third configuration is investigated in which LSECs and PRHs 
were cultured on the opposite sides of a microporous membrane. 
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Figure 1-8. Microfluidic platform configurations that mimic the liver sinusoid (a) and 
schematic diagram of microfluidic cell culture platforms for mini-liver bioreactor (b). (c) 
Continuous perfusion system. 
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In order to achieve the three configurations proposed as our in vitro liver model, we 
executed a stepwise study from a macroscale culture system to a microfluidic culture 
system. First, we cultured primary hepatocytes and endothelial cells on the commercial 6-
well or 6-transwell tissue culture dishes. Second, we transferred the successful layered 
co-culture configurations of the transwell system to microfluidic platforms with the goal 
to accurately mimic the fundamental architecture of the liver sinusoid, where most liver 
activities take place (Figure 1-9). The layered co-culture of PRHs and endothelial cells 
were performed in a single and a dual microchannel system under static condition 
without flow introduction or under continuous perfusion. Based on the experimental data 
of the liver on a chip using rat, we applied primary human hepatocytes to the liver on a 
chip and demonstrated the utility of the liver model for liver disease.   
 
Figure 1-9. Approach to develop the in vitro liver model. 
1st step 
Static co-culture 
using 6-well and 6-
transwell 
3rd step 
Dynamic co-
culture using  
microfluidic 
channel 
2nd step 
Static co-culture 
using 
microchannel 
Layered co-culture of primary hepatocytes and endothelial cells  
(Test: morphology, viability, function, and differentiation) 
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Recently, we made an interesting observation that cells cultured on the bottom of a 
transwell membrane (‘hanging’ configuration) maintain their viability and morphology 
for a longer period of time compared to the cells cultured on top of a membrane (normal 
configuration). Thus, hanging configuration for primary hepatocytes only was proposed 
as one configuration of our in vitro liver models. It remains to be investigated if indeed 
hanging culture configuration can support a long-term primary liver-cell culture.  
We believe that our liver model can serve as an accurate, long-term liver model for 
fundamental liver biology studies, liver disease research, toxicology studies and drug 
screening applications.  
 
1.3. Objective and specific aims 
The objective of this study was to develop an authentic human in vitro liver model 
that closely mimics the human liver sinusoidal unit, the location of most liver activities. 
A key component of our liver model is a long term layered co-culture of primary 
hepatocytes and endothelial cells that enables hepatocytes to maintain their phenotypes 
and function long term. The potential applications of our liver model are to be used for 
fundamental liver biology studies, liver disease research, toxicology studies, and drug 
screening. In order to achieve the research objective, specific aims were listed as below; 
 
1.3.1. A layered long term co-culture on a transwell membrane 
The first goal was to generate an in vitro liver model system using commercial 
standard 6-well and 6-transwell tissue culture plates under static condition. For this goal, 
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primary liver cells were co-cultured with endothelial cells on the 6-well and 6-transwell 
plates under static condition and we verified whether the cultured liver cells retained the 
phenotypes and functions like in vivo by investigating cell morphology, liver-specific 
functions and liver de-differentiation. 
 
1.3.2. The rat liver sinusoid on a chip 
The second goal was to develop the liver sinusoid on a chip using a PDMS 
microfluidic platform. To achieve this goal, we co-cultured PRHs and endothelial cells in 
both single microchannel and dual microchannel that are fabricated using 
microfabrication and microfluidic technologies. We investigated whether primary rat 
liver cells cultured in the microchannel under static or perfusion condition retain the 
phenotypes and functions like in vivo.  
 
1.3.3. The human liver model for HBV replication study 
The third goal was to develop the human liver on a chip using a dual microfluidic 
channel to mimic the liver sinusoid based on the reliable results obtained from the rat 
liver sinusoid on a chip. However, to develop the human liver sinusoid on a chip depends 
on availability of the primary human hepatocytes. The developed human liver model will 
provide us an effective platform for HBV replication study with primary hepatocytes. 
Hepatocytes are the predominant target of HBV infections, a major cause of liver cancer. 
Thus, once our liver sinusoid model has been developed, we demonstrated the utility of 
our human liver model via HBV replication study.   
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1.3.4. The hanging culture system for primary hepatocytes only culture 
The fourth goal is to investigate if indeed hanging culture configuration of 
primary hepatocytes only can support a long-term primary liver-cell culture. In order to 
achieve this goal, we have compared hanging culture and normal culture for up to 30 
days in terms of cell morphology and function. Furthermore, we investigated the factors 
that play critical roles in the long term maintenance of cell phenotype and function in the 
hanging monoculture of primary hepatocytes.   
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CHAPTER 2. ENGINEERING THE LIVER SINUSOID USING A TRANSWELL 
MEMBRANE 
 
2.1. Introduction 
This chapter presents a novel in vitro liver model system using commercial standard 
6-well and 6-transwell tissue culture plates under static condition. Our liver model system 
mimics the layered organization of the liver sinusoid, and hepatocytes were able to 
maintain their functions and differentiation status for at least 57 days. Three different 
configurations were investigated (Figure 2-1)[94]. The first configuration is the simplest 
design where hepatocytes and endothelial cells are co-cultured in a 6-well plate; a thin 
layer of matrigel was placed between hepatocytes and endothelial cells to mimic the 
Space of Disse (Figure 2-1a). In the second configuration, the cells were co-cultured 
similar to the first configuration on a 6-transwell membrane (24 mm diameter, 0.4 μm 
pore size) (Figure 2-1b). This configuration was designed so that the bile can be removed 
at the bottom of the 6-transwell. It was difficult to achieve completely visualize separated 
LSECs and PRHs in configurations 1 and 2. Therefore, a third configuration was 
investigated in which LSECs and PRHs were cultured on the opposite sides of a 6-
transwell membrane (24 mm diameter, 0.4 μm pore size) (Figure 2-1c).In this 
configuration, a microporous transwell membrane was used to mimic the Space of Disse. 
Configuration 3 of our liver model facilitated the layered long-term co-culture of PRHs 
and endothelial cells on the 6-transwell membrane. We believe that our liver model 
presented in this chapter can serve as an accurate, long-term liver model for fundamental 
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liver biology studies, liver disease research, toxicology studies, and drug screening 
applications.  
 
 
                (a)                       (b)         (c) 
Figure 2-1. Schematic diagram of cell culture platforms to mimic the liver sinusoid. 
 
2.2. Materials and Methods 
2.2.1. Primary liver cell isolation and culture 
PRHs were isolated from 6-12 weeks old Sprague-Dawley rats as previously 
described [95]. Approximately 4x10
5
 cells that were 70–100% viable were seeded on 
0.198 mg/ml collagen-coated 6-well or 6-transwell plates. The 6-transwell had a 
microporous PET membrane of approximately 24 mm diameter, 0.4 μm pore size and 10 
μm thickness (Dow Corning). Dulbecco's Modified Eagle Medium (Cat.No.10-017-CV, 
Cellgro
®
) supplemented with 1mM Na Pyruvate (Cellgro
®
), 4 µg/ml Insulin-Transferrin-
Selenium (ITS, Gibco), 5 µg/ml Hydro cortisone (HC, Sigma), 5 ng/ml Epidermal growth 
factor (EGF, BD Sciences), 1% penicillin-streptomycin, 10% (vol/vol) Fetal Bovine 
Serum (FBS, Gemini Bioproduct) was used for culturing primary hepatocytes. On the 
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first day after plating hepatocytes, the medium was changed after 2-6 hours. Thereafter 
the medium was changed every 24 hours. 
Primary LSECs were isolated from the suspension of liver cells derived from the liver 
perfusion and hepatocyte isolation after removal of the hepatocytes by differential 
centrifugation, as previously described [58]. Briefly, the supernatant that remained after 
removal of hepatocytes was centrifuged at 350 g for 10 minutes to pellet the non-
parenchymal cells. The pellet was then resuspended in DMEM and added to a 25/50% 
percoll density gradient (Table 2-1), followed by centrifugation at 900 g for 23 min. The 
LSECs accumulated at the interface of the 25% and 50% percoll density gradient and 
were collected. The cells isolated from the first percoll density gradient were then added 
to an identical percoll density gradient and the centrifugation was repeated one more time. 
The purified LSECs at the interface of this 25% and 50% percoll density gradient were 
resuspended in DMEM followed by centrifugation at 350 g for 10 minutes to remove any 
remaining percoll solution. The pellet of purified LSECs was finally resuspended in PRH 
medium and the LSECs were plated. On the first day the medium was changed 2-6 hours 
after plating; thereafter the medium was changed every 24 hours. 
Table 2-1. Preparation of percoll density gradient. 
  
Material 25% 50% 
10x Phosphate Buffered Saline (Cellgro
®
) 0.375 ml 0.375 ml 
Percoll 3.125 ml 6.5 ml 
DMEM 6.5 ml 3.375 ml 
Bovine Calf Serum(BCS)  2.5 ml 2.5 ml 
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2.2.2. Bovine aortic endothelial cell culture 
The Bovine Aortic Endothelial Cells (BAECs) are an established, immortalized, 
endothelial cell line that was a kind gift from Dr. Robert Levy (Children’s Hospital of 
Philadelphia). BAECs were cultured in DMEM supplemented with 10% (vol/vol) FBS 
and 1% (vol/vol) penicillin-streptomycin (Cellgro
®
). Cells were maintained at 37°C in 5% 
CO2, and medium was replaced every 2–3 days.  
 
2.2.3. Medium selection test for co-culture 
The medium selection test for co-culture of PRHs and endothelial cells was done so 
that both cell types can be cultured in the same medium conditions. PRHs were cultured 
on 12-well tissue culture plates (22 mm diameter) in a medium that was made by 
combining PRH medium, LSEC medium and BAEC medium (Table 2-2) in different 
ratios; 1:1 mix of PRH and LSEC media, 1:1 mix of PRH and BAEC media, 1:1 mix of 
LSEC and BAEC media, and 1:1:1 mix of PRH, LSEC and BAEC media. Similarly, the 
same medium conditions were tested for the culture of BAECs. Based on the observed 
retention of cell morphology and the longevity of cell survival (data not shown), a 
modified PRH medium in Table 2-2 was used for co-culture of PRHs, and LSECs or 
BAECs.  
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Table 2-2. Component of different medium for PRHs and endothelial cells 
PRH Medium LSEC Medium 
BAEC 
Medium 
Modified PRH 
Medium 
2 mM Glutamine (Cellgro
®
) 
1 mM Na Pyruvate (Cellgro
®
) 
4 µg/ml  Insulin-Transferrin-
Selenium (ITS, Gibco) 
10 µg/ml Gentamycin (Gibco) 
5 µg/ml Hydro cortisone(HC, 
Sigma) 
5 ng/ml Epidermal growth factor  
(EGF, BD Sciences) 
500 ml Williams E (Gibco) 
2 mM Glutamine 
1 mM Na Pyruvate 
4 µg/ml ITS 
10 µg/ml 
Gentamycin 
5 µg/ml HC 
5 ng/ml EGF 
500 ml Williams E  
10% FBS 
1%  penicillin-
streptomycin 
 
500ml DMEM 
 
10% FBS 
 
1 mM Na- 
Pyruvate 
4 µg/ml ITS 
5 µg/ml HC 
5 ng/ml EGF 
1% penicillin-
streptomycin 
500 ml DMEM 
10% FBS 
 
 
2.2.4. Re-plating of primary liver cells 
 PRHs and LSECs were isolated and purified on the same day; after plating, these 
cells typically require 24-48 hours to form confluent monolayers. Because we wanted to 
plate the second cell-type only when the first cell-type has formed a confluent monolayer 
in configuration 1 and 2, we could not plate both the cell types on the same day. 
Moreover primary cells can be difficult to re-plate; there is significant cell death during 
re-plating resulting in low confluence of re-plated cells. To circumvent this issue, we 
plated one cell type in 6-well tissue culture plate or 6-transwell on day 1, and other cell 
type was plated on 10 cm tissue culture plate. After the first cell-type formed a confluent 
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monolayer in the 6-well tissue culture plate or 6-transwell, we re-plated the second cell 
type from the 10 cm plate to the 6-well tissue culture plate or 6-transwell. Since we re-
plated the cells from a much larger plate to a smaller plate, we were able to salvage 
enough cells to form a confluent monolayer. Re-plating of PRHs worked better than re-
plating of LSECs (our unpublished observations). 
 
2.2.5. Layered co-culture of PRHs and endothelial cells 
To create a layered co-culture of PRHs and LSECs/BAECs in configurations 1 and 2, 
PRHs were first plated in collagen-coated 6-well tissue culture plates or 6-transwell tissue 
culture plates and allowed to adhere. 30% (v/v) growth factor reduced matrigel (BD 
Biosciences), which was mixed with PRH culture medium, was layered on top of PRHs. 
2 hours after matrigel coating, endothelial cells were plated on top of the matrigel to 
create a co-culture of PRHs and endothelial cells that was separated by matrigel. Cells 
were incubated at 37°C in 5% CO2. 
 For a layered co-culture of PRHs with LSECs or BAECs in configuration 3, both 
sides of a 6-transwell membrane were first coated with rat-tail collagen. The microporous 
membrane of a second 6-transwell was then removed by cutting it out. The two 6-
transwells were then attached together using poly-parafilm (ThermoFisher) so that both 
of the 6-transwells shared a common membrane (Figure2-2). We first cultured PRHs on 
the bottom side of the first 6-transwell membrane for a minimum of 3 hours to allow the 
cells to attach to the membrane. After attachment of PRHs, the second 6-transwell was 
removed, and the first 6-transwell was put in a 6-well plate that contained a 1 mm thick 
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supporting ring to increase the gap between the first 6-transwell and 6-well plate. The 
PRH-plated side of the membrane now faced down, and the increased gap provided by 
the support ring reduced the possibility that the PRH layer would be damaged by the 6-
transwell membrane and 6-well plate. Endothelial cells were then plated on the topside of 
the 6-transwell membrane to generate the layered co-culture of PRHs and endothelial 
cells separated by the transwell membrane. Alternatively, we plated the endothelial cells 
first and the PRHs second in configuration 3 using the same procedure. To visualize 
BAECs in the layered co-culture, BAECs were infected with a GFP-expressing lentivirus 
followed by puromycin selection to generate a BAEC cell line that stably expressed GFP 
as previously described [96].  
 
Figure 2-2. Conceptual diagram of co-culture structure of hepatocytes and endothelial 
cells in configuration 3. 
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2.2.6. RNA isolation, reverse transcription and PCR analysis 
Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect 
hepatocyte-specific mRNA transcripts in cultured PRHs [95]. The long-term co-cultured 
PRHs were collected from the plate with a plastic scraper. Total RNA was isolated from 
PRHs using TRIzol reagent (Invitrogen, Life Technologies, USA) according to the 
manufacturer’s directions. Total RNA was then treated with DNase (RQ1 RNase-Free 
DNase, Promega, USA) and incubated at 65°C for 30 min to remove any DNA 
contamination. The reverse transcription (RT) of total RNA was done with M-MuLV 
reverse transcriptase (New England BioLabs Inc.) according to the manufacturer’s 
instructions. The cDNA generated by RT was then amplified by PCR using specific 
primers [95]. Hepatocyte nuclear factor 4 (HNF-4), transferrin (TFN), and albumin (ALB) 
were used as hepatocyte specific markers; the primers that were used are listed in Table 
2-3. 
PCR was performed in a programmable thermal cycler (Eppendorf) with the 
following amplification profile: 30 sec at 94°C followed by 30 cycles at 94°C for 30 sec, 
61°C for 45 sec and 72°C for 1 min. The samples amplified by PCR were visualized on a 
1.0% agarose gel containing 0.001 mg/ml ethidium bromide.  
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Table 2-3. Hepatocyte gene-specific primers sequences for PCR [94]. 
 
a
 previous designed primer of HNF-4 [95]. 
b
 newly designed primer of HNF-4. 
 
2.2.7. Urea synthesis assay 
Hepatocyte functions were evaluated by monitoring urea synthesis [34, 41]. Medium 
samples from the layered co-cultures were collected every two days and stored at -80°C 
until assayed. Urea concentration in the media was determined by a colorimetric endpoint 
assay utilizing diacetylmonoxime (Urea Nitrogen (BUN), Stanbio Labs), according to the 
manufacturer’s instructions. This reaction involves acid catalyzed condensation of urea 
with diacetylmonoxime in the presence of thiosemicarbazide to give a red-purple color 
Primer Sequence (5 '  3 ' ) Size (bp) Cycle 
ALB AAAGCACTGGTCGGAGCTGTCCG 
TCGCTGGCTCATACGAGCTACTGC 
105 30 
HNF-4
a
 CGGGCCACTGGCAAACAC 
GTAATCCTCCAGGCTCACC 
770 30 
HNF-4
b
 
 
AGTGCTGCCTTGGACCCAGCCT 
GGCACACAGGGCACTGACACCC 
138 30 
TFN TTACGGGTGCCCCCAAGGATGGAC 
ATTTCACTGGCGCGCTGTCGATGG 
121 30 
β-actin GTCCACACCCGCCACCAGTT 
GGCCCACGATGGAGGGGAAG 
133 30 
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that can be measured by spectrophotometer at 520 nm. The urea concentration was 
normalized for expression as µg/ml/day.  
 
2.2.8. Western blot analysis for CYP2E1 expression 
Total protein from co-cultured hepatocytes was isolated from the interphase of the 
phenol-chloroform layer left after the RNA isolation using TRIzol reagent (Invitrogen, 
Life Technologies, USA) according to the manufacturer’s directions. When proteins were 
not collected after RNA isolation; cells were scraped in Phosphate Buffered Saline (PBS) 
and were lysed in 0.8% Sodium Dodecyl Sulfate (SDS) buffer (0.8% SDS, 240mM Tris 
pH 6.8, 10% glycerol). Protein samples were loaded into a 10% sodium dodecyl sulfate 
(SDS)-polyacrylamide gel and run at 100 V. The proteins were then transferred onto a 
nitrocellulose membrane (Bio-Rad Laboratories, Munich, Germany) at 100 V for 1 hr. 
The membrane was blocked with 5% nonfat milk in TBST (w/v), and was incubated 
overnight at 4°C with a rabbit anti-CYP2E1 polyclonal antibody (1:1000 dilution 
ABCam). The membrane was then washed three times with TBST and incubated with 
IRDye
®
 800 CW conjugated, goat anti-rabbit (1:5000, Li-COR) secondary antibody at 
room temperature for 1 hr. The protein CYP2E1 was detected by Odyssey Infrared 
Imaging System. For GAPDH detection, membranes were stripped with 0.2 N NaOH, 
blocked with 5% milk, and then incubated with a GAPDH (14C10) rabbit monoclonal 
antibody (1:5000, Cell signaling technology
®
) at room temperature for 2 hrs. The 
membrane was then washed three times with TBST and was incubated with IRDye
®
 800 
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CW conjugated goat anti-rabbit (1:5000, Li-COR) secondary antibody for 1 hr. GAPDH 
levels were assessed with the Odyssey Infrared Imaging Systems. 
 
2.2.9. Cytoskeleton staining 
Actin filaments in PRHs and BAECs co-cultured on the opposite side of 6-transwell 
membrane were stained with Rhodamine phalloidin (Cytoskeleton, Inc.) according to the 
manufacturer’s instructions. Nuclear staining for the same set of cells was performed by 
use of DNA staining with DAPI. Samples were observed by a fluorescent confocal 
microscopy (Leica microsystems).  
 
2.3. Results and Discussion 
2.3.1. PRHs or endothelial cells only culture 
PRHs that were plated on 6-well tissue culture plates and 6-transwells tissue culture 
plates formed confluent monolayers within three days of plating. The adhesion, 
morphology, viability, and differentiation of hepatocytes on 6-transwell plates with a 
microporous membrane were similar to those of hepatocytes on 6-well tissue culture plate 
(Figure2-3a, 3b). This result showed that the polyester membrane substrate with 0.4 µm 
pores in 6-transwell was suitable for hepatocyte adhesion and survival. However, PRHs 
plated on 6-transwell did not maintain their viability for more than 11 days; similar 
results were observed with PRHs that were plated on 6-well tissue culture plates 
(Figure2-3c and 3d). These data are consistent with previous published reports that show 
that hepatocytes do not survive more than 7 days when cultured in the absence of other 
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cells [12, 20, 35, 97, 98]. LSECs were also plated in 6-well tissue culture plates (or tissue 
culture plates with 54 mm diameter) and 6-transwell plates; LSECs formed a monolayer 
on both plates but did not survive beyond day 7 (Figure 2-3e, 3f, 3g, and 3h).  
BAEC, an immortalized endothelial cell line, formed a confluent monolayer on 6-
well tissue culture plates and also in 6-transwell plates; these cells remained viable up to 
55 days (data not shown). These results demonstrate that while PRHs and LSECs can be 
cultured in 6-transwell plates, they do not survive long in the absence of other cells in 
contrast to an established cell line such as BAEC. 
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(a) (b) 
  
(c) (d) 
  
(e) (f) 
  
(g) (h) 
Figure 2-3. Phase-contrast micrographs of PRHs and LSECs single culture (a) 
hepatocytes on 6-well at day 2. (b) hepatocytes on 6-transwell at day 1. (c) hepatocytes 
on 6-well at day 7. (d) hepatocytes on 6-transwell at day 11. (e) LSECs on tissue culture 
plate (54mm diameter) at day 2. (f) LSECs on 6-transwell at day 1. (g) LSECs on tissue 
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culture plate (54mm diameter) at day 7. (h) LSECs on 6-transwell at day 7. PRHs and 
LSECs isolated from a different rat at a different day were used in a culture. 
 
2.3.2. PRHs and endothelial cells co-cultured in configuration 1. 
In the first configuration, a layered co-culture of PRHs with BAECs separated by 
matrigel was created on a 6-well tissue culture plate as described in Materials and 
Methods. Figure 2-4a shows a phase-contrast micrograph (10X magnification) at day 2 of 
PRHs and BAECs co-cultured on a 6-well tissue culture plate. In this representative 
picture of the co-culture, PRHs were plated at the bottom of the plate, were layered with 
matrigel, and then BAECs were plated on top of the matrigel layer. In order to investigate 
whether the order of cell layering can affect the viability and morphology of PRHs, PRHs 
were also plated on top of the EC layer. Figure 2-4b shows the layered co-culture of 
PRHs and BAECs cells in configuration 1 at day 3, except that the BAECs were plated at 
the bottom of the plate and PRHs on top of the matrigel. The change in order of plating 
PRHs and endothelial cells did not alter the viability or morphology of PRHs. PRHs in 
configuration 1 retained their normal morphology and were viable for 3 days; however, in 
this configuration it was difficult to observe whether a homogenous layer of matrigel was 
formed between the PRHs and BAECs and PRHs did not always maintain a confluent 
monolayer.  
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(a) (b) 
Figure 2-4. Phase-contrast micrographs of co-culture of hepatocytes and BAECs on 6-
well in configuration 1. (a) BAECs were layered on matrigel, which was placed on PRHs 
layer in 6-well (image at day 2 of co-culture). (b) BAECs were laid on 6-well plate first, 
followed by matrigel coating and hepatocyte culture (image at day 3 of co-culture). 
 
2.3.3. PRHs and endothelial cells co-cultured in configuration 2 
In configuration 2, a 6-transwell plate was used to form a layered co-culture of PRHs 
with BAECs so that secretion (e.g. bile) from hepatocytes could be removed from PRHs. 
PRHs were first plated on the microporous membrane of a 6-transwell plate and then a 
layer of matrigel was coated on the hepatocyte layer, followed by plating BAECs on the 
matrigel. The cells retained normal morphology and viability for 3 days. Figure 2-5a 
shows a phase-contrast micrograph (10X magnification) of co-culture of PRHs and 
BAECs on a 6-transwell in configuration 2 at day 1. The cells in configuration 2 were 
also plated in the reverse order such that BAECs were plated at the bottom of 6-transwell 
and PRHs formed the layer on top of the matrigel. As shown in Figure 2-5b, changing the 
order of plating the cells did not affect the morphology or viability of the cells. Similar to 
configuration 1, it was difficult to tell whether the monolayer formed by matrigel was of 
uniform thickness and whether the two cell types were completely separated into two 
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monolayers. It was observed at some locations that the endothelial cells plated on top of 
the matrigel invaded through the matrigel into the PRHs layer. 
 
  
(a) (b) 
Figure 2-5. Phase-contrast micrographs of co-culture of hepatocytes and BAECs on 6-
transwell in configuration 2. (a) BAECs were layered on matrigel, which was placed on 
PRHs layer in 6-transwell (image at day 1 of co-culture). (b) PRHs were layered on 
matrigel, which was placed on BAECs layer in 6-transwell (image at day 2 of co-culture). 
 
2.3.4. PRHs and endothelial cells co-culture in configuration 3 
To overcome the limitations of configuration 1 and 2, we designed and generated 
configuration 3. In this configuration, the hepatocytes and endothelial cells were cultured 
on opposite sides of the microporous membrane of a 6-transwell, as described in 
Materials and Methods. Long-term co-culture of PRHs and BAECs was successfully 
achieved using this configuration. To monitor the viability of BAECs, we generated a 
BAEC cell line that constitutively expressed GFP, and plated these in configuration 3; 
expression of GFP is indicative of cell survival. PRHs in configuration 3 retained their 
normal morphology and were viable for 57 days. Figure 2-6a is a representative picture 
of PRHs at day 15 in co-culture, and Figure 2-6b is a representative picture at day 38 of 
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the co-culture in configuration 3. For Figures 2-6a and 6b, BAECs were plated on top of 
the microporous membrane, and PRHs were plated at the bottom of the membrane. The 
morphology of PRHs at day 15 and day 38 was similar, and the cells formed a confluent 
monolayer in the long-term co-culture (Fig. 2-6a and 6b). We also observed the 
formation of certain structures between hepatocytes that resemble bile canaliculi (Fig. 2-
6a and6b). The formation of bile canaliculi may be important for PRHs to maintain 
morphology and function for a long period and may also be related to hepatocytes 
polarization.  Figure 2-6c shows the morphology of BAEC cells at day 5 in a 6-transwell 
single culture. As evident from Figure 2-6a and 6c, the morphology of BAECs and PRHs 
is distinct. In order to monitor BAEC cells in co-culture, we utilized GFP-expressing 
BAECs. Figure 2-6d shows BAEC cells (circled) in the co-culture system. While green 
fluorescence can be observed (Fig. 2-6f), no fluorescence was observed when these cells 
were visualized using the red filter (Fig. 2-6e). These results demonstrate that both cell 
types are viable in the long-term co-culture configuration 3 system.  
We next co-cultured PRHs and LSECs in configuration 3. PRHs were plated at the 
bottom of the microporous membrane of a 6-transwell, and LSECs were plated on the top 
side of the microporous membrane. PRHs retained their normal morphology and 
remained viable for 39 days; Figure 2-6g is a representative picture of PRHs at day 21 of 
the co-culture with LSECs.  Overall, these results demonstrate that the configuration 3 is 
better than the configurations 1 and 2 for a long-term layered co-culture of hepatocytes 
and endothelial cells.  
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(a) (b) 
  
(c) (d) 
  
(e) (f) 
 
 
(g)  
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Figure 2-6. Phase-contrast micrographs of co-culture of PRHs and BAECs/LSECs on 6-
transwell in configuration 3. Comparison of PRHs morphology (a) at D15 and (b) at D38 
of co-culture of PRHs on the bottom of membrane and BAECs on the top of membrane. 
Arrow indicates potential bile canaliculi. (c) BAECs single culture on the 6-transwell at 
day 5. (d) Long term co-culture of PRHs on the bottom of the membrane and BAECs 
with ad-GFP on the top of membrane at day 40. (e) Micrograph of red fluorescent field of 
(d). (f) GFP micrograph of (d). (g) LSECs were layered on top of the membrane and 
PRHs were placed on the bottom of membrane in transwell after 21 days of co-culture. 
 
2.3.5. Structural and design comparison of configurations 1, 2 and 3 
In order to mimic the layered organization of the liver sinusoid, three configurations 
were designed and tested (Figure 2-1). From the experimental results reported here, it 
seems that configuration 3 is a better system than configurations 1 and 2 for the layered 
long-term co-culture of PRHs and endothelial cells. Although the matrigel layer in 
configurations 1 and 2 mimics the Space of Disse in the liver more closely than the 
microporous membrane used in configuration 3, the matrigel layer use in configurations 1 
and 2 had critical limitations. One critical limitation that precluded use of these 
configurations and matrigel was the persistent difficulty in completely separating the cell 
monolayers; this may be due to non-uniform coating of matrigel that is spread on the cell 
layer. Cells placed on the matrigel layer were able to invade into the bottom cell layer in 
configurations 1 and 2. On the other hand, a stiff microporous membrane efficiently 
separated the hepatocyte and endothelial cell layers in configuration 3. Although not 
entirely reminiscent of the Space of Disse, the complete separation of the cell monolayers 
enabled to create a stable layered co-culture model and also facilitated isolation of either 
hepatocytes or endothelial cells from this system for evaluation of cell-specific functions. 
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This configuration also allowed ease in analyzing urea synthesis from medium 
supernatant collected from the channel exposed to hepatocytes.  
A potential advantage to configurations 1 and 2 that would be important if matrigel 
could be used to efficiently separate the two cell types is that the layering of endothelial 
cells directly on top of the hepatocyte could minimize shear stress on the hepatocytes that 
results from medium flow during a medium replacement; in configuration 3, hepatocytes 
are directly exposed to the medium flow. However, mass transport considerations suggest 
that hepatocytes placed on the bottom of the plate in configurations 1 and 2 are limited in 
their exposure to the medium because they are covered by both endothelial cells and 
matrigel.  Growth factors and bile secreted from hepatocytes in configurations 1 and 2 
may also stagnate around cells, which may be harmful to cell viability. In contrast, the 
exposure of hepatocytes to medium in configuration 3 may allow for more efficient 
exposure to oxygen, nutrients, and growth factors.  Materials secreted from hepatocytes 
in configuration 3 can also be released into the surrounding medium and diluted.  
Direct cell-to-cell contact between PRHs and endothelial cells cannot take place in 
configuration 3 because the two cell types are plated on either side of a membrane that is 
10 µm thick in section 2.3.9. Our data suggests that exchange of secreted factors between 
PRHs and endothelial cells can take place through the microporous membrane, which 
might be important for long-term survival of hepatocytes. 
 
2.3.6. PRHs remain differentiated in long-term co-culture in configuration 3. 
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In vivo, hepatocytes are differentiated cells and one of the problems of culturing these 
cells is that the hepatocytes de-differentiate shortly after plating. To determine whether 
PRHs that were co-cultured with LSECs in configuration 3 remained differentiated, we 
assessed the mRNA expression of the established hepatocyte specific differentiation 
markers albumin (ALB), transferrin (TNF), and hepatocyte nuclear factor 4 (HNF-4) [99]. 
The expression of ALB (105bp), TFN (121bp), and HNF-4 (770bp) mRNA in PRHs that 
were co-cultured with BAECs for 28 days indicated that they remain differentiated 
(Figure 2-7a). Expression of hepatocyte specific differentiation markers in freshly 
isolated, unplated PRHs was used as the control. The expression levels of differentiation 
markers in PRHs that were co-cultured for 28 days was lower as compared to the 
expression levels in freshly isolated PRHs. This decrease in the expression levels of 
differentiation markers as compared to the control was most likely due to the loss of cells 
during cell seeding and long-term co-culture; however, the continued expression of the 
hepatocyte differentiation markers indicate that the hepatocytes remained differentiated 
during the long-term co-culture. 
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(a) 
 
 
(b) 
 
Figure 2-7. Confirmation of PRH differentiation on a transwell culture in configuration 3. 
(a) RT-PCR was performed after total RNA isolation from freshly isolated PRH and PRH 
co-cultured for 28days (PRHs on the bottom of membrane and BAECs on the top of 
membrane) to check mRNA expression of the liver-specific differentiation markers; 
ALB(105bp), TFN(121bp), HNF-4(770bp) and β-actin (133bp). Fresh PRHs and PRHs in 
* 
* 
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co-culture were isolated from a same rat at a same day. Asterisk * indicates likely 
detection of alternatively spliced HNF-4 mRNA [100].  (b) RT-PCR was performed on 
PRHs co-cultured for 37days (PRHs on the bottom of membrane and LSECs on the top 
of membrane) and 45days (PRHs on the top of membrane and LSECs on the bottom of 
membrane) to check mRNA expression of the liver-specific differentiation markers; 
(ALB (105bp), TFN (121bp), and HNF-4 (138bp). 37 days and 45 days PRHs co-cultures 
were from different rats. 
 
To confirm similar long-term expression of hepatocyte differentiation markers when 
PRHs were plated with LSECs, PRHs were plated on the bottom side of the microporous 
membrane of a 6-transwell and LSECs were plated on the topside as in configuration 3 
followed by analysis of differentiation markers at the indicated times. PRHs were 
harvested at day 37 of the co-culture, and RT-PCR was performed (Figure 2-7b). We 
were able to detect the mRNA of ALB (lane 2), TFN (lane 4) and HNF-4 (lane 7), 
suggesting that the PRHs remain differentiated in long-term co-culture with LSECs in 
configuration 3. Lane 3, 5, 8 represents the control for ALB, TFN, and HNF-4 
respectively; PCR was performed without prior reverse transcription to ensure the 
absence of DNA contamination in the RNA samples.   
Similarly, we plated PRHs on the top side of the microporous membrane of a 6-
transwell and LSECs on the bottom in configuration 3. PRHs were harvested at day 45, 
and RT-PCR was performed (Figure 2-7b).We detected expression of ALB (lane 10), 
TFN (lane 12) and HNF-4 (lane 15) mRNA; lanes 11, 13, 16 represents the controls for 
ALB, TFN, and HNF-4 RT-PCR respectively, where the PCR was done without prior 
reverse transcription. Overall, these results demonstrate that PRHs remain differentiated 
in long-term co-culture with LSECs in configuration 3 irrespective of whether PRHs 
were plated on the tops or bottom of the microporous membrane of the 6-transwell. 
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2.3.7. Functional analysis of PRHs in configuration 3 
To determine whether PRHs retain normal functions in long-term co-culture with 
endothelial cells in configuration 3, urea synthesis by hepatocytes was analyzed. We also 
compared urea synthesis in co-cultures and single cultures. Media of PRHs in co-culture 
or single culture were collected on different days after seeding, and urea synthesis was 
analyzed. Urea synthesis in the single culture was high in the beginning but decreased to 
very low levels by two weeks (Figure 2-8). This was consistent with the fact PRHs in 
single culture were undergoing cell-death (Figure 2-3) and as a result of which urea 
synthesis decreased with time. PRHs that were co-cultured with endothelial cells showed 
lesser urea synthesis in the beginning as compared to single PRHs culture. In our 
experiments, day 1 of co-culture corresponds to day 2 of single culture because co-culture 
was established one day after the single culture when BAECs were plated. Thus, urea 
synthesis by hepatocytes at day 1 of co-culture was lower as compared to day 1 of the 
single culture. However, urea concentration reached steady levels after 1 week and 
remained steady for at least 28 days (Figure 2-8).  
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Figure 2-8. Urea synthesis analysis of hepatocytes. Media from Single culture of PRHs 
(blue line), and from long-term co-culture of PRHs with BAECs in configuration 3 (red 
line), were collected and urea concentration was determined. PRHs used in single culture 
and co-culture were from same rat; all data was normalized and expressed as µg/ml/day. 
 
2.3.8. Expression of CYP2E1 in PRHs maintained in configuration 3. 
The Cytochrome P450, CYP2E1, is an important hepatocyte enzyme that can convert 
ethanol to acetaldehyde, which is relevant to hepatocyte metabolism of circulating 
xenobiotic [101, 102]. To determine whether PRHs retain CYP2E1 expression when co-
cultured with endothelial cells in configuration 3, we analyzed the expression of CYP2E1 
in PRHs co-cultured with endothelial cells using western blot analysis. CYP2E1 
expression in freshly isolated PRH and in PRHs that were co-cultured with endothelial 
cells for long-term (up to 48 days) was relatively similar (Figure 2-9a,b). PRHs in co-
culture and in single culture were from the same rat and thus could be directly compared. 
Figure 2-9a is a representative Western blot and Figure 2-9b shows the average of three 
independent experiments. All the values were normalized to GAPDH, which was used as 
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a loading control. These results also confirm that the co-cultured PRHs from day 1 to day 
48 remain viable without obvious changes in hepatocyte function. The lower levels of 
GAPDH at later time points coincided with an observed slight increase in hepatocyte 
death at later times of cell collection. 
 
 
(a) 
 
(b) 
Figure 2-9. CYP2E1 protein expression in PRHs co-cultured with BAECs in 
configuration 3. (a) Representative image of a Western blot analysis of CYP2E1 and 
GAPDH expression in PRHs co-cultured with BAECs. (b) Bar graph showing the 
average CYP2E1 expression, in long-term co-cultured PRHs. The CYP2E1 expression 
was normalized to the GAPDH expression levels and the data represents the average of 
three independent experiments. Error bars represent +/-SEM. 
 
0
0.2
0.4
0.6
0.8
1
1.2
0 1 13 28 35 48
Intensity ratio 
(CYP2E1/GAPDH) 
Day 
 64 
 
 
2.3.9. Investigation of cell-cell interaction in co-culture 
Our results relating to cellular morphology, differentiation, and function 
corresponded to the results from other references that primary hepatocytes maintain their 
viability for a long term with the help of other cell type such as fibroblasts [103]. Our co-
culture system was much better than hepatocytes only culture. One of reasons why 
primary hepatocytes co-cultured with endothelial cells maintain their morphology and 
function for a long term more than hepatocytes only culture is the influence of cell-cell 
communication on cell function although mechanism has not been clearly understood yet. 
Two cell-cell interactions exist in our co-culture configuration. One is cell-cell direct 
contact that cells extrude through a transwell membrane (10 µm thick and 0.4 µm pore 
size) and contact other cell type directly. The other is cell-cell indirect contact that the 
small molecules secreted from cells pass through the membrane and associate with the 
other cell type.  
Initially, we investigated the effect of the distance between hepatocytes and 
endothelial cells on cell morphology. Hepatocytes were co-cultured with endothelial cells 
in three different configurations with changes in distance between hepatocytes and 
endothelial cells (Figure 2-10). The first configuration had approximately 260 µm 
between the two cell types by co-culturing hepatocytes on the top of membrane and 
endothelial cells on the 6-well plate. The second configuration had approximately 230 
µm between the two cell types by co-culturing hepatocytes on the bottom of membrane 
and endothelial cells on the 6-well plate. The third configuration had approximately 10 
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µm between the two cell types by co-culturing hepatocytes and endothelial cells on the 
opposite side of membrane. Hepatocytes cultured with endothelial cells on the opposite 
side of membrane for 15 days maintained better morphology. Hepatocytes that were 
closer to endothelial cells maintained a better morphology.  
 
 
  
   
(a) (b) (c) 
Figure 2-10. Three different configurations with the difference distance between 
hepatocytes and endothelial cells. (a) Hepatocytes on the top of membrane and 
endothelial cells on the 6-well plate. (b) Hepatocytes on the bottom of membrane and 
endothelial cells on the 6-well plate. (c) Hepatocytes and endothelial cells on the opposite 
side of membrane. 
 
Next, we investigated whether small molecules secreted by PRHs or LSECs pass 
through a membrane with 0.4 µm pore size into the other side during co-culture by 
measuring urea concentration of medium samples taken from both PRHs and BAECs 
compartments. Samples were taken from both sides of the transwell membrane at day 2, 3, 
4, and 6 and urea synthesis was subsequently measured. The urea concentration in the 
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media sample from either side of the co-culture was similar in concentration difference of 
less than 100 µg/ml/day (Figure 2-11), suggesting that small molecules such as urea are 
able to pass through the membrane. These results suggest that exchange of secreted 
factors can take place through the porous membrane, even though PRHs and LSECs are 
not in direct contact, and this exchange of secreted factors help PRHs to survive better in 
long-term co-culture.  
 
 
Figure 2-11. Urea synthesis analysis. Urea concentration of medium samples taken from 
both sides of 6-transwell membrane in co-culture of PRHs and BAECs was measured. 
 
 
 
0
100
200
300
400
500
600
0 2 4 6 8
Urea concentration from PRH on top of membrane
Urea concentration from BAEC on bottom of membrane
Conc. 
(µg/ ml/day) 
Day 
  
 67 
 
 
 
 
Figure 2-12. Actin distribution in PRHs and BAECs stained with Rhodamine phalloidin. 
PRHs on the top of a membrane and BAECs on the bottom of a membrane were co-
cultured and Actin distributions of PRHs and BAECs were observed as movement of a 
microscopy focus using a confocal microscopy at day 12. 
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Furthermore, we investigated whether cells extrude through a membrane and contact 
other cell type directly by staining actin in PRHs and BAECs with Rhodamine phalloidin 
(Figure 2-12). Actin in PRHs and BAECs co-cultured on the opposite side of 6-transwell 
membrane were stained with Rhodamine phalloidin at day 12. The actin structures were 
observed using confocal microscopy. When we focused on hepatocytes on the bottom 
side of a membrane, actin structures of hepatocytes were observed. As the focus of the 
microscope was moved up to membrane, we could observe membrane pores and red 
fluorescence that seems to be actin structures in the pore. When the microscopy focus 
was continuously moved up to other cell type, we observed actin structure of BAECs. 
From these observations, we conclude that cells extrude the micropore of membrane. 
There also is a potential that cell-cell direct contact between PRHs and BAECs may take 
place by passing through a transwell membrane in the co-culture of PRHs and BAECs. 
 
2.4. Conclusions 
We presented a novel liver model that mimics the liver sinusoid and facilitates long-
term culture of PRHs. A key aspect of our current liver model is a layered co-culture of 
PRHs and LSECs or BAECs on a transwell membrane. Three different configurations 
were investigated. In configurations 1 and 2, layered co-culture of PRHs and endothelial 
cells was attempted by introducing a thin matrigel layer between them. However, these 
configurations had critical limitations. In particular, it was difficult to achieve complete 
separation of PRHs and endothelial cells. Other concerns include ineffective removal of 
secretion (e.g. bile) from hepatocytes and limited interaction of cells placed at the bottom 
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with culture media. On the other hand, the use of a stiff microporous membrane instead 
of matrigel in configuration 3 and cell culture on the opposite sides of the microporous 
membranes turned out to be a reliable model. PRHs co-cultured with BAECs or LSECs 
in this configuration retained their morphology and viability for 57 or 39 days with a 
confluent monolayer on the 6-transwell, respectively. We also assessed the presence of 
hepatocyte-specific differentiation markers to verify that PRHs remained differentiated in 
the long-term co-culture and analyzed hepatocyte function by monitoring urea synthesis. 
In addition, the expression of cytochrome P-450 remained similar in the co-cultured 
system from day 1 to day 48. In contrast, PRHs cultured in the absence of endothelial 
cells lost their morphology and viability 4-5 days after plating. Furthermore, endothelial 
cells also retained morphology and viability for a longer period of time compared to 
endothelial cells cultured in the absence of hepatocytes. This demonstrates that 
endothelial cells and hepatocytes have critical roles in influencing the viability and 
function of each other, and thus supports the importance of including both cell types in 
long-term liver model systems. Configuration 3 of our liver model supports the layered 
long-term co-culture of PRHs and endothelial cells, which is difficult to achieve in single 
cultures. This layered long-term co-culture system is a novel liver model that mimics the 
layered organization of the liver sinusoid and can be used as a model for studying 
fundamental liver biology studies, liver disease research, toxicology studies and drug 
screening applications. This novel model system can now be expanded to incorporate 
primary human hepatocytes and develop a novel human liver model system.  
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CHAPTER 3. RAT LIVER SINUSOID ON A CHIP 
 
3.1. Introduction 
In the study described here, we have successfully transferred the layered long-term 
co-culture configurations of the transwell system to microfluidic platforms with the goal 
of mimicking the fundamental architecture of the liver sinusoid (Figure 1-1). In vivo, the 
hepatic sinusoid is a microfluidic system that carries blood from the hepatic artery and 
portal vein, exposing the liver to oxygen and nutrients; this blood supply can also expose 
the liver to toxins and infectious agents [1]. The hepatic sinusoid is lined with LSECs and 
also contains other resident cell types such as Stellate cells and liver-specific 
macrophages. The hepatocytes are separated from LSECs by a small, extracellular-
matrix-protein-enriched, Space of Disse. Bile is secreted from hepatocytes and 
transported to the intestines through bile ducts. Overall, the hepatic sinusoid can be 
considered to be a fundamental unit where most liver activities occur. This paper presents 
a progressional study for creating a liver sinusoid on a chip system. Each step in this 
progression was directed towards testing and optimizing cell culture conditions in 
microfluidic devices with the goal of attaining increasing levels of similarity to an in vivo 
liver sinusoid. To achieve this, we first investigated a single-channel configuration 
(configuration 1) in which a layered co-culture of PRHs and endothelial cells was created 
with a thin matrigel layer added between the two cell layers (Figure 1-8). Next, a dual-
channel configuration (configuration 3) was investigated in which two microchannels 
separated by a porous membrane simulates the sinusoid and a channel to allow removal 
of secreted factors from hepatocytes (Figure 1-8). Finally, the dual-channel configuration 
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(configuration 3) was linked to a continuous flow system. In this dual-channel 
configuration (configuration 3) with continuous perfusion, hepatocytes lasted at least 30 
days, maintaining their polygonal morphology and detectable hepatocyte functions. In 
addition to standard function tests, we also demonstrated that our liver model could be 
used to analyze replication of the HBV, which is dependent on expression of hepatocyte-
specific factors. Although there are limitations to the use of in vitro liver models for 
studying liver biology and drug-induced liver injury, our in vitro liver model still 
represents important progress in the continuing efforts to generate biologically relevant in 
vitro liver model systems. 
 
3.2. Materials and Methods 
3.2.1. Fabrication of microfluidic platforms 
Soft lithography technique was used to make Polydimethylsiloxane (PDMS) 
microchannels. Templates for rectangular microchannels (approximately 15 mm long, 1 
mm wide and 80-160 μm high) were fabricated by photolithography. SU-8 2035 
(Microchem Corporation) was patterned on a 3 inch silicon wafer for this purpose. 
Stereolithography technique was also used for fabricating microchannel templates for 
higher dimension (approximately 15 mm long, 1 mm wide and 200-800 μm high). 
PhotoSilver 100 (EnvisionTEC GmbH) resin and Envision Tec® Perfectory SXGA+ 
Standard UV Stereolithography system were used for this process. Once the 
microchannel templates were fabricated using photolithography or stereolithography, 
PDMS microchannels were made using the replica molding method [38]. 
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To construct the single-channel device, a PDMS channel was bonded to a 10 cm cell 
culture dish after air-plasma treatment (Figure 3-1a). For the dual-channel device, a 
microporous membrane obtained from commercially available transwells was cut down 
to the desired size and placed between two PDMS microchannels. The membrane was 
made of polyethyleneterephthalate (PET) and is about 10 μm thick with a pore size of 
approximately 0.4 μm. The two PDMS channels were then bonded together with the 
microporous membrane in the middle after oxygen-plasma treatment (Figure 3-1b). The 
bonded dual-channel device was then wrapped with Kapton tape (Micronova) to seal the 
device and prevent leakage. Inlets and outlet ports were created during PDMS replica 
molding by implanting silicone tubes or attaching afterward via holes punched into the 
PDMS channel.  
The bottom surface of the microchannel or the PET membrane was coated with 
collagen type I by introducing a collagen solution (0.198 mg/ml) into the microchannel 
followed by spontaneous evaporation. The assembled microchannel device was then 
sterilized under ultraviolet (UV) light (Intensity ~ 20 mJ/cm2) for 30 seconds.  
In order to provide continuous perfusion of culture medium effectively, the dual 
microchannel was connected to a syringe pump, and a flow rate of 30-40 µl/hr was 
applied (Figure 1-8). A 0.2 µm sterile filter was placed upstream of the channel inlets to 
maintain sterile conditions and remove particulates. Flow was applied in counter 
directions in the dual-channel for effective mass transfer and removal of factors secreted 
from the cells. The outlet of the microchannel was connected to a waste bottle with a 
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silicone tube (0.0625” ID x 0.125” OD, Dow corning). Multiple valves were located in 
the middle of the outlet line for sampling the cell-culture medium (Figure 1-8).  
 
 
Figure 3-1. Fabrication of microfluidic cell culture platforms. (a) single channel device 
was made by attaching a PDMS microchannel (15 mm long, 1 mm wide and 80-160 μm 
high) to the tissue culture dish, and (b) dual channel device was made by combining two 
PDMS microchannels (15 mm long, 1 mm wide and 200-800 μm high) with a 
microporous PET membrane in the middle. Digital camera images of the actual devices 
are shown on the right. 
 
3.2.2. Cell isolation and culture  
Top PDMS 
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Primary hepatocytes were isolated from the liver of 6-12 weeks old Sprague-Dawley 
rats as previously described [104, 105]. Approximately 1-2x104 cells with 70-100% 
viability were plated in the collagen-coated microchannel. Dulbecco's Modified Eagle 
Media (DMEM) (Cellgro) supplemented with 1 mM sodium pyruvate (Cellgro), 4 µg/ml 
insulin-transferrin-selenium (ITS, Gibco), 5 µg/ml hydrocortisone (HC, Sigma), 5 ng/ml 
epidermal growth factor (EGF, BD Sciences), 1% penicillin-streptomycin, and 10% 
(vol/vol) fetal bovine serum (FBS, Gemini Bioproducts) was added to the channel. Cells 
were maintained at 37°C in 5% CO2 for cells cultured in static conditions, the medium 
was changed daily [93].  
Primary rat adrenal medullary endothelial cells (RAMECs) were obtained from the 
Drexel Tissue Engineering and Regenerative Medicine Laboratory (courtesy of Dr. Peter 
Lelkes). Isolation and characterization of RAMECs have been previously described [106, 
107]. RAMECs were cultured on collagen-coated tissue culture dishes in Minimal 
Essential Media (MEM) supplemented with 10% fetal bovine serum (FBS), nonessential 
amino acids, 1 mM sodium pyruvate, 2 mM L-glutamine, and 5 μg of gentamicin per ml. 
Cells were maintained at 37°C in 5% CO2 and cell-culture medium was replaced every 2-
3 days. BAECs, which are immortalized, microvascular endothelial cells, were also used 
in co-culture because they are more readily available than primary endothelial cells. 
BAECs were a kind gift from Dr. Robert Levy (Children’s Hospital of Philadelphia) and 
the isolation and characterization of BAECs, including their endothelial cell functions, 
has been previously described [108]. BAECs were cultured in DMEM supplemented with 
10% (vol/vol) FBS and 1% (vol/vol) penicillin-streptomycin (Cellgro) at 37°C in 5% 
CO2 with medium replacement every 2-3 days  as previously described [93]. 
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3.2.3. Layered co-culture of PRHs and endothelial cells 
Both single- and dual-channel configurations were investigated in this study (Figure 
3-1a,b). In the single-channel configuration (configuration 1), PRHs were first plated in 
the collagen-coated microchannel and then incubated 48 hours to allow the cells to 
adhere and form a complete monolayer. After 48 hours, RAMECs suspended in growth 
medium mixed with 30% (v/v) of matrigel (BD Biosciences) were placed on the PRH 
monolayer and incubated at 37°C in 5% CO2. Culture medium was replaced daily.  
For the dual-channel configuration (configuration 3), PRHs were seeded into one 
channel and cultured for a minimum of 4 hours to allow the cells to adhere to the 
microporous membrane and create a confluent monolayer. After the formation of the 
PRH monolayer, the device was flipped over and endothelial cells were then seeded into 
the other channel so that these cells could adhere to the opposite side of the microporous 
membrane. In order to investigate the effect of continuous perfusion, we tested both static 
and flow culture conditions. In the case of static condition, medium was replaced every 
24 hours. For flow culture, the microchannel was connected to a syringe pump, and a 
flow rate of 30-40 µl/hr of fresh PRH medium was applied to both the top and bottom 
channels.  
 
3.2.4. RNA isolation, reverse transcription, and PCR analysis 
In order to confirm the differentiation status and identity of PRHs, reverse 
transcriptase-polymerase chain reaction (RT-PCR) was conducted for cell-type specific 
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markers as previously reported [38, 93]. To isolate total RNA from cultured cells, the 
PDMS microchannel was disassembled, and the PRHs were gently scraped and collected 
from their respective sides of the PET membrane. Total RNA was obtained using TRIzol 
reagent (Life Technologies, USA) according to the manufacturer’s directions.  
Genomic DNA was removed from samples by incubating total RNA with 1 U/μg 
RQ1 RNase-Free DNase (Promega, USA) at 37°C for 30 min followed by incubation at 
65°C for 10 min with stop solution to inactivate the DNase reaction. cDNA was then 
generated by oligo(dT)-primed reverse transcription, followed by PCR for hepatocyte-
specific differentiation markers. Specific primers for hepatocyte nuclear factor 4 (HNF-
4), transferrin (TFN), and albumin (ALB) were used as previously described [38, 93]. 
The expression of hepatocyte-specific genes was normalized to the level of β-actin 
expression. The cycling conditions for PCR amplification were: 30 sec at 94°C, followed 
by 30 cycles at 94°C for 30 sec, 45 sec at the specific annealing temperature for each 
primer set (Table 3-1), and 72°C for 1 min, followed by a final extension at 72°C for 5 
min. Amplified PCR products were analyzed using agarose gel electrophoresis.  
 
3.2.5. Urea synthesis assay 
As one test of retention of hepatocyte functions, we measured urea synthesis [34, 41]. 
Cell-culture medium samples were collected every two days from the PRH-containing 
side of the dual microchannel and stored at -80°C until assayed. As a control, medium 
samples were taken from microchannels containing only PRHs without endothelial cells. 
Urea concentration in the medium was evaluated by a colorimetric endpoint assay 
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utilizing diacetylmonoxime (Urea Nitrogen (BUN), Stanbio Labs) as previously 
described [93]. Each experiment was performed in duplicate from the same rat liver-cell 
isolation. Error bars in the plotted graph using quantitative data represent the mean ± 
standard error (± SEM). The urea concentration was normalized from the measured urea 
concentration (µg/µl) by one day of culture as µg/µl/day. 
 
3.2.6. Adenovirus infection of PRHs 
As a final method for analyzing retention of hepatocyte-specific function during the 
time course of our experiments, we analyzed HBV replication in our system. 
Recombinant adenoviruses encoding either hrGFP alone (AdGFP) or hrGFP with the 
HBV genome (AdGFP-HBV) have been described previously [38, 104]. HBV cannot 
directly infect rat hepatocytes, necessitating the use of a recombinant adenovirus 
containing a replication-competent copy of the HBV genome. The use of recombinant 
adenoviruses for similar types of studies in rodent hepatocytes has been previously 
described [109, 110]. For infection, the PRHs were incubated at day 1 after plating with 
either AdGFP or AdGFP-HBV for 16 hours. After infection, the hepatocytes were washed 
with 1X phosphate buffered saline (PBS) buffer and fresh primary rat hepatocyte medium 
was added to the microchannels. Microchannel platforms were connected to a perfusion 
system and incubated at 37ºC in 5% CO2. Supernatants from infected cells were collected 
at the indicated time points and stored at -80ºC for analysis by PCR. 
 
3.2.7. Analysis of secreted HBV DNA 
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The 1-2 ml supernatants collected from the microchannels were mixed with 30% 
(w/v) PEG 8000 /1.5 M NaCl to reach a final concentration of 8% (w/v) PEG 8000. 
Samples were incubated at 4ºC for 16 hours and then centrifuged at 15,000 x g for 15 
minutes. The pellet was resuspended in 50 μl PBS and treated with 1.5 μl of DNase I (10 
mg/ml) and 0.5 μl of 1 M MgCl2 for one hour at 37ºC. Samples were then incubated for 
1-2 hours at 55ºC after the following reagents were added: 5 μl of 0.5 M EDTA, 10 μl of 
10% SDS, 0.2 μl of 2 M CaCl2 and 2.5 μl of proteinase K at 10 mg/ml. After incubation, 
samples were centrifuged at 15,000 x g for 15 minutes. 0.3 μl of 3 M sodium acetate (pH 
4.8-5.2) and 75 μl of chilled 100% ethanol were added to samples to precipitate HBV 
DNA. Samples were kept at -20ºC over night, followed by an additional 15 minutes 
centrifugation (15,000 x g). The pellet was washed with 500 μl of 70% ethanol and was 
air-dried. It was then resuspended in 20 μl of deionized water. The extracted DNA was 
used for PCR using HBV-specific primers (568 bp) and GFP-specific primers (154 bp) 
listed in Table 3-1 [38]. A plasmid containing the HBV genome was used as a positive 
control for PCR analysis. 
 In order to confirm the differentiation and identity of PRHs, the gene-specific 
primers for hepatocyte nuclear factor 4 (HNF-4), transferrin (TFN), and albumin (ALB) 
as hepatocyte-specific differentiation markers were used for PCR (Table 3-1). 
Additionally, HBV and GFP primers were added in the Table 3-1. 
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Table 3-1. Hepatocyte gene-specific primers, HBV primers and GFP primers sequences 
for PCR. 
a
 1
st
 designed primers [38].  
b
 2
nd
 designed primers [93] . 
 
 
3.2.8. Western analysis for cytochrome P450 2E1 (CYP2E1) expression 
In order to verify that these hepatocytes retained their normal hepatocyte phenotype, 
and therefore support the utility of our model system as mimicking the functional unit of 
the liver, we examined the levels of CYP2E1. CYP2E1, a cytochrome P450, plays an 
important role in the liver's ability to metabolize circulating xenobiotic, particularly in the 
conversion of ethanol to acetaldehyde and acetate and was selected as one marker of 
Primer Sequence (5 '  3 ' ) 
Size 
(bp) 
Annealing 
temperature 
(⁰C) 
ALB
 a
 
GCCGAAAACTGTGACAAGTC 
TCTCGTAAAGCTCACAGTTAG 
914 61 
HNF-4
 a
 
CGGGCCACTGGCAAACAC 
GTAATCCTCCAGGCTCACC 
770 68 
TFN
 a
 
GGCTCAGGAACACTTTGGC 
GTTGTTCCAGTTGATGCTGG 
530 61 
ALB
 b
 
AAAGCACTGGTCGGAGCTGTCCG 
TCGCTGGCTCATACGAGCTACTGC 
105 61 
HNF-4
 b
 
AGTGCTGCCTTGGACCCAGCCT 
GGCACACAGGGCACTGACACCC 
138 68 
TFN
 b
 
TTACGGGTGCCCCCAAGGATGGAC 
ATTTCACTGGCGCGCTGTCGATGG 
121 61 
β-actin b 
GTCCACACCCGCCACCAGTT 
GGCCCACGATGGAGGGGAAG 
133 58 
HBV 
a
 
GCCTCGAGATGGACATCGACCCTTATAAAG 
GCGATATCCTAACATTGAGATTCCCGAG 
568 59 
GFP 
a
 
ACGCGGTACACGAACATCTC    
CCTTCACCAAGTACCCCGAG 
154 59 
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functional hepatocytes [101, 102]. Co-cultured hepatocytes and RAMEC cells were 
collected and washed twice with cold 1X PBS. Cells were then homogenized in a 
Laemmli sample buffer (8% SDS, 240mM Tris pH 6.8, 40%Glycerin, 0.02% 
Bromophenol blue). Samples were separated by SDS-PAGE on a 12%polyacrylamide 
gel, and transferred onto a nitrocellulose membrane (Bio-Rad Laboratories, Munich, 
Germany). The membranes were blocked with 5% milk in 1X TBST at 4°C overnight, 
and were then incubated with a rabbit CYP2E1 polyclonal antibody (1:1000 dilution, 
Abcam) and monoclonal mouse anti-β-actin antibody (1:1000,Sigma) at room 
temperature for 1.5 h. IRDye® 800 CW conjugated goat anti-rabbit (1:5000, Li-COR) 
and Alexa Fluro® 680 anti-mouse secondary antibodies(1:5000, Molecular Probes) were 
detected using the Odyssey infrared imaging system (Li-COR, Nebraska, USA). 
 
3.3. Results and Discussion 
3.3.1. Layered co-culture of PRHs and RAMECs in single-channel configuration 
(configuration 1) under static condition 
Prior to layered co-culture studies, PRHs were cultured without endothelial cells in 
microchannels under static conditions to analyze their viability in the microchannel 
environment. PRHs cultured alone made a confluent monolayer in the microchannel by 
day 2 after seeding (Figure 3-2a). PRHs maintained a normal phenotype (confluent 
polygonal shape) for about 4 days before the cells began to detach from the surface, 
resulting in large empty spaces that were observed by day 7 (Figure 3-2b). This 
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observation is similar to previous observations with PRHs cultured on conventional 6-
well culture plates [93].  
 
  
(a) (b) 
  
(c) (d) 
 
Figure 3-2. Morphology of PRHs in single channel configuration (configuration 1). (a) 
PRHs only in the microchannel at day 2 and (b) day 7, (c) PRHs only in the microchannel 
at day 2 before co-culture with RAMECs, (d) PRHs co-cultured with RAMECs at day 7. 
Scale bar: 200 μm. 
 
 
Next, we co-cultured PRHs with RAMECs in the single channel configuration 
(configuration 1). When PRHs were layered with RAMECs, the PRHs retained their 
normal hepatocyte morphology at day 7, unlike in the hepatocyte-only culture (Figure 3-
2c,d). These results also agree with the findings from others that primary hepatocytes 
show better viability and function when co-cultured with other cell types, such as 
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fibroblasts [20, 103, 111]. Although we did not elucidate a specific mechanism for the 
increased hepatocyte viability in our system, the results of previous studies suggest that 
both cell-cell interactions and cell-secreted soluble factors seem to be crucial for 
maintaining hepatocyte viability and function [20, 103]. 
To further investigate the extended viability of PRHs co-cultured with RAMECs, we 
continued to observe the co-cultured cells for 30 days. The layered configuration (PRHs 
at the bottom and RAMECs at the top) was verified using phase-contrast microscopy. 
When the RAMECs were in focus, the hepatocytes were not and similarly, when the 
hepatocytes were in focus, the RAMEC cells were not (Figure 3-3a,b). In order to verify 
the viability of PRHs layered beneath the RAMEC layer, we utilized a recombinant 
adenovirus that expresses GFP to infect viable PRHs 30 days after seeding. Importantly, 
we have confirmed that endothelial cells cannot be infected with adenovirus, so GFP 
expression is specific to AdGFP-infected PRHs (Figure 3-3c,6b). As shown in Figure 3-
3c, cells expressing GFP were clearly visible 24 hours after infection with AdGFP, and 30 
days after seeding of the PRHs and RAMECs in the microchannel. Together, these 
studies show that PRHs retained normal morphology and remained viable for at least 30 
days when they were co-cultured with RAMECs in layers in microchannels under static 
condition even though the cells did not maintain a confluent monolayer at day 30 over the 
entire surface of the microchannel. A significant drawback of this co-culture 
configuration was that over time the RAMECs settled into the empty spaces that formed 
between hepatocytes, possibly due to non-uniform coating of matrigel between the cell 
layers. These results suggest that this layered co-culture model does not allow for 
maintenance of long-term stable layering of hepatocytes and endothelial cells and will 
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eventually resemble a random co-culture monolayer, limiting its use for more 
physiologically relevant studies. 
 
 
Figure 3-3. Phase-contrast microscopy of long-term, layered, static co-culture of PRHs 
and RAMECs in single channel configuration (configuration 1). PRHs co-cultured with 
RAMECs remained viable for 30 days as verified by GFP expression in cells infected 
with an adenovirus expressing GFP. (a) RAMECs in focus (arrow) at day 30, (b) PRHs in 
focus (arrow) at day 30, and (c) GFP expression in AdGFP-infected PRHs at day 30. 
Scale bar: 200 µm. 
 
 
An additional drawback of this single-channel layered PRHs and RAMECs 
configuration was that many cells accumulated at the inlet and outlet of the microchannel. 
We hypothesized that this might be due to rapid depletion of nutrients and growth factors 
present in the small volume of cell-culture medium within the microchannel. We 
increased the channel height from 80-160 µm (the height of the original microchannel) to 
200-800 µm to increase the volume of cell-culture medium. We observed that the 
Single channel 
configuration RAMECs 
Hepatocytes 
Matrigel 
(a) (b) (c) 
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increased channel height of 800 µm allowed a more homogenous cell layer and resulted 
in a more stable morphology of PRHs (Figure 3-4). Therefore, the microchannel height of 
800 µm was then applied to the dual-channel configuration (configuration 3).  
 
  
 
(a) 
 
(b) 
 
Figure 3-4. The morphology of PRHs. (a) PRHs on the single microchannel with 160 µm 
height at day 2. (b) PRHs on the single microchannel with 800 µm height at day 2 (scale 
bar: 200 µm). 
  
 
3.3.2. Layered co-culture of PRHs and BAECs in dual-channel configuration 
(configuration 3) under static condition  
Since primary RAMECs can only be passaged for a limited time and thus it is 
difficult to use them in the subsequent optimization of our microfluidic platform, which 
would require a large number of endothelial cells, we decided to use immortalized 
BAECs for the optimization studies. BAECs can be passaged indefinitely and their 
endothelial characteristics are well characterized [108]. In order to distinguish endothelial 
cells from PRHs during co-culture in the microfluidic dual channel, GFP- and red 
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fluorescent protein (RFP)-expressing BAECs cell lines were developed and used [93]. 
PRHs co-cultured with BAECs on the opposite sides of a microporous membrane within 
a dual-PDMS microchannel made a confluent monolayer. Later on, the hepatocyte cell 
layer was partially peeled off but remaining PRHs retained their morphology for up to 30 
days (Figure 3-5). Figure 3-6a shows PRHs morphology at day 13 under bright-field 
microscopy, and Figure 3-6b shows BAECs expressing RFP at day 13.   
 
 
 
Figure 3-5. The morphology of co-culture of PRHs and BAECs in the dual microchannel 
under static condition at day 31 (scale bar: 400 µm). 
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Figure 3-6. Phase-contrast microscopy and urea synthesis of co-culture of PRHs and 
BAECs in dual-channel configuration (configuration 3) under static conditions. (a) PRHs 
co-cultured with BAECs at day 13, and (b) RFP expression of BAECs at day 13. Scale 
bar: 200 µm. (c) Urea synthesis in PRHs-only vs. PRHs co-cultured with BAECs under 
static condition. PRHs used in this experiment were from the same rat. All data was 
normalized and expressed as µg/µl/day. 
 
 
We also investigated urea synthesis as a measure of hepatocyte function. Urea 
synthesis from oxidation of amino acids or ammonia is a hepatocyte-specific function 
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that occurs in vivo [112]. We compared PRHs cultured in the absence of BAECs and 
PRHs co-cultured with BAECs. The urea synthesis level of the PRHs cultured in the 
absence of endothelial cells rapidly decreased from a high urea concentration (> 1.0 
µg/µl/day) in the channel to a negligible level within one week and remained at this low 
level until the end of culture. This correlates with the observation of extensive cell death 
that occurs in the PRHs-only culture system, as described in section 3.1. In contrast, the 
urea synthesis level of the PRHs co-cultured with BAECs under static condition 
decreased much less during the first 7 days and remained at a stable level (~ 0.3-0.4 
µg/µl/day) in the channel until the end of culture period (Figure 3-6c). The urea amount 
secreted at the stable urea level was estimated as 15-20 µg per one day considering the 
daily replacement of about 50 µl of medium. The large error in the urea concentration at 
the early time points may be caused by the large variation in the number of cells that may 
not have fully attached to the substrate after cell seeding. At later time points, once cell 
numbers have been stabilized, urea concentration remained at the low levels and showed 
only small variation.  
An issue with this configuration under static conditions was that the PRH layer 
sometimes peeled off the microporous membrane. This problem was more noticeable 
after medium changes, implying that it was related to the sudden shear stress exerted on 
the cell layer by the flow that was induced during manual medium replacement. We 
surmised that this limitation could be overcome by applying a continuous perfusion of 
medium at a low flow rate for the long-term co-culture of PRHs and endothelial cells. 
Moreover, such a flow condition would better simulate the flow condition of the liver 
sinusoid and is described below. 
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3.3.3.  Liver sinusoid on a chip: layered co-culture of PRHs and BAECs in dual-
channel configuration (configuration 3) under flow condition  
In the next step toward developing the liver sinusoid on a chip, PRHs were co-
cultured with BAECs in a dual-microchannel under a continuous perfusion, as shown in 
Figure 3-7a. First, we generated a layered co-culture of PRHs and BAECs in a dual-
channel configuration (configuration 3) as described above. The dual-channel was then 
connected to a syringe pump for continuous perfusion of cell-growth medium. We tested 
a range of flow rates (0-100 µl/hr) to identify the optimal flow rate. If the flow rate is too 
high the cell layer can be peeled and if the flow rate is too low dead cells cannot be 
washed out of the channel. A flow rate of 30-40 µl/hr was selected based on our 
experimental observation and applied to each channel beginning from day 1. In order to 
check the viability of PRHs, the cells were infected with AdGFP at day 1. The AdGFP 
infected PRHs maintained GFP expression at day 8 (Figure 3-7b). PRHs co-cultured with 
BAECs under flow condition maintained a confluent mono layer for over 21 days (Figure 
3-7c). Peeling of cells from the monolayer or deformation of cell morphology was less 
evident under flow conditions than with PRHs cultured under static conditions. 
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Figure 3-7. Long-term morphology and urea synthesis of PRHs co-cultured with BAECs 
in a dual microchannel platform under flow conditions. (a) Continuous perfusion system, 
(b) PRHs infected with ad-GFP at day 2 expressed GFP in co-culture of PRHs and 
BAECs at day 8, (c) PRHs co-cultured with BAECs at day 21. Scale bar: 200 µm. (d) 
Urea synthesis in PRHs-only vs. PRHs co-cultured with BAECs under flow condition. 
PRHs used in this experiment were from the same rat. All data was normalized and 
expressed as µg/µl/day. 
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We estimated the shear stress applied to the PRHs in both static and flow conditions 
in the dual-channel configuration. With a steady-state, laminar flow profile, the maximum 
shear stress (τ) at the bottom of the channel where the cells are located is expressed as: 
 τ = 
6µ𝑄
ℎ2𝑤
 
where µ = flow viscosity (kg/m·s), Q = volumetric flow rate (m3/s), h = channel height 
(m), and w = channel width (m) [113]. For the flow rate of 30-40 µl/hr and a channel 
height of 600-800 µm, the range of the shear stress is determined to be between 7.8x10-4 
and 1.9x10-3 dyne/cm2 (Figure 3-8). On the other hand, the shear stress exerted on 
hepatocytes during medium replacement in static condition can be as high as 0.9-2.8 
dyne/cm2 since the flow rate during media replacement by pipette is estimated to be very 
high (10.0-16.7 µl/sec) (Figure 3-8). Therefore, the shear stress exerted on PRHs under 
flow condition is about 1,000-2,000 times less than the shear stress exerted on PRHs 
under static conditions during media replacement. Since the impact of shear stress on cell 
morphology and viability can be minimized under flow conditions, it is likely to 
contribute to retaining cell phenotypes for a longer time. It must also be noted that while 
the physiological range of the shear stress in the liver sinusoid in vivo (< 2 dyne/cm2) [57, 
113] may be higher than what is seen in our flow system, the actual shear stress that 
hepatocytes experience in the liver sinusoid is much less than this value due to the 
presence of the endothelial cell layer that prevents hepatocytes from being directly 
exposed to the fluid flow.  
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(a) 
 
(b) 
Figure 3-8. Shear stress with different channel height under static condition (a) and 
dynamic condition (b). 
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the hepatocyte-only culture under flow condition gradually decreased over 20 days, in 
contrast to the rapid decline that occurred over 7 days in primary rat hepatocyte-only 
culture in the static condition (Figure 3-6c). By 22 days of culture, few PRHs remained in 
the dual-channel, flow-exposed, primary rat hepatocyte-only systems, and we stopped our 
analyses of hepatocyte-specific markers and function. On the other hand, urea synthesis 
in PRHs co-cultured with BAECs under flow condition showed a slight increase initially 
and then decreased to a stable level (~ 0.3 µg/µl/day) in the channel that was maintained 
for at least 30 days (Figure 3-7d). The urea amount secreted at the stable urea level was 
estimated as 216-288 µg per one day under flow rate 30-40 µl/hr. The decrease in the 
urea concentration over the time course of the experiment is caused not by hepatocyte 
differentiation and loss of function, but is likely due to the total level of urea in the 
sample decreasing because of an increase over time in the number of dead cells, and 
therefore a decrease in cells producing urea. We therefore believe that levels of urea 
detected in our various monoculture and co-culture platforms is mostly related to the 
number of surviving, differentiated hepatocytes in the various configurations over the 
time course of our studies. The urea secretion per day from the co-culture system exposed 
to flow demonstrates that PRHs maintained under flow condition showed higher urea 
secretion in comparison to static cultures, as reported in previous studies [50, 53]. In 
addition, prolonged urea secretion supports the conclusion that our culture model 
maintains hepatocyte function for at least 30 days.  
In order to verify that the PRHs co-cultured in the liver sinusoid on a chip continued 
to express specific markers of differentiated hepatocytes throughout the time course of 
our studies, RT-PCR was performed on total RNA obtained from PRHs co-cultured with 
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BAECs in the dual-channel configuration (configuration 3) and exposed to flow. The 
mRNA expression of hepatocyte-specific differentiation markers such as ALB, TNF and 
HNF-4α was determined by RT-PCR [99]. Total RNA was isolated from freshly isolated 
PRHs, as well as from PRHs co-cultured with BAECs exposed to flow for 15 and 21 
days. For each study, all hepatocytes that were analyzed were isolated from the same rat. 
The expression of ALB (105 bp), TFN (121 bp), HNF-4α (138 bp) and β-actin (133 bp) 
mRNA was apparent in freshly isolated PRHs and in PRHs that were co-cultured with 
BAECs for 15 and 21 days in the dual-channel, flow-exposed devices (Figure 3-9). The 
expression level of the three hepatocyte-specific genes was quantified from a gel image 
and the intensity ratio of each band to the band for β-actin was evaluated. The expression 
level of the three hepatic-specific genes of PRHs at day 15 and day 21 was not changed 
significantly compared to freshly isolated PRHs. This indicates that PRHs co-cultured 
with BAECs in the dual-channel configuration (configuration 3) under flow condition 
retained their differentiation status for at least 21 days.  
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Figure 3-9. Differentiation of PRHs co-cultured with BAECs in dual channel 
configuration (configuration 3) under flow condition. RT-PCR was performed after total 
RNA isolation from freshly isolated PRHs (a), PRHs co-cultured for 15 days (b) and 
21days (c) to check mRNA expression of the liver-specific differentiation markers; 
ALB(105 bp), TFN(121 bp), HNF-4(138 bp) and β-actin (133 bp). Freshly isolated PRHs 
and PRHs in co-culture were isolated from the same rat. 
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To demonstrate the utility of our liver model, we analyzed its use in studying 
replication of HBV. Because HBV cannot directly infect rat hepatocytes, we used a 
recombinant adenovirus containing a replication competent copy of the HBV genome 
(AdGFP-HBV) for these studies. Use of AdGFP-HBV to introduce the HBV genome into 
non-human cells is an accepted method for studying HBV biology [109, 110]. 
Importantly, HBV is hepatotropic and expression of HBV RNA transcripts is dependent 
on expression of hepatocyte specific factors. Hence, our ability to detect HBV replication 
in our microfluidic platform serves as an additional confirmation that the differentiation 
and functional status of hepatocytes were retained throughout the time course of our 
studies. 
 PRHs were infected with AdGFP or AdGFP-HBV at day 1 after plating and 
expressed GFP by day 3 (Figure 3-10a,b). Adenovirus infection efficiency resulted in 
approximately 30-70% of primary rat hepatocyte being infected in our experiments as 
verified by fluorescent microscopy image of GFP expressed cells. The GFP expression 
from the infected cells was maintained for several days and then disappeared gradually 
(Figure 3-10c,d). In order to detect the secretion of replicated HBV into the cell culture 
media, we used specific primers for regions on the HBV genome. HBV was detected in 
samples of PRHs infected with AdGFP-HBV (Figure 3-11, lane 1 and 2) and was 
identical in size to the band from the positive control (lane 4) in Figure 3-11. These 
results indicate that PRHs infected with AdGFP-HBV secreted HBV into the culture 
media. To check contamination of the culture medium samples with recombinant 
adenovirus used for infection of PRHs, PCR using GFP primers for samples from PRHs 
infected with AdGFP-HBV was performed. A GFP-specific PCR product; a positive 
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control PCR product was detected when direct PCR was performed on DNA isolated 
from AdGFP-HBV (lane 7, 8 and 10). Finally, we were unable to detect a HBV-specific 
PCR product from samples of PRHs infected with AdGFP, confirming that our HBV-
specific PCR product was only detected in cells infected with AdGFP-HBV (lane 3 and 
9).  
 
    
(a) (b) 
    
(c) (d) 
 
Figure 3-10. Image of PRHs infected with AdGFP or AdGFP-HBV using the liver 
sinusoid on a chip. (a) PRHs co-cultured with BAECs were infected with AdGFP at day 1 
after seeding. Bright field (left) and GFP image (right) at day 3. (b) PRHs co-cultured 
with BAECs were infected with AdGFP-HBV at day 1 after seeding. Bright field (left) 
and GFP image (right) at day 3. (c) Bright field (left) and GFP image (right) at day 11 of 
(a). (d) Bright field (left) and GFP image (right) at day 11 of (b). Scale bar: 400 µm. 
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         1       2         3        4       5        6 
 
         7       8         9        10      11       12 
(a) (b) 
 
Figure 3-11. PCR from supernatants of PRHs co-cultured with BAECs on the liver 
sinusoid on a chip under perfusion system. (a) PCR using HBV primers. (b) PCR using 
GFP primers. Lane 1,2,7 & 8: supernatants from PRHs infected with AdGFP-HBV (day 
8), 3 &9: supernatants from PRHs infected with AdGFP (day 8), 4&10: AdGFP-HBV 
virus, 5&11: water, and 6&12: DNA ladder. 
 
 
Overall these results verified that PRHs infected with AdGFP-HBV secreted HBV 
into culture media in the microchannel platform, indicating that hepatocytes retained their 
hepatocyte specific phenotype throughout the time course of our studies and could be 
used for analysis of replication of a hepatotropic virus. These studies also strongly 
suggest that our liver sinusoid on a chip might also be amenable for studies involving 
HBV infection of primary human hepatocytes that are cultured in our microfluidic device 
and also applied to diverse liver biology studies and liver-related disease research such as 
toxicology, other hepatotropic infections agents, and drug screening. 
 
3.3.5. Comparison of different configurations  
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Previously, we presented long-term co-culture of PRHs with endothelial cells using 
commercial transwell devices [93]. Because of the size of the culture chamber (24 mm 
diameter), a large amount of cells (4-6x105 cells) and culture medium are required in this 
model. Moreover, the transwell did not support continuous perfusion of medium. In 
contrast, the microfluidic platforms presented in this paper require much smaller amounts 
of cells (1x104 cells) and culture medium and facilitate continuous perfusion. We 
investigated both single- and dual-channel configurations, and our results show that the 
layered co-culture in the dual-channel configuration supports long-term culture of PRHs, 
and is better than the layered co-culture in the single channel configuration (configuration 
1) (Table 3-2).  
The single channel configuration (configuration 1) has only one microchannel with 
one inlet and one outlet for supplying culture medium to both PRHs and endothelial cells 
(Figure 1-8). Mass transfer by hepatocytes, such as nutrient and growth factor uptake and 
oxygen exchange, was limited in this system because hepatocytes were covered with a 
matrigel layer and an EC layer. Moreover, factors secreted from hepatocytes may 
stagnate around the cell layers and negatively affect the cultured hepatocytes [114, 115]. 
In contrast, the dual-channel configuration (configuration 3) with two inlets and two 
outlets can support much better mass transfer for hepatocytes, especially when the two 
different cell types are cultured on the opposite side of the membrane (Figure 1-8). Thus, 
the co-culture system in the dual-channel configuration (configuration 3) supports better 
cell-medium interactions than the co-culture system in the single-channel configuration 
(configuration 1). 
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Strictly speaking, the current dual-channel configuration (configuration 3) does not 
perfectly mimic the structure of the liver sinusoid since PRHs and endothelial cells are 
separated by a relatively thick porous membrane unlike the actual liver sinusoid in which 
the cells are separated by a very thin, protein-rich matrix, the Space of Disse.  In addition, 
our co-culture model uses a non-liver endothelial cell line instead of primary LSECs, 
which would be the most physiologically relevant in vitro liver model, and does not 
include non-parenchymal cells such Stellate cells and Kupffer cells. These limitations 
result in an incomplete understanding of the cell-cell interactions in the in vivo system. 
Including these primary non-parenchymal liver cells in our liver on a chip remains future 
work, which will move us closer to a model that fully mimics the in vivo liver 
environment. In terms of recreating Space of Disse, we attempted to mimic this structure 
using a thin matrigel layer but the endothelial cells eventually invaded into the hepatocyte 
layer, disrupting the layered structure. This result led us to come up with the 
incorporation of a microporous membrane to physically separate the two cell layers. 
Although the interaction between hepatocytes and endothelial cells might be limited in 
this configuration due to the presence of the microporous membrane, the direct exposure 
of hepatocytes to the continuous perfusion of medium seemed to have a positive effect in 
the long-term culture. In this configuration with continuous flow, the hepatocytes are 
exposed to a consistent level of nutrients, growth factors, and a low level of secreted 
factors from hepatocytes. The peeling-off of the cell layer due to shear stress is also 
minimized, and as a result, hepatocyte morphology and function remained for a longer 
time than in the other systems we tested. In addition, this culture system has less 
possibility of contamination because it does not require daily medium replacement. 
 100 
 
Finally, the dual-channel, continuous flow configuration also allows continuous 
collection of medium or isolation of cells from each channel for the analysis of cell 
function without contamination from the other cell type.  
Among all configurations and conditions tested, the layered co-culture of PRHs and 
endothelial cells in a dual-channel configuration (configuration 3) under flow condition 
seems to be the best long-term liver model and more closely mimics the structure and 
microenvironment of the liver sinusoid than the other configurations that we have tested. 
The cell culture results obtained from the model were highly reproducible. It must also be 
noted that the current liver sinusoid on a chip is clearly distinct from other existing 
microfluidic in vitro liver models [31, 41, 42] and supports long-term maintenance of 
hepatocyte functions.  
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Table 3-2. Comparison of structure and design differences between a single microchannel 
(configuration 1) and a dual microchannel (configuration 3) 
Content 
Configuration 1 
(Single microchannel) 
Configuration 3 
(Dual microchannel) 
Structural 
Schematic 
  
Cell-Cell 
or  
Cell-ECM 
Interaction 
 
Space of Disse - Matrigel layer  
• Thin, compliant matrigel. 
• Possible cell-cell direct 
interaction.  
• Difficult to separate two cell 
layers for a long term. 
• Difficult to form matrigel layer 
with uniform thickness. 
• Top layer tends to invade into the 
bottom layer.   
Space of Disse - Microporous 
membrane  
• Relatively thick, rigid 
membrane. 
• Cell-cell indirect interaction by 
medium through membrane.  
• Easy to separate two cell layers.  
• Easy to collect hepatocytes or 
medium for the analysis of cell 
function. 
• Collagen on both sides of the 
membrane. 
Cell-
Medium 
Interaction 
• Limited exposure to nutrients and 
oxygen. 
• Limited bile removal. 
• Full exposure to nutrients and 
oxygen.   
• Effective bile removal. 
Mechanic
al Stress 
• Endothelial cells minimize shear 
stress on the hepatocytes. 
• Hepatocytes under direct shear 
stress.   
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3.3.6. Comparison of static culture vs. dynamic culture for a long-term layered co-
culture.  
In this section we re-confirmed that dynamic culture system is the best culture system 
which is the most closely related to in vivo systems by comparing a cell culture platform, 
culture condition and experimental results from the previous hepatocytes culture using 6-
transwell to that of the microfluidic platform-based liver models (Table 3-3). 
Hepatocytes were cultured using 6-transwell plates with 24 mm diameter insert in an 
open static culture system. About 4-6x105 cells were plated on the 6-transwell at day 1 
and 104-105 cells retained their differentiation status and function for at least 30 days. The 
culture chamber is large and no fluid flow was employed; thus this model does not 
accurately mimic the liver sinusoid. Moreover, larger amounts of cells and culture media 
are required in this model. One advantage is that analysis of cell phenotype and function 
is easier with this model mainly because it provides sufficient number of cells. Shear 
stress still occurs during the media replacement and it can cause the peeling-off of cell 
layer [113]. Also, cells under static condition are exposed to the inconsistent level of 
nutrients and to the negative effect of bile accumulation compared to dynamic culture. 
In the static culture of hepatocytes using the microchannel, a small number of about 
1x10
4
 cells were required for cell culture because the culture area of a PDMS 
microchannel (1x15x0.8 mm: WxLxH with the open-inlet and outlet) was approximately 
30 times smaller as compared to the 6-transwell. About 1x104 cells were plated in the 
microchannel at day 1 and about 1x10
3
 cells retained their morphologies for 30 days. The 
microchannel has several advantages over cell culture, which include using a smaller 
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amount of cells and culture media. Nonetheless, the microchannel still has similar 
limitations of static culture which were described in the transwell model.  
In contrast, the dynamic microchannel culture system closely mimics the liver 
sinusoid and thus is more physiologically relevant (cells are exposed to a consistent level 
of nutrient and a lower level of bile under the continuous flow) than the other models. 
The peeling-off of the cell layer due to shear stress is minimized and as a result, cell 
phenotype remains for long-term periods of time. In addition, this culture system has less 
possibility of contamination and does not require daily media replacement.  
Thus, the dynamic co-culture system in the PDMS microchannel as our ultimate goal 
is the best culture system for long-term layered co-culture of hepatocytes and endothelial 
cells among the liver models that we have presented and provides better control of the 
cellular microenvironment and more accurately mimics the microfluidic environment of 
the liver sinusoid [116].   
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Table 3-3. Comparison of static culture vs. dynamic culture for a long-term layered co-
culture of PRHs and endothelial cells in a microfluidic platform. 
 
PDMS microchannel under static 
condition 
PDMS microchannel under 
dynamic condition 
Culture 
platform 
  
Dimension 
1 mm width, 15 mm length, 0.8 mm height, 
area: 15 mm
2
 
1 mm width, 15 mm length, 0.8 mm 
height, area: 15 mm
2
 
Open/closed Open system with inlet/ outlet  Closed system 
Flow rate 
3.6x104-6x104 µl/hr  
(during media replacement) 
30–40 µl/hr 
Shear stress 0.939- 2.783 dynes/cm2 7.8x10-4-1.9x10-3 dynes/cm2 
Cell number 
1x10
4
 cells/channel at day 1 
10
3
 cells /channel at day 30  
1x10
4
 cells/channel at day 1 
10
3
 cells /channel at day 30 
Cell 
morphology 
Over 30 days Over 30 days (max. 63 days) 
Differentiation N/A 21 days 
Cell function 
(Urea) 
Over 30 days  Over 30 days (max. 56 days) 
Advantage 
 Small amount of cells and medium.  
 Closely mimic in vivo 
microenvironment.  
 Small amount of cells and 
medium.  
 Closely mimic in vivo 
microenvironment. 
 Enhancement of cell to media 
interaction due to continuous 
flow (i.e., nutrient uptake, gas 
exchange and bile removal). 
 Less possibility of 
contamination. 
 Constant exposure to flow is 
more physiologically relevant 
than static flow. 
Disadvantage 
 Frequent deformation of cell layer by 
shear stress and variant flow rate 
during media replacement. 
 Limitation of cell to media interaction 
(i.e., nutrient uptake, gas exchange 
and bile removal).  
 Complexity of device fabrication. 
 Inconsistent exposure level of nutrient 
and stagnation of secretion from cells. 
 Complexity of device 
fabrication.  
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3.4. Conclusions 
We presented a novel liver model that mimics the architecture and microenvironment 
of a liver sinusoid, where most liver activities occur. Our liver sinusoid on a chip support 
long-term co-culture of primary hepatocytes and endothelial cells in a layered 
configuration with or without continuous perfusion of culture medium. This paper 
describes a progressional study of creating such a liver sinusoid on a chip system. Each 
step in the progressional study was designed to help optimize cell survival and 
maintenance of hepatocyte functions while simultaneously achieving a configuration that 
closely mimics the structure and microenvironment of a liver sinusoid unit. First, we 
investigated a single-channel configuration (configuration 1) in which a layered co-
culture of PRHs and endothelial cells was created with a thin matrigel layer added 
between the two cell layers. Next, a dual-channel configuration (configuration 3) was 
investigated in which two microchannels simulate the blood sinusoid and a lower channel 
for the removal of the secreted factors from hepatocytes. When PRHs and BAECs were 
co-cultured on the opposite sides of a microporous membrane in a dual microchannel 
platform, along with the addition of continuous perfusion, the hepatocytes maintained 
their normal morphology and hepatocyte-like functions for at least 30 days. In addition, 
studies of secreted HBV were used to show the effective application of our in vitro liver 
sinusoid on a chip to studies of hepatotropic viruses. We believe that our liver sinusoid on 
a chip closely mimics the in vivo liver sinusoid and supports long-term primary liver-cell 
culture within a microfluidic liver model. This novel liver model could be applied to the 
study of liver diseases and liver toxicology.  
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CHAPTER 4. HUMAN LIVER SINUSOID ON A CHIP FOR HEPATITIS B 
VIRUS REPLICATION STUDY 
 
4.1. Introduction 
In our previous studies, we presented the rat liver sinusoid on a chip to mimic the 
liver sinusoid that consists of two main cell layers such as hepatocytes and LSECs, and 
two capillary lines such as blood sinusoid and bile duct (Figure 1-8) [117]. Also, we 
demonstrated the long term maintenance of PRHs by co-culturing PRHs with endothelial 
cells on the opposite side of membrane in the dual microfluidic channel [117]. In the 
study described here, we present the human liver on a chip using the same dual 
microfluidic channel to mimic the liver sinusoid based on the reliable results obtained 
from rat liver sinusoid on a chip. Furthermore, we describe that our liver model can be 
used as a liver disease model by demonstrating its utility via an HBV replication study. 
We believe that our human liver model closely mimics the in vivo liver sinusoid and 
could be extended to diverse liver biology studies and liver-related disease research such 
as drug induced liver toxicology.    
  
4.2. Materials and Methods 
 
4.2.1. Fabrication of microfluidic platforms 
Templates for rectangular microchannels (approximately 15 mm long, 1 mm wide and 
600-800 μm high) were fabricated with PhotoSilver 130 (EnvisionTEC GmbH) resin and 
Envision Tec® Perfectory SXGA+ Standard UV Stereolithography system using 
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stereolithography technique. PDMS microchannels were then made by the replica 
molding method using the fabricated microchannel templates [38]. 
After treating two PDMS microchannels with air plasma, they were combined with a 
microporous membrane that was cut down into the desire size and placed between them 
(Figure 3-1). The bonded dual-channel was sealed by wrapping it with Kapton tape 
(Micronova). For inlets and outlet ports of the microchannels, silicone tubes were 
implanted during PDMS replica molding.  
The bottom surface of the microchannel or the PET membrane was coated with 
collagen type I by introducing a collagen solution (0.198 mg/ml) into the microchannel 
followed by spontaneous evaporation. The assembled microchannel device was then 
sterilized under ultraviolet (UV) light (Intensity ~ 20 mJ/cm2) for 30 seconds.  
In order to provide continuous perfusion of culture medium effectively, the dual 
microchannel was connected to a syringe pump, and a flow rate of 30-40 µl/hr was 
applied (Figure 1-8). A 0.2 µm sterile filter was placed upstream of the channel inlets to 
maintain sterile conditions and remove particulates. Flow was applied in counter 
directions in the dual-channel for effective mass transfer and removal of factors secreted 
from the cells. The outlet of the microchannel was connected to a waste bottle with a 
silicone tube (0.0625” ID x 0.125” OD, Dow corning). Multiple valves were located in 
the middle of the outlet line for sampling the cell-culture medium (Figure 1-8).  
 
4.2.2. Culture of primary hepatocytes 
Normal primary human hepatocytes in suspension were obtained through the Liver 
Tissue Cell Distribution System, Pittsburgh, Pennsylvania, which is funded by NIH 
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Contract # HHSN276201200017C. Approximately 1-2x104 cells with 70-100% viability 
were plated in the collagen-coated microchannel by slowly adding them from one side of 
the microchannel until they start to come out from the other side. The cells were 
maintained in Dulbecco's Modified Eagle Media (DMEM) (Cellgro) supplemented with 1 
mM sodium pyruvate (Cellgro), 4 µg/ml insulin-transferrin-selenium (ITS, Gibco), 5 
µg/ml hydrocortisone (HC, Sigma), 5 ng/ml epidermal growth factor (EGF, BD 
Sciences), 1% penicillin-streptomycin, and 10% (vol/vol) fetal bovine serum (FBS, 
Gemini Bioproducts) at 37 ⁰C in 5% CO2. The media was changed after 4 hours of 
plating and was then changed after every 24 hours [117].  
BAECs, which are immortalized, microvascular endothelial cells, were used in co-
culture because they are more readily available than primary endothelial cells. BAECs 
were a kind gift from Dr. Robert Levy (Children’s Hospital of Philadelphia). The 
isolation and characterization of BAECs have been previously described [108]. BAECs 
were maintained in DMEM supplemented with 10% (vol/vol) FBS and 1% (vol/vol) 
penicillin-streptomycin (Cellgro) at 37°C in 5% CO2 and cell-culture medium was 
replaced every 2-3 days [117].  
 
4.2.3. Layered co-culture of primary human hepatocytes and endothelial cells 
For the dual-channel configuration (configuration 3), primary human hepatocytes 
were seeded into one channel and cultured for a minimum of 4 hours to allow the cells to 
adhere to the microporous membrane and create a confluent monolayer. After the 
formation of the PHH monolayer, the device was flipped over and endothelial cells were 
then seeded into the other channel so that these cells could adhere to the opposite side of 
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the microporous membrane. In order to investigate the effect of continuous perfusion, we 
tested flow culture conditions. For flow culture, the microchannel was connected to a 
syringe pump, and a flow rate of 30-40 µl/hr of fresh PHH medium was applied to both 
the top and bottom channels.  
 
4.2.4. Live-dead staining and imaging 
The viability of primary human hepatocytes cultured in the microchannel was 
examined using LIVE/DEAD Viability /Cytotoxicity Kit (Molecular probes). Primary 
human hepatocytes were stained with calcein AM (5 mg/mL) and ethidium homodimer 
(2.5 mg/mL) fluorescent stains by incubating with cells for 15 min at 37°C) to stain live 
and dead cells, respectively. Images were acquired using an inverted fluorescence 
microscope. 
 
4.2.5. HBV infection of primary human hepatocytes 
As a method for analyzing retention of hepatocyte-specific function during the time 
course of our experiments, we analyzed HBV replication in our system. HBV were used 
to infect primary human hepatocytes in the microchannels. In addition, we use 
recombinant adenoviruses encoding either hrGFP alone (AdGFP) or hrGFP with the HBV 
genome (AdGFP-HBV) in order to check whether primary human hepatocytes are 
infected with virus. The construction of these adenoviruses has been previously described 
[104]. For infection, 30-40 µl of the virus solution was added slowly from one end of the 
microchannel until it came out of the other end of the microchannel. Primary human 
hepatocytes were incubated at day 1 after plating with recombinant adenovirus or HBV 
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for approximately 16 hours. After infection, the hepatocytes were washed with 1X 
phosphate buffered saline (PBS) buffer three times and fresh primary human hepatocyte 
medium was added to the microchannels. Microchannel platforms were connected to a 
perfusion system and incubated at 37ºC in 5% CO2. Supernatants from infected cells 
were collected at the indicated time points and stored at -80ºC for analysis by PCR. 
 
4.2.6. Analysis of secreted HBV DNA 
The 1-2 ml supernatants collected from the microchannels were mixed with 30% 
(w/v) PEG 8000 /1.5 M NaCl to reach a final concentration of 8% (w/v) PEG 8000. 
Samples were incubated at 4ºC for 16 hours and then centrifuged at 15,000 x g for 15 
minutes. The pellet was resuspended in 50 μl PBS and treated with 1.5 μl of DNase I (10 
mg/ml) and 0.5 μl of 1 M MgCl2 for one hour at 37ºC. Samples were then incubated for 
1-2 hours at 55ºC after the following reagents were added: 5 μl of 0.5 M EDTA, 10 μl of 
10% SDS, 0.2 μl of 2 M CaCl2 and 2.5 μl of proteinase K at 10 mg/ml. After incubation, 
samples were centrifuged at 15,000 x g for 15 minutes. 0.3 μl of 3 M sodium acetate (pH 
4.8-5.2) and 75 μl of chilled 100% ethanol were added to samples to precipitate HBV 
DNA. Samples were kept at -20ºC over night, followed by an additional 15 minutes 
centrifugation (15,000 x g). The pellet was washed with 500 μl of 70% ethanol and was 
air-dried. It was then resuspended in 20 μl of deionized water. The extracted DNA was 
used for PCR using HBV-specific primers (568 bp product) and GFP-specific primers 
(154 bp) listed in Table 3-1 [38]. A plasmid containing the HBV genome was used as a 
positive control for PCR analysis.  
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4.2.7. Immunofluorescence Assay 
Media was removed from the primary human hepatocytes in the microchannel and the 
cells were permeable by incubating the cells with 95% ethanol and 5% acetic acid 
mixture overnight at -20 C. The cells were then washed once with Phosphate buffered 
saline (PBS) followed by washing twice with PBS-2% Bovine serum albumin (BSA) 
solution. PBS-2%BSA solution was aspirated and then the cells were dried for 20 
minutes. The cells were incubated with primary antibody diluted in PBS-2%BSA solution 
for 1 hour at room temperature followed by 4 washes with PBS-2%BSA. The cells were 
then incubated with a Fluorescein isothiocynate (FITC)-conjugated secondary antibody 
for 1 hour at room temperature. The cells were washed 3 times with PBS and once with 
water. Mounting media was added to the cells and were observed under a fluorescence 
microscope. 
 
4.3. Results and Discussion 
4.3.1. Layered co-culture of primary human hepatocytes and BAECs in dual-
channel configuration (configuration 3) under flow condition 
Prior to layered co-culture studies, primary human hepatocytes were cultured without 
endothelial cells in microchannels under flow conditions to analyze their viability in the 
microchannel environment.  
Primary human hepatocytes were only cultured without BAECs on a microporous 
membrane within a dual-PDMS microchannel under a continuous perfusion, as shown in 
Figure 1-8. The dual-channel was then connected to a syringe pump for continuous 
perfusion of cell-growth medium with a flow rate of 30-40 µl/hr. Primary human 
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hepatocytes cultured alone formed a confluent monolayer in the microchannel by day 2 
after seeding. Primary human hepatocytes maintained a normal phenotype (confluent 
polygonal shape) for about 5 days before the cells began to detach from the surface, 
resulting in large empty spaces that were observed by day 13 (Figure 4-1a,b). This 
observation is similar to previous observations with PRHs cultured on dual-channel 
platform under flow condition and could be due to the fact that cultured primary 
hepatocytes do not survive for long unless they are cultured with endothelial cells [117].  
Next, we co-cultured primary human hepatocytes with BAECs in the dual-channel 
configuration (configuration 3). When primary human hepatocytes were layered with 
BAECs, the primary human hepatocytes retained their normal hepatocyte morphology at 
day 20, unlike in the hepatocyte-only culture (Figure 4-1c,d). These results also agree 
with the findings from others that primary hepatocytes show better viability and function 
when co-cultured with other cell types, such as fibroblasts [20, 103, 111]. After primary 
human hepatocytes made a confluent monolayer at day 1 or 2, primary human 
hepatocytes retained their morphology for 3 weeks. Figure 4-1 shows primary human 
hepatocytes morphology at day 20 under bright-field microscopy.   
To further investigate the extended viability of primary human hepatocytes co-
cultured with BAECs, we continued to observe the co-cultured cells for 26 days. The 
layered configuration (primary human hepatocytes at the bottom and BAECs at the top) 
was verified using phase-contrast microscopy. Primary human hepatocytes stained with 
LIVE/DEAD Viability /Cytotoxicity Kit (Molecular probes) expressed green 
fluorescence. It indicated that primary human hepatocytes are viable for 26 days (Figure 
4-1e).  
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(a) (b) 
  
(c) (d) 
 
 
(e)  
 
Figure 4-1. Primary human hepatocytes only culture vs. co-culture of primary human 
hepatocytes and BAECs under flow condition in dual microchannel. (a) Primary human 
hepatocytes only in the microchannel at day 5 and (b) day 13. (c) Primary human 
hepatocytes co-cultured with BAECs at day 4 and (d) day 20. (e) Primary human 
hepatocytes were stained with LIVE/DEAD Viability /Cytotoxicity Kit (Molecular 
probes). GFP image of primary human hepatocytes co-cultured with BAECs at day 26. 
(Scale bar: 400 µm). 
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Together, these studies show that primary human hepatocytes retained normal 
morphology and remained viable for at least 26 days when they were co-cultured with 
BAECs in layers in microchannels under flow condition even though the cells did not 
maintain a confluent monolayer at day 26 over the entire surface of the microchannel, but 
partial areas.  
 
4.3.2. Viral infection of primary human hepatocytes in microchannels 
In our human liver model, only ten-thousand cells are plated in the small dimensions 
of microchannels. We investigated whether the small number of primary human 
hepatocytes cultured in the limited area could be infected with a virus in single or dual 
microchannels before usage of our liver model for the viral infection associated liver 
disease studies.   
Initially, primary human hepatocytes were only cultured in the single microchannels 
and then infected with recombinant adenoviruses expressing GFP (AdGFP) 36 hours after 
plating the cells [118]. Hepatocytes infected with AdGFP expressed GFP after two days 
of infection in Figure 4-2 [118].  
Next, primary human hepatocytes co-cultured with BAECs in the dual microchannel 
were infected with recombinant adenoviruses encoding hrGFP with the HBV genome 
(AdGFP-HBV) at day 1 after plating cells [109, 110]. Microchannels that contained 
cultured primary human hepatocytes were connected to a continuous perfusion system. 
The cells infected with AdGFP-HBV at day 1 after plating maintained GFP expression 
for day 5 after plating (Figure 4-2). We did not observe GFP-expressing endothelial cells, 
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but GFP-expressing hepatocytes [117]. It indicates that the small amount of primary 
human hepatocytes cultured in the microchannel was infected with recombinant 
adenovirus that would enable us to introduce a gene of interest into the hepatocytes for 
specific studies.  
 
  
(a) (b) 
 
 
(c)  
Figure 4-2. Primary human hepatocytes infected with recombinant adenovirus. (a) and (b) 
Primary human hepatocytes infected with AdGFP at day 4 after plating [118]. (c) Primary 
human hepatocytes infected with AdGFP-HBV at day 5 after plating. 
 
4.3.3. Immunofluorescent assay for staining of Hepatitis B core antigen 
Among many factors that lead to the development of liver cancer or hepatocellular 
carcinoma (HCC), chronic infection with HBV is one of the most common causes of 
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HCC development. Also, HBV associated HCC is a major cause of deaths worldwide. 
However, the mechanisms of HBV-associated HCC are not well understood. In addition, 
there is the paucity of good in vitro model systems to study the role of HBV in the 
development HCC over a long period of time. Moreover, one of the difficulties of HBV 
associated study is that HBV is a species-specific virus which only infects humans and 
primates [118]. Due to frequent unavailability of human hepatocytes, most HBV studies 
have been done in other model systems such as transgenic mouse models, cultured 
primary hepatocytes (when available), but more often transformed or immortalized liver 
cell lines. Since these model systems do not exactly mimic primary human hepatocytes, 
the results of these studies have often varied and may be different than what occurs 
during an in vivo infection with HBV [118]. With the development of mini-liver model 
system, we would be able to establish a long-tern culture of primary human hepatocytes, 
which then could be infected with HBV, a potential model of cultured hepatocyte 
differentiation status. Such studies might prove crucial in determining the molecular 
mechanisms of HBV-associated HCC and potentially, can provide novel drug targets 
[118]. 
In order to demonstrate HBV associated study using our human liver sinusoid on a 
chip, HBV replication study was conducted in our human liver chip system. Primary 
human hepatocytes cultured under a continuous perfusion were infected with the HBV 
day 1 after plating. The Hepatitis B core antigen (HBcAg) of primary human hepatocytes 
infected with HBV was stained with Hepatitis B core antibody (HBcAb) at day 14. 
HBcAg from the infected primary human hepatocytes was detected by expressing red 
fluorescence through immunofluorescence assay (Figure 4-3b). In contrast, we could not 
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detect any red fluorescence from a mock sample that primary human hepatocytes were 
not infected with HBV (Figure 4-3a). Thus, we successfully detected HBcAg that may 
indicate the replicated HBV in cells infected with HBV.  
 
  
(a) (b) 
Figure 4-3. Immunofluorescence staining of HBcAg in primary human hepatocytes 
infected with HBV. Nuclear staining for the same set of cells was performed by use of 
DNA staining. DAPI stain shows as blue. (a) Control (Mock): primary human 
hepatocytes co-cultured BAECs without viral infection under flow condition in dual 
microchannel at day 14. (b) Primary human hepatocytes infected with HBV at day1 
express RFP at day 14. 10X magnification. 
 
 
4.3.4. Functional analysis of liver sinusoid on a chip through support of HBV 
replication 
As a further investigation of HBV replication study, we collected supernatants at the 
indicated time points from microchannel, where primary human hepatocytes infected 
with HBV were co-cultured with BAECs in order to detect the secretion of replicated 
HBV into the cell culture media. Supernatants collected from infected cells (day 22 
shown in the Figure 4-4) were used for PCR with specific primers for regions on the 
HBV genome in order to analyze the secreted HBV. The secreted HBV from the infected 
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hepatocytes was successfully detected by PCR data (Figure 4-4) and was identical in size 
to the band from the positive control (lane 6). We were unable to detect a HBV-specific 
PCR product from supernatant that was collected from primary human hepatocytes 
without viral infection at day 22. To check whether HBV isolation from sample using 
30% PEG precipitation properly works or not, we collected supernatant from 
HepG2.1.1.5 that is the established cell line to produce HBV. A HBV-specific PCR 
product was detected when direct PCR was performed on DNA isolated from 
HepG2.1.1.5 using 30% PEG precipitation (lane 5).  This HBV-specific PCR product was 
identical in size to the band from the positive control (lane 6).  
As a result, we confirmed that HBV-specific PCR products were only detected in 
cells infected with HBV (lane 4). Importantly, HBV is hepatotropic and expression of 
HBV RNA transcripts is dependent on expression of hepatocyte specific factors. Hence, 
the ability to detect HBV replication in our microfluidic platform serves as a confirmation 
that the differentiation and functional status of hepatocytes were retained throughout the 
time course of our studies.  
These studies also strongly suggest that our liver sinusoid on a chip might also be 
amenable for studies involving HBV infection of primary human hepatocytes that are 
cultured in our microfluidic device and also applied to diverse liver biology studies and 
liver-related disease research such as toxicology, other hepatotropic infections agents, and 
drug screening. 
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Figure 4-4. PCR using HBV primers from supernatants of primary human hepatocytes 
co-cultured with BAECs on the liver sinusoid on a chip under perfusion system was 
performed for detection of the secreted HBV from the infected primary human 
hepatocytes. Lane 1: water, Lane 2: Mock (supernatants from primary human hepatocytes 
without viral infection at day 22), Lane 3: DNA ladder, Lane 4: supernatants from PRHs 
infected with HBV (day 22), Lane 5: supernatants from HepG2.215, Lane 6: positive 
control of HBV plasmid. 
 
 
4.3.5. Discussion 
We have presented a human liver on a chip where primary human hepatocytes are co-
cultured with BAECs in the microfluidic channels. However, there remains a need to 
improve our liver model that more closely mimics the liver sinusoid including 
parenchymal cells (hepatocytes) and non-parenchymal cells (LSECs, Stellate cells, and 
Kupffer cells). Our liver model allows non-parenchymal cell types such as Kuppfer cells 
and hepatic stellate cells to be plated in the microchannel where the primary hepatocytes 
and endothelial cells are co-cultured. Furthermore, our liver model can be improved by 
considering a bile removal mechanism and no exposure of hepatocytes to flow in the 
microchannel. If a human liver model that allows multi-culture of primary hepatocytes 
with non-parenchymal cell types is developed, it could be an authentic human liver model 
1 2 3 4 5 6 
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to closely mimic the liver sinusoid and to be facilitated in the liver biology and liver-
related disease research.  
 
4.4. Conclusions 
We have developed a human liver model that closely mimics the architecture of the 
liver sinusoid. Primary human hepatocytes and BAECs were co-cultured on the opposite 
sides of a microporous membrane in a dual microfluidic microchannel platform. Primary 
human hepatocytes co-cultured with BAECs retained their morphology and viability for 
up to 40 days. Primary human hepatocytes cultured under a continuous perfusion were 
infected with HBV. The HBcAg of primary human hepatocytes infected with HBV was 
stained with HBcAb. HBcAg from the infected primary human hepatocytes was detected 
through immunofluorescence assay. Supernatants collected from infected cells were used 
for assay of secreted HBV. The secreted HBV was successfully detected by PCR. The 
ability to detect HBV replication in our microfluidic platform serves as a confirmation 
that the differentiation and functional status of hepatocytes were retained throughout the 
time course of our studies. We believe that our human liver sinusoid on a chip could find 
numerous applications in liver-related research and drug development. 
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CHAPTER 5. HANGING CULTURE OF PRIMARY HEPATOCYTES ONLY 
 
5.1. Introduction 
Conventionally, hepatocytes in ‘normal culture’ are cultured within culture dishes 
with cells attaching to a surface beneath the cells; however, most of the conventional 
culture methods have a significant limitation. Not only is the in vivo-like three 
dimensional cell structure deformed by growing on a flat surface under pressure from 
gravity against a plate, but also the cell to media interaction is limited by reducing the 
cell surface area exposed to nutrients and oxygen due to cell adhesion on a flat surface 
[119]. This results in that primary liver cells cultured conventionally on tissue culture 
platforms to lose their differentiated function within a week, even though primary 
hepatocytes maintain their viability for up to two weeks after isolation from the liver [12, 
20, 35, 93].  
Many culture technologies have been developed to overcome these limitations and to 
establish a long-term in vitro culture system that maintains hepatocyte function. One 
common approach is to mimic the physiological structure of the liver or to create a 
physiological microenvironment that mimics the in vivo environment. For example, 
hepatocytes have been co-cultured with other cell types such as fibroblasts and 
endothelial cells in many studies for several decades [12, 36, 37, 93]. Though the 
interplay between different cell types may be important to understand, co-culture of 
primary hepatocytes and other cell type has some limitations such as selection of donor 
cells, complicated culture, inconsistent expression, and the influence of cell function by 
other cell types [120]. Unlike a co-culture system, the monoculture system of primary 
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hepatocytes is a simple and useful culture method. One example of monoculture of 
primary hepatocytes, three-dimensional culture of PRHs using micropatterned 
semisynthetic polyethylene glycol-fibrinogen hydrogels, was presented in order to 
investigate the role of growth factor and autocrine signaling in maintaining cell viability 
and function. However, hepatocytes in the three dimensional monoculture system did not 
maintain cell viability and liver-specific functions for a long term period of time [61]. 
Although various approaches to prolong liver-specific function including cell 
suspensions, scaffolders, cell encapsulation using hydrogels and physiological fluid 
dynamic system have been attempted [119], it is still challenging to maintain hepatocyte-
specific function for a long term in monoculture system of primary hepatocytes. 
Recently, we found an interesting observation that primary hepatocytes cultured on 
the bottom of a transwell membrane with 0.4 µm pores (‘hanging’ configuration) 
maintain their viability and differentiated morphology for a little longer period of time 
compared to the cells cultured on top of a membrane (normal configuration) (Figure 5-1). 
The goal of this study is to investigate if indeed the hanging culture configuration can 
support cell phenotype longer than normal culture. In order to achieve this goal, we have 
compared hanging culture to the normal culture for the culture course of the time in terms 
of cell morphology, and differentiation. Furthermore, we investigated the effect of the 
actin distribution and the increased gap on primary liver function that may play a role in 
the hanging monoculture.  
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                                   (a)                                           (b) 
 
Figure 5-1. Schematic diagram for (a) normal culture versus (b) hanging culture of 
hepatocytes on 6-transwell plate. 
 
 
5.2. Materials and Methods 
5.2.1. Primary liver cell isolation and culture 
PRHs were isolated from 6-12 weeks old Sprague-Dawley rats as previously 
described [104]. The isolated primary hepatocytes were resuspended in Dulbecco's 
Modified Eagle Media (DMEM, Cellgro) supplemented with 1 mM sodium pyruvate 
(Cellgro), 4 µg/ml insulin-transferrin-selenium (ITS, Gibco), 5 µg/ml hydrocortisone 
(HC, Sigma), 5 ng/ml epidermal growth factor (EGF, BD Sciences), 1% (vol/vol) 
penicillin-streptomycin, and 10% (vol/vol) fetal bovine serum (FBS, Gemini 
Bioproducts). Approximately 4-6x105 cells with 70-100% viability were plated on the 
substrates that were coated by 0.198 mg/ml collagen. The 6-transwell (Dow Corning) 
with a microporous polyester membrane (0.4 μm pore size and 10 μm thickness) was 
used as a substrate. Cells were incubated at 37°C under 5% CO2 and the medium was 
replaced  every day [93].  
 
5.2.2. The established and immortalized cell lines 
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The HepG2 cells obtained from the American Type Culture Collection (ATCC) were 
maintained in Eagle's Minimum Essential Medium (DMEM) supplemented with 10% 
(vol/vol) FBS [38]. The AML 12 cells (ATCC) were cultured in Dulbecco's Modified 
Eagle's Medium: Ham's F12 medium (1:1) supplemented with 0.005 mg/ml insulin, 0.005 
mg/ml transferrin, 5 ng/ml selenium, 40 ng/ml dexamethasone, and 10% (vol/vol) FBS. 
The immortalized BAECs were also used in co-culture and the isolation, characterization 
and functions of BAECs were previously described [108]. BAECs obtained from Dr. 
Robert Levy (Children’s Hospital of Philadelphia) were maintained in DMEM 
supplemented with 10% (vol/vol) FBS and 1% (vol/vol) penicillin-streptomycin (Cellgro) 
at 37°C in 5% CO2. The medium was replaced every 2-3 days as previously described 
[93]. 
 
5.2.3. Layered hanging monoculture of PRHs 
To create a layered hanging monoculture of PRHs, one 6-transwell membrane coated 
by collagen type I was combined with other 6-transwell using poly-parafilm (Fisher 
Scientific) that removed the membrane (Figure 5-2a,b). PRHs were placed on the bottom 
side of the first 6-transwell membrane (Figure 5-2c). After PRHs were incubated at 37°C 
in 5% CO2 for at least 5 hours to allow the cells to attach to the membrane, the second 6-
transwell without membrane was removed. Then the 6-transwell with a membrane was 
flipped over and put in a 6-well plate that inserted about 1 mm thick spacer to increase 
the gap between the 6-transwell and 6-well plate (Figure 5-2d). The PRH-plated side of 
the membrane now faced down. We added media into the lower compartment with 1.8-2 
ml and the upper compartment with 1 ml. Media was replaced every day. In order to 
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check whether PRHs are viable or not, we used the recombinant adenoviruses encoding 
hrGFP alone (AdGFP) that have been described previously [38, 104]. Cells with over 
70% confluence were infected with AdGFP at day 1 after plating. 
 
 
(a) (b) (c) (d) 
 
Figure 5-2. Conceptual diagram for hanging culture of primary hepatocytes using 6-
transwell from step (a) to step (d). 
 
In order to investigate the effect of a different substrate on cells, a supporting ring 
was designed as the shape of the round table in order to put the substrate on it. It was 
fabricated by stereolithography technology that a supporting ring has a 30 mm diameter 
ring with 0.8 mm thick and 12 legs with 0.8 mm high (Figure 5-3). Tissue culture dish 
(54mm diameter, polystyrene) was cut into the size of 24 mm diameter. PDMS layer with 
about 3 mm thick was cured in the 6-well plate and cut into the size of 24 mm diameter. 
Commercial cover glass (1 inch x 1 inch square, Fisher Scientific) was used as it is. Each 
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substrate such as polystyrene, PDMS and cover glass was coated by collagen type I. Cells 
were loaded on the top of each substrate and fed with the media. After day 1, substrates 
adhered cells were flipped over and put on the support ring in the 6-well plate for hanging 
monoculture of hepatocytes. Hepatocytes were cultured with hanged on the bottom of 
substrate. Media was replaced every day. 
 
  
(a)              (b) 
Figure 5-3. Schematic diagram for normal monoculture versus hanging monoculture of 
hepatocytes in order to investigate the effect of a substrate with different mechanical 
properties on cells (a) normal monoculture of hepatocytes on a substrate (b) hanging 
monoculture of hepatocytes using a support ring. 
 
5.2.4. RNA isolation, reverse transcription and PCR analysis 
Reverse transcriptase-polymerase chain reaction (RT-PCR) was used to investigate 
whether PRHs remain differentiated in the hanging monoculture of PRHs [93].  PRHs 
cultured in the hanging monoculture were collected. Total RNA isolated from PRHs was 
treated with DNase (RQ1 RNase-Free DNase, Promega) at 37°C for 30 min to get rid of 
any DNA contamination according to the method of RNA isolation and RT-PCR 
described in our previous study [93]. The cDNA made by reverse transcription was then 
amplified by PCR using the designed primers of HNF-4, TFN, and ALB as hepatocyte 
specific markers. Also, β-actin as a house keeping gene was used in order to normalize 
the expression of hepatocyte-specific genes to the level of β-actin expression. A 
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programmable thermo cycler for PCR (Eppendorf) was used with the following program 
for amplification: 30 sec at 94°C followed by 30 cycles at 94°C for 30 sec, 45 sec at the 
specific annealing temperature for each primer set (Table  5-1) [93, 117], and 72°C for 1 
min, followed by a final extension at 72°C for 5 min. The amplified samples were 
electrophoresed on a 1.8 % agarose gel. 
 
Table 5-1. Hepatocyte gene-specific primers sequences for PCR [38, 93]. 
a
 newly designed primer of β-actin. 
 
 
5.2.5. Cytoskeleton staining 
Actin filaments in primary hepatocytes cultured in the normal culture and hanging 
culture configuration were stained with Rhodamine phalloidin (Cytoskeleton, Inc.) 
according to the manufacturer’s instructions. Nuclear staining for the same set of cells 
was performed by staining with DAPI. Samples were observed by a fluorescent confocal 
microscopy (Leica microsystems).  
 
5.3. Results and discussion 
5.3.1. Comparison of the morphology of PRHs between the normal and the 
hanging configuration. 
Primer Sequence (5 '  3 ' ) Size (bp) Cycle 
β-actin a CCCGCGAGTACAACCTTCTT 
AACACAGCCTGGATGGCTAC 
481 30 
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In order to investigate whether PRHs cultured in the hanging culture is better than 
PRHs in the normal culture, we first investigated the morphology of PRHs cultured in the 
hanging configuration by comparing it to the normal culture and co-culture configuration. 
PRHs were cultured under four different configurations such as the normal mono-/ co-
culture and hanging mono-/ co-culture using 6-transwells (Figure 5-4). It was observed 
that PRHs lost their function within 14 days in the normal and hanging monoculture of 
hepatocytes, however, some PRHs cultured in the hanging configuration retained their 
morphology (polygonal shape) in a partial area of a culture plate for 23 days (Figure 5-
4a,b). In order to check whether PRHs cultured in the hanging configuration are viable or 
not, we infected PRHs with AdGFP at day 2 after plating. The infected PRHs expressed 
GFP at day 4 (Figure 5-4e,f). Adenovirus infection efficiency was verified from the 
fluorescent image taken from an inverted microscope. The percentage of GFP positive 
cells was approximately 40-90 % of PRHs in our experiment. PRHs infected with AdGFP 
expressed GFP for several days and then lost their GFP expression gradually with the 
culture course of the time.  
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Normal culture 
(Hepatocytes only) 
Hanging culture 
(Hepatocytes only) 
Normal culture 
(Co-culture with 
BAECs) 
Hanging culture 
(Co-culture with 
BAECs) 
    
    
(a) (b) (c) (d) 
  
  
(e) (f)   
 
Figure 5-4. Phase-contrast micrographs of PRHs cultured in 6-transwells in normal 
culture and hanging culture configurations. (a) normal monoculture of PRHs at day 23, 
(b) hanging monoculture of PRHs at day 23, (c) co-culture of PRHs (top) and BAECs 
(bottom) at day 23, (d) co-culture of PRHs (bottom) and BAECs (top) at day 23. A scale 
bar indicates 100 µm. (e) PRHs infected with AdGFP at day 2 expressed GFP at day 4 in 
hanging monoculture (bright field image). (f) Fluorescent image of PRHs showing GFP 
expression of (e). A scale bar indicates 400 µm. 
 
In addition, we applied the hanging configuration to co-culture of PRHs and BAECs. 
The morphology of PRHs co-cultured with BAECs in the normal configuration was not 
as good as hepatocytes in the hanging co-culture configuration (Figure 5-4c,d). The 
morphology of PRHs in the hanging monoculture was not much different from cell 
morphology of hanging co-culture of PRHs and BAECs during the culture course of time. 
However, primary hepatocytes in the hanging co-culture remained viable for longer 
periods of time and more stable than the hanging monoculture. In addition, the 
 130 
 
detachment of the cell layer from substrate in the hanging monoculture was observed 
more frequent than co-culture.  
Together, primary hepatocytes in the hanging culture were detached from the 
substrate due to cell death within two weeks, but the remaining cells maintained their 
morphology in partial culture areas for over three weeks. The stretched longitudinal 
elongation of cells observed from hepatocytes cultured in normal configuration was 
relatively less observed in hepatocytes cultured in hanging configuration. As an aspect of 
overall culture area, the maintenance of cell morphology in hanging monoculture is not 
better compared to co-culture system, but is similar to normal culture. Moreover, the 
hanging co-culture of PRHs and BAECs is the best culture system among our cell culture 
configurations.  
 
5.3.2. Comparison of the differentiation of PRHs between the normal and the 
hanging configuration. 
In order to investigate whether hanging monoculture is better than normal 
monoculture, we investigated the mRNA expression level of hepatocytes specific 
differentiation markers in the normal monoculture, the hanging monoculture, and the 
hanging co-culture configuration. PRHs cultured in the normal monoculture, the hanging 
monoculture, and the hanging co-culture were collected at the indicated time points and 
used for RT-PCR to assess the mRNA expression of hepatocytes specific differentiation 
markers such as ALB, TFN, and HNF-4. PRHs cultured in the hanging monoculture and 
hanging co-culture with BAECs expressed the mRNA of hepatocytes specific 
differentiation markers such as ALB (105bp), TFN (121bp), and HNF-4 (138bp) at day 0, 
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day 1, day 4, day 10, and day 15 and day 20. In contrast to the results in the hanging 
configuration, PRHs cultured in the normal configuration expressed mRNA of 
hepatocytes specific differentiation markers for day 15, but produced low mRNA levels at 
day 20 and thus the data could not be obtained (Figure 5-5).   
 
 
 
Figure 5-5. mRNA expression of the liver-specific differentiation markers using RT-PCR: 
ALB (105 bp), TFN (121 bp), HNF-4 (138 bp) and β-actin (133 bp). Freshly PRHs (F), 
normal culture (N), hanging culture (H) and co-culture of PRHs and BAECs (C) with 
time for day 1, day 4, day 10, day 15 and day 20. DNA ladder (M). Normal culture at day 
20 produced too low mRNA and thus the data could not be obtained. 
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Figure 5-6. Confirmation of PRH differentiation for PRHs cultured in hanging 
configuration for 30 days. 
 
Furthermore, RT-PCR with the liver-specific differentiation markers was performed 
from freshly isolated PRHs and PRHs cultured in hanging configuration for 30 days. 
Fresh PRHs and PRHs in culture were isolated from a same original rat. We verified that 
PRHs cultured in the hanging monoculture expressed the mRNA of hepatocyte-specific 
differentiation markers for 30 days. However, mRNA expression level in the hanging 
configuration was lowered relatively compared to the expression levels in freshly isolated 
PRHs (Figure 5-6). It indicates that some cells might not remain differentiated during the 
long term culture of PRHs in the hanging monoculture.  
 133 
 
Overall, these results present that PRHs in the hanging monoculture using the 6-
transwell remained differentiated longer than the normal monoculture and similar to the 
co-culture of PRHs and BAECs. 
 
5.3.3. Hanging monoculture of the immortalized cell lines. 
We presented that PRHs in the hanging culture maintained a little better 
differentiation than PRHs in normal monoculture. Here, we applied the immortalized cell 
lines to our hanging configuration in order to investigate how the immortalized cell lines 
cultured in the hanging configuration behave. AML12 were cultured in both the normal 
configuration and the hanging configuration. AML12 cultured in the normal 
configuration formed more compact monolayer at day 6 compared to day 1. The 
morphology of AML12 cultured in the hanging configuration was similarly observed 
compared to the normal configuration at day 6 (Figure 5-7). In both the normal and the 
hanging culture of HepG2, it was observed that HepG2 grew piling up for the culture 
course of the time (Figure 5-7). Furthermore, the morphology of HepG2 and AML12 
cultured in the hanging monoculture was not much different from the morphology of 
HepG2 and AML12 cultured in the normal monoculture, respectively (Figure 5-7). This 
might be caused by the characteristic of the immortalized cell line to proliferate and 
survive under the harsh environment. Thus, the hanging configuration is not effective for 
the culture of the immortalized cell lines, unlike hanging monoculture of primary 
hepatocytes.  
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(a) (b) (c) (d) 
    
(e) (f) (g) (h) 
Figure 5-7. Phase-contrast micrographs of AML12 and HepG2 in normal culture and 
hanging culture. (a) Normal monoculture of AML12 on the top of 6-transwell at day 1, 
(b) normal monoculture of AML12 on the top of 6-transwell at day 6, (c) hanging 
monoculture of AML12 on the bottom of 6-transwell at day 1, (d) hanging monoculture 
of AML12 on the bottom of 6-transwell at day 6, (e) normal monoculture of HepG2 on 
the top of 6-transwell at day 1, (f) normal monoculture of HepG2 on the top of 6-
transwell at day 6, (g) hanging monoculture of HepG2 on the bottom of 6-transwell at 
day 1, and (h) hanging monoculture of HepG2 on the bottom of 6-transwell at day 6. 
 
5.3.4. Investigation of actin filament distribution of PRHs in hanging monoculture. 
In order to investigate which factor plays a critical role in cell phenotype in the 
hanging monoculture of PRHs, we first compared cell morphology in the hanging 
monoculture to that in the normal monoculture with the culture course of the time (Figure 
5-8). The size of several cells selected from cell images was measured by using Image J 
software and the schematic drawings of cell spreading with time from 0 hour to day 7 for 
both the normal monoculture and the hanging monoculture were drawn based on the 
observation of cell morphology. The average cell size measured in the normal culture was 
increased from 32.9 µm to 36.8 µm with the culture course of the time. It indicates that 
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cells stretched out longitudinally with time as shown in Figure 5-8. Eventually, stretched 
cells were dead and detached from the substrate as their cell structures were not 
maintained. In contrast, the average cell size of hepatocytes in the hanging monoculture 
was about 33 µm without a significant change of a cell size for 7 days since day 1 of the 
hanging culture. It indicates that cells did not stretch longitudinally with time and 
maintained their cell structures during the culture of time.   
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       Morphology Schematic drawing         Morphology Schematic drawing  
  
  
  
  
                                      (a)  
 
                                       (b) 
                      
                                      (c)                                        (d) 
 
Figure 5-8. Comparison of cell morphology and schematic drawing of cell spreading with 
time from 0 hour to day 7 for both (a) normal culture and (b) hanging culture. Schematic 
diagram for the hypothesized balance of the force acted on the cell in (c) normal culture 
and (d) hanging culture. 
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Figure 5-9. The effect of gravity on a cell. 
 
 
In addition to these observations, cells are sensitive to the alternation of the outside 
force such as the gravity (Figure 5-9) [121, 122]. Cells in the hanging configuration do 
not experience any pressure from gravity against a plate, while cells cultured in the 
normal configuration are subject to gravity. Cells trigger signals to induce the release of 
intracellular calcium in order to adopt into the altered environment [123-126]. Via signal 
transduction, matrix proteins (i.e. cadherin) are bound to the actin filaments comprising 
the cytoskeleton [123-126]. This bonding related to polymerization of actin cytoskeleton 
results in the alternation of cell to cell junction and cell adhesion [123, 127]. This change 
can lead the alternation in the cell structure and shape that depend on the cytoskeleton 
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formation and eventually affect cell function such as cell growth and apoptosis [128]. 
Thus, the pressure from gravity against a plate in the hanging configuration may play a 
role in cytoskeleton formation and distribution, as well as affect the long term cell 
viability. Based on this understanding, we surmise that actin filaments in the hanging 
monoculture may be depolymerized like distributed dots along a cell membrane and cells 
may result in maintaining their polygonal morphology without elongation with time 
(Figure 5-8). In normal culture, actin filaments may be polymerized like rigid straight 
lines at the edge of the membrane of cells adhered on a substrate due to the influence of 
the gravity. If the force to be exerted by actin filaments at the edge of the cell membrane 
is larger than the force to maintain the structure of cell by cell membrane, cells may be 
elongated gradually and become an unstable structure of cell shapes. On the other hand, if 
the force exerted by actin filaments is balanced to the force resisted by cell membrane, 
cells may retain their stable cell structure during the cell culture and it may support to 
survive longer. 
With this hypothesis, we investigated the distribution of actin filaments of PRHs in 
both the normal and hanging monoculture. PRHs were cultured on a cover glass in both 
the normal culture and hanging culture. Actin filaments of PRHs were stained with 
Rhodamine phalloidin and observed by confocal microscopy. In the normal culture, rigid 
straight lines of actin filaments, which were polymerized, were observed at day 3 (Figure 
5-10a). The polymerized actin filaments in normal culture may lead cells to stretch out 
longitudinally. In contrast to the straight lines of actin filaments, we observed the 
depolymerized actin filaments that are like the distributed dots inside of cells at day 3 in 
the hanging culture (Figure 5-10b). The depolymerized actin filaments in the hanging 
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culture may be relevant with the observed cell morphology that cells are not stretched out 
and maintain their structures. Additionally, the size of nuclei in the hanging configuration 
was smaller, compared to nuclei of cells in the normal configuration. This result is similar 
to the decreased size of cell nuclei in microgravity [129]. However, it was observed that 
PRHs on the bottom of a cover glass in the hanging culture lost their morphology faster 
than PRHs on the top of a cover glass in the normal culture.  
 
 
Figure 5-10. Actin distribution of PRHs stained with Rhodamine phalloidin. Actin 
distribution of PRHs cultured on the top of a cover glass (a) and on the bottom of a cover 
glass (b) at day 3. Actin distribution of PRHs cultured on the top of a PET membrane (c) 
and on the bottom of a PET membrane (d) at day 7. 
 
(a) (b) 
(c) (d) 
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Instead of a rigid glass substrate, PRHs were cultured on a PET membrane in both the 
normal culture and the hanging culture. Actin distribution of PRHs on day 7 was 
observed by confocal microscopy. Similar to the hanging configuration using glass slides, 
PRHs in the hanging configuration using transwell membrane showed more cortical 
localized actin distribution and smaller nuclei compared to the normal configuration 
(Figure 5-10c,d). Actin distribution in the hanging configuration was similar to both the 
in vivo actin distribution and the actin distribution in three dimensional hepatocytes 
culture that have a more cortical localization [130, 131]. Thus, the hanging configuration 
provides cells with culture environment eliminating the pressure from gravity against a 
plate and forming an in vivo-like actin distribution that is distributed like dots along with 
a cell membrane. This supports cells not only to retain the three dimensional cell shape, 
but also to increase the cell surface area exposed to nutrients and oxygen, compared to 
cells deformed by growing on a flat surface subject to gravity. However, we need to 
further investigate the effect of gravity on cell longevity and function in hanging 
monoculture.  
 
5.3.5. Investigation of the effect of the distance between the lower compartment 
and the upper compartment on cell viability. 
The gap between the lower compartment and the upper compartment in the hanging 
culture was increased to 1.25 mm from the original gap 0.25 mm of the normal culture 
due to a spacer with 1 mm thickness used in the hanging culture. The 1 ml medium was 
additionally supplied to the lower compartment due to 1 mm increased gap by a spacer. 
Thus, we surmised that the increased medium due to the increased gap may affect the 
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longevity of cells in the hanging monoculture by enhancing cell-medium interaction 
(Figure 5-11). In order to investigate the effect of the increased gap between the lower 
and the upper compartment on the phenotype of primary hepatocytes, PRHs were 
cultured on the 6-transwell membranes with 0.25 mm gap (1 ml medium in the upper 
compartment and 1 ml medium in the lower compartment), 1.25 mm gap (1 ml medium 
in the upper compartment and 1.8-2 ml medium in the lower compartment) and 2.25 mm 
gap (1 ml medium in the upper compartment and 2.8-3 ml medium in the lower 
compartment) in both the normal culture and the hanging culture. PRHs in the normal 
culture with 1.25 mm gap maintained similar morphology to PRHs in the normal culture 
with 2.25 mm gap and a little better morphology than PRHs in the normal culture with 
0.25 mm gap at day 10 (Figure 5-11). However, PRHs in all normal culture 
configurations lost their morphology within 14 days. Similar to the normal culture, PRHs 
in the hanging culture with 1.25 mm gap maintained similar morphology to PRHs 
cultured in 6-transwell with 2.25 mm gap and better morphology than PRHs cultured in 
6-transwell with 0.25 mm gap at day 10 (Figure 5-11). Additionally, it was observed that 
PRH layer in the hanging culture with 0.25 mm gap was jammed between the upper and 
lower compartment, and the cell layer was partially detached and washed out during 
medium replacement. Thus, the increased gap in both the normal culture and the hanging 
culture affected the morphology of PRHs.   
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(a) (b) (c) 
   
(d) (e) (f) 
 
Figure 5-11. The effect of a gap between lower and upper compartment on the 
morphology of hepatocytes in both normal culture and hanging culture. (a) PRHs were 
cultured on the top of the PET membrane with (a) 0.25 mm gap, (b) 1.25 mm gap and (c) 
2.25 mm gap at day 10. PRHs were cultured on the bottom of the PET membrane with 
(d) 0.25 mm gap, (e) 1.25 mm gap and (f) 2.25 mm gap at day 10. 
 
We investigated the effect of actin filaments distribution and the increased gap in the 
hanging culture on cell longevity. However, we need to further investigate other factors 
that can affect cell phenotype and function in the hanging monoculture of primary 
hepatocytes. For instance, cell-substrate interaction and cell-ECM interaction may play 
an important role in the function of cells adhered to the substrate coated with ECM in 
hanging configuration [132, 133].  
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5.3.6. Effect the different substrate on the cell morphology in the hanging culture 
Cell-biomaterial interaction plays an important role on the function of cells adhered to 
the biomaterial surface. A substrate with different mechanical properties may affect the 
cell adhesion and phenotype in hanging monoculture of primary hepatocytes. In order to 
investigate how a substrate with different mechanical properties affects cell morphology 
in the hanging culture, four different substrates such as PDMS, polystyrene, PET 
membrane, and a cover glass were used in hanging monoculture [134].  
PRHs were cultured on the bottom of four different substrates with different mechanical 
properties. The mechanical properties of four substrates are described in the Table 5-2.  
 
Table 5-2. Mechanical properties for four substrates 
 PDMS Polystyrene 
PET 
membrane 
Cover glass 
Culture period in 
normal culture 
4-10 days 4-10 days 4-14 days 4-7 days 
Culture period in 
hanging  culture 
4-10 days 
 
2-5 days 
 
4-21 days 
 
2-5 days 
 
Mainly 
deformation of 
cell morphology 
Delamination 
of cell layer 
Stretchiness, 
elongation and 
less confluence 
Stretchiness 
and 
elongation 
Stretchiness, 
elongation and 
less confluence 
Cell image of 
mainly 
deformation 
    
Young’s 
Modulus, E  
2.6 MPa for 
base/agent 
mass ratios 
10:1 [135] 
1.9 to 3.7 GPa 
[136, 137] 
7.56 MPa 
[138] 
63 to 81 GPa 
[139] 
*Young’s modulus of collagen: 6.2-100 kPa for the underlying bed of the small fibrils 
[140] 
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Among the tested materials, cover glass is the stiffest material and PDMS is the most 
compliant material. PRHs on PET membrane in the hanging monoculture maintained 
their morphology longer than PRHs in normal culture, while the morphology of PRHs on 
PDMS, polystyrene, and cover glass in hanging culture were not maintained longer than 
normal culture. Primary hepatocytes cultured on the polystyrene and a cover glass were 
stretched out to the empty space and lost their functions within two weeks (Table 5-2). 
Specifically, PRHs in hanging monoculture using polystyrene and cover glass lost their 
morphology faster than normal monoculture (Figure 5-12). It was observed that cell layer 
on the PDMS was often peeled off from the substrate after hepatocytes made a confluent 
monolayer for day 2 (Table 5-2). This phenomenon was observed in both normal and 
hanging monoculture of primary hepatocytes. Our data suggests that hanging culture 
using the different substrate except PET membrane is not better than normal culture 
regardless of stiffness of a substrate. The result that cell morphology in the hanging 
monoculture using PET membrane was retained longer might be caused by other factors 
such as numerous micropores. However, in order to have a better understanding about the 
cell to substrate interaction, investigation of the effect of a substrate on cell function and 
its influence on extracellular matrix is necessary. 
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Normal culture Hanging culture 
or  or  
    
(a) (b) (c) (d) 
    
(e) (f) (g) (h) 
    
(i) (j) (k) (l) 
    
(m) (n) (o) (p) 
 
Figure 5-12. Phase-contrast micrographs of PRHs on different substrates in normal 
monoculture versus hanging monoculture. Normal monoculture of PRHs on PET 
membrane at day 2 (a) and day 7 (b). Hanging monoculture of PRHs on PET membrane 
at day 2 (c) and day 7 (d). Normal monoculture of PRHs on polystyrene at day 1 (e) and 
day 7 (f). Hanging monoculture of PRHs on polystyrene at day 1 (g) and day 7 (h). 
Normal monoculture of PRHs on PDMS at day 1 (i) and day 7 (j). Hanging monoculture 
of PRHs on PDMS at day 1 (k) and day 7 (l). Normal monoculture of PRHs on cover 
glass at day 2 (m) and day 8 (n). Hanging monoculture of PRHs on cover glass at day 2 
(o) and day 6 (p). 
 
 146 
 
5.4. Conclusions 
We presented a hanging monoculture model where primary hepatocytes only were 
cultured on the bottom of PET membrane in 6-transwell plate. PRHs in hanging culture 
retained their morphology, and differentiation a little longer than PRHs in the normal 
monoculture configuration. In the hanging monoculture, the cortical localized and 
depolymerized actin distribution was observed and it was similar to actin distribution in 
vivo. PRHs cultured in the increased gap between two compartments of the hanging 
culture retained better morphology as compared to hepatocytes cultured in the original 
gap. Thus, our hanging monoculture system has the potential to be a viable culture 
method to culture primary hepatocytes without the help of other cell types.  
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CHAPTER 6. CONCLUSION AND FUTURE WORK 
 
6.1. Conclusion 
 In this thesis, we developed a novel human liver model that closely mimics the 
architecture and function of a liver sinusoid where most liver activities take place. The 
liver sinusoid is a blood-carrying microfluidic system lined with LSECs. The hepatocytes 
are separated from LSECs by a small extracellular-matrix-protein-enriched Space of 
Disse. Bile is secreted from the hepatocytes and transported to the intestines through bile 
ducts. In order to develop in vitro liver model to mimic the liver sinusoid, we executed a 
progressional study from a macroscale culture system to a microfluidic culture system 
(Figure 6-1). First, PRHs were co-cultured with endothelial cells in layers using a 
transwell plate without flow. Second, PRHs were co-cultured with endothelial cells in a 
dual PDMS microchannel with or without continuous perfusion that simulates the blood 
sinusoid and a lower channel for the removal of the secreted factors from hepatocytes. 
Third, as our ultimate goal, we developed an in vitro human liver on a chip using a dual 
microfluidic channel to mimic the liver sinusoid based on the reliable results obtained 
from rat liver sinusoid on a chip. Morphological and biochemical analyses data support 
that our liver models mimics the liver sinusoid and maintain the viability and 
functionality of hepatocytes for a long-term. Extensive experimental studies were 
conducted to optimize the culture conditions and design parameters. In addition, we 
demonstrated the utility of our human liver model via HBV replication study. We found 
an interesting observation ‘hanging monoculture’ where only hepatocytes were cultured 
on the bottom of a transwell membrane, while we were developing the in vitro liver 
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model. The morphology, and differentiation of PRHs cultured in hanging configuration 
were maintained a little longer compared to hepatocytes in normal monoculture.  
Thus, we believe that our in vitro human liver model closely mimics the in vivo liver 
sinusoid and could be extended to diverse liver biology studies and liver-related disease 
research such as drug induced liver toxicology, and drug study. In addition, our hanging 
monoculture system has the potential to be a viable culture method to culture primary 
hepatocytes without the help of other cell types.  
Each study in this thesis was directed towards testing and optimizing cell culture 
conditions in each culture system with the goal of the development of ‘Engineering the 
liver sinusoid’. The results and conclusions for each progressional study were 
summarized in this chapter as following: 
  
6.1.1. A layered long term co-culture on a transwell membrane 
The first goal was to develop a novel in vitro liver model system using commercial 
standard 6-well and 6-transwell tissue culture plates under static condition. For this goal, 
primary liver cells were co-cultured with endothelial cells on the 6-well and 6-transwell 
plates under static condition. We verified that the cultured liver cells retained the 
phenotypes and functions for at least 30 days like in vivo through the study of cell 
morphology, viability, liver-specific functions and liver de-differentiation, when PRHs 
and endothelial cells were co-cultured on the opposite side of membrane.  
  
6.1.2. The rat liver sinusoid on a chip 
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The second goal was to develop the liver sinusoid on a chip using the PDMS 
microfluidic platform. To achieve this goal, we combined the layered co-culture of PRHs 
and endothelial cells with a single and dual microchannel system that is fabricated using 
microfabrication and microfluidic technology. The primary rat liver cells were co-
cultured with endothelial cells in the microchannel under static or perfusion condition. 
When PRHs and BAECs were co-cultured on the opposite sides of a microporous 
membrane in a dual microchannel platform, along with the addition of continuous 
perfusion, the hepatocytes maintained their normal morphology and hepatocyte-like 
functions for at least 30 days. In addition to standard function tests, we also demonstrated 
the utility of our liver model by detecting successfully the HBV secreted from PRHs in 
the microfluidic channel.  
 
6.1.3. The human liver model for HBV replication study 
The third goal was to develop the human liver on a chip using a dual microfluidic 
channel to mimic the liver sinusoid based on the reliable results obtained from the rat 
liver sinusoid on a chip. Primary human hepatocytes co-cultured with BAECs in a dual 
microfluidic microchannel platform retained their viability for up to 40 days. The 
developed human liver model was provided as an effective platform for HBV replication 
study with primary hepatocytes. Primary human hepatocytes cultured in liver on a chip 
were infected with HBV. HBcAg from the infected primary human hepatocytes was 
detected through an immunofluorescence assay. The HBV secreted from the infected 
cells was successfully detected by PCR. Thus, we demonstrated the utility of our human 
liver model via HBV replication study.   
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6.1.4. The hanging culture system for primary hepatocytes only culture 
The fourth goal was to investigate, if indeed, hanging culture configuration of 
primary hepatocytes only can support a long-term primary liver-cell culture. In order to 
achieve this goal, we had compared hanging culture and normal culture for up to 21 days 
in terms of visible cell morphology, differentiation, and function. PRHs in hanging 
culture retained their morphology, function, and differentiation longer than PRHs in the 
normal monoculture configuration without the help of any other cell type. Furthermore, 
we investigated into the factors that play critical roles in the long term maintenance of 
cell phenotype and function in the hanging monoculture of primary hepatocytes. First, the 
cortical localized and depolymerized actin distribution was observed in the investigation 
of actin distribution of primary hepatocytes in hanging culture. Second, primary 
hepatocytes cultured in the increased gap showed improved morphology than the original 
gap in the investigation for gap difference between two compartments of hanging culture. 
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Figure 6-1. Summary of liver on a chip: Engineering the liver sinusoid. 
 
6.2. Contribution 
We developed the in vitro human liver sinusoid on a chip that mimic the liver 
sinusoid in vivo by co-culturing primary hepatocytes and endothelial cells on the opposite 
of membrane in the microfluidic dual channel. Our human liver model makes a 
significant contribution to liver studies, drug development, and further human life as 
following;  
 
6.2.1. Contribution to the development of the human liver model 
The conventional liver-cell culture model has some limitations in that primary liver 
cells cultured on conventional tissue culture platforms lose their function shortly after 
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isolation and two-dimensional monoculture do not recapitulate the in vivo architecture of 
the liver. In order to overcome these limitations, microtechnology and microfluidic 
technology was applied to recreate the physiological microenvironment. As a result, 
many in vitro liver models using microtechnology and microfluidics have been developed 
for past decade, which demonstrated recreation of in vivo liver structure, and the 
improvement of cell viability and function.  
In this thesis, we also presented the development of human in vitro liver on a chip that 
mimics the liver sinusoid. Primary hepatocytes co-cultured with non-parenchymal cell 
types in our liver model showed better and longer maintenance of visible cell 
morphology, differentiation, and cellular function when compared to other conventional 
culture models. In addition, we confirmed the fact demonstrated from other references 
that primary hepatocytes maintained their function for a long term period of time with the 
help of other cell types [20]. Thus, we believe that we contributed to the developing work 
of the in vitro liver model that closely mimics the liver sinusoid and improves the long-
term maintenance of cell phenotype and function. Our work will further be extended to 
develop human-on-a-chip by connecting to other human organ model and will have a 
significant impact on the development of human on a chip for diverse biology studies, 
disease research, and drug screening applications.  
  
6.2.2. Contribution to liver related disease study and drug study 
Our human in vitro liver model can have significant impact on the assessment of 
potential drug studies. Such models can be used to predict metabolic activities more 
precisely prior to in vivo screenings. Furthermore, the animal studies for drug screening 
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and drug testing can substituted for the study using human in vitro liver model that not 
only can predict the accurate results in human, but also save a time and cost. Thus, our 
human liver model can greatly help researchers in the pharmaceutical industry to develop 
drugs and test them to predict performance in human clinical trials. 
Patient-specific drug screening can also be achieved with our liver-on-a-chip systems 
because our miniaturized liver model requires a small number of liver cells that can be 
obtained from patients by biopsy, and provides the patient-specific in vitro test 
environment to simulate the in vivo liver structure. Thus, our work will make a significant 
contribution to providing drug screening platforms for liver-related diseases.  
 
6.2.3. Contribution to providing a reliable in vivo-like environment for liver 
biological studies 
Many researchers have used the monoculture of hepatocytes in the conventional 
culture platform that is not different from the in vivo liver environment in most studies of 
viral infection of liver, drug screening and liver cancer. However, our liver model 
provides a reliable in vivo-like test environment for evaluating liver toxicity and drug 
metabolism as well as studying cell-cell interaction and hepatic zonation. The 
relationship between cellular organization and cell-specific functions are clarified in our 
liver model. Particularly, the interactions of liver cells and the effect of the cellular 
microenvironment on the maintenance of cell function are demonstrated in this thesis. 
Thus, our liver model could be facilitated for the analysis of molecular mechanisms that 
 154 
 
underlie hepatocyte, or other liver cell activities in various liver biology studies such as 
toxicology, viral infection, cancer research and drug screening.  
 
6.3. Future research 
6.3.1. Development of authentic human in vitro liver model  
Although we developed the human in vitro liver model, our liver model has 
drawbacks such as exposure of hepatocytes to flow and absence of minority cell types 
like Stellate cells and Kupffer cells. Thus, there remains a need to improve the in vitro 
liver model that can be the authentic in vivo like liver model. 
To attempt to create this model, our initial approach would be to add one more PDMS 
channel into the middle of current dual PDMS microchannel in order not to expose 
hepatocytes to flow. Triple-PDMS microchannels that have three compartments (the top, 
the middle and the bottom channel) will be separated by two PET membranes or parylene 
membranes (Figure 6-2). In order to introduce hepatic stellate cells to the channel, PET 
membrane or parylene with 3 or 8 µm pore size will be used. Hepatocytes will be 
cultured in the middle compartment surrounding two membranes not to expose to 
medium flow. Hepatic stellate cells will be implanted into 3 or 8 µm pore of membrane. 
And then endothelial cells will be plated on the membranes of both the top and the 
bottom compartments. Lastly Kupffer cells will be seeded on the endothelial cell layer in 
the top and bottom microchannels. Both the top and bottom compartment will be 
connected to perfusion system to mimic blood sinusoid, but the middle compartment will 
be connected to the bile collection bottle without the introduction of flow. This approach 
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allows hepatocytes not to be exposed by flow like in vivo sinusoid and to collect the bile 
from the middle channel of hepatocytes.  In addition, this system allows collecting the 
supernatant from each compartment at the indicated time points and harvesting the 
desired cells separately from other cell type for cell function analysis such as RT-PCR 
and western blotting. This innovative liver model can be expanded to become a more 
authentic human liver model that mimics the liver sinusoid.  
 
(a) 
 
(b) 
Figure 6-2. Schematic drawing (a) of human in vitro liver model to multi-culture 
hepatocytes with non-parenchymal cell types in PDMS microchannel and its fabrication 
method (b). 
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6.3.2. Application using the liver sinusoid on a chip  
6.3.2.1. Application of in vitro liver models for studying liver pathophysiology  
In vitro hepatocyte culture system has been utilized for the investigation study of 
various physiological and pathophysiological processes that include host response to 
sepsis, xenobiotic toxicity, response to oxidative stress, and induction of the acute phase 
response [111]. Among the many applications of in vitro liver models, our liver model 
can be used for the study of the behavior of pathogens such as HBV, hepatitis C virus 
(HCV) and malaria that target hepatocytes and screening for therapeutics of the 
associated diseases. Chronic infection with HBV is a major cause of HCC development. 
It is important to study the role of HBV, HBV infection, HBV replication, and the 
mechanisms that lead to HBV-related HCC development. Thus, our liver model can be 
provided as a platform for the studies of liver cancer or HCC. In addition to study of 
HBV-associated HCC, our liver model can be used for studies of HCV infection, 
replication and screens for small molecule inhibitors of the replicative enzymes of HCV 
that is composed of a subgenomic replicon stably-transfected into carcinoma cells [141].  
  
6.3.2.2. Hepatic zonation study 
Our liver model can be used for the study of hepatic zonation (Figure 6-3). In vivo the 
liver forms hepatic zonation. Opposing or complementary metabolic pathways in the liver 
are carried out within distinct non-overlapping regions of the liver lobule to maintain 
optimal metabolic homeostasis. Hepatocytes located in different parts of the liver are 
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exposed to different microenvironments. Accordingly, hepatic zonation in the liver may 
be determined by the concentrations of species or components of media such as oxygen, 
hormones, drugs or metabolites in the blood. Thus, our liver model that is a long-term 
layered co-culture of primary hepatocytes and non-parenchymal cells will provide the 
physiological test environment for hepatic zonation studies. Furthermore, we will confirm 
the formation of liver zonation by measuring the concentration of species such as oxygen 
and glucose along with the channel length.  
 
6.3.2.3. Hepatic fibrosis study 
One of the liver functions includes the immune response to infection or cell injury. 
The hepatic stellate cells are the major cell type involved in liver fibrosis, which is the 
formation of scar tissue in response to liver damage. The Kupffer cells are involved in the 
liver's immune response to infection, toxins, resection, and other stresses. They play a 
role in the pathogenesis of various liver diseases. Thus, our liver model can be used for 
the study of hepatic fibrosis of stellate cells or Kupffer cells in immune response to 
infection or toxin and cell injury (Figure 6-3). The hepatic stellate cells or Kupffer cells 
cultured in microfluidic channel will be stimulated by the introduction of endotoxin or 
drug or mechanical stress and their response to the stimulation will be investigated. 
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Figure 6-3. Schematic drawing for hepatic zonation and fibrosis study. 
 
 
6.3.3. Numerical simulation for mass transport phenomenon 
Hepatic sinusoid that composes the sinusoid functional unit is a microfluidic channel 
which is an approximately 10 µm wide capillary between 225 and 475 µm long. It is 
based on blood flow delivered from the intestines, pancreas and gallbladder [2, 15]. The 
blood flow includes the various soluble components such as the nutrients, growth factor, 
and oxygen and carbon dioxide. Hepatocytes are interacted with hepatic blood fluid by 
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uptaking necessary oxygen and nutrients from hepatic sinusoid and secreting the bile into 
hepatic sinusoid because the cells depend on constant transport and exchange of oxygen 
and carbon dioxide [14].The gradient of oxygen concentration is formed because the 
dissolved oxygen is consumed by the cells along the capillary line within the liver. 
Hepatocytes survival within the liver as well as in vitro liver model is influenced by the 
oxygen gradient.  
The media used for cell culture usually contains high level of hormones (i.e.4 µg/ml 
Insulin-Transferrin-Selenium (ITS, Gibco) in DMEM media) compared to physiological 
condition (1.2 *10 
-12
µg/ml (6.945 pmol/L) in blood) [142, 143].  The existing in vitro 
liver models do not support experiments in more physiologically relevant environments. 
Thus the study for the effect of media with physiologically relevant hormone level on the 
maintenance of cell function may enable us to use experiments with more physiologically 
relevant media in our in vitro liver model.  
In future work, we will focus on two main mass transports such as oxygen 
concentration, and culture medium formation that are related to maintain cell function. 
Numerical simulation of mass transport phenomenon in our in vitro liver model can be 
used to understand the relationships between the microchannel design and in vivo 
microenvironment to reduce expensive and time-consuming experimentation [144]. Thus, 
we will consider a numerical simulation of mass transport using the single PDMS 
microchannel (LxWxH: 1.5 mm x 1 mm x 80 - 800 µm) and dual PDMS microchannel 
(LxWxH: 1.5 mm x 1 mm x 800 µm). The diffusion profile of species concentration (i.e. 
oxygen) in our in vitro liver model will be simulated using commercially available 
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software, COMSOL multiphysics. Numerical simulation of mass transport phenomenon 
can provide proper interpretations of experimental data, and thus our simulated results 
may be compared to the results obtained from experiments as one of our numerical 
simulation goals.  
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Appendix 1. Isolation of liver sinusoidal endothelial cells (LSECs) 
 
 
1. LSECs are isolated from the suspension of liver cells derived from the liver perfusion 
and hepatocyte isolation after removal of the hepatocytes by differential 
centrifugation (Figure A1-1). 
2. Obtain the supernatant remaining after removal of hepatocytes.  
3. Centrifuge it at 710 rpm (when you use the centrifuge for 15 -50 ml tubes in Medical 
school lab) for 3 minutes. Take the supernatant only and put it into 50 ml tube.  
4. Centrifuge it at 350g (1320 rpm when you use the centrifuge for 15 -50 ml tubes in 
Medical school lab) for 10 minutes. Remove the supernatant using vacuum suction 
device in the clean bench. Take the pellet which contains the non-parenchymal cells.  
5. Add 20 ml DMEM medium into it and resuspend it.  
6. For the preparation of a 25/50 % percoll density gradient, place materials described in 
Table 2-1 (Preparation of percoll density gradient) in the clean bench.   
7. Prepare 25 ml of 25 % percoll in 50 ml tube and 25.5 ml of 50 % percoll in 50 ml 
tube. 
8. Take 12.5 ml of 25 % percoll and put it into new 50 ml tube.  
9. Take 12.5 ml of 50 % percoll and insert the tip of the pipette into the bottom of 25 % 
percoll in 50 ml tube. Add it very slow into the bottom of 25 % percoll. Observe the 
formation of interface between 25 % and 50 % percoll. When you add 50 % percoll 
into 25 % percoll, make sure that the interface between 25 % and 50 % percoll is not 
disrupted.  
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10. After preparing 25/ 50 % percoll density gradient, add 10 ml of the resuspended non-
parenchymal cells to 25/ 50 % percoll. When you introduce the resuspension solution, 
decline the 50 ml tube, let the tip of pipette in contact with the tube wall, and 
introduce the resuspension solution by letting it flow on the tube wall very slowly in 
order to prevent disruption of the percoll interface. Ensure the maintenance of the 
interface when handling them. 
11. Repeat step 8-10 to prepare the second 25/ 50 % percoll density gradient. 
12. Centrifuge them at 900g (2120 rpm when you use the centrifuge for 15 -50 ml tubes 
in Medical school lab) for 23 min without acceleration and deceleration. 
13. Observe the interface of the 25% and 50% percoll density gradient. The cells will be 
accumulated at the bottom and top interfaces of the 25% and 50% percoll density 
gradient. 
14. Collect cells from the bottom interface of percoll gradient into new 50 ml tube. You 
can collect cells from the top interface, but it was observed that cells from the bottom 
interface showed better LSEC morphology than cells from the top interface.   
15. In order to obtain pure LSECs, you can repeat step 10-14. For example, the cells 
isolated from the first percoll density gradient were then added to an identical percoll 
density gradient and the centrifugation was repeated one more time.  
16. Resuspend the collected cells at the interface of 25% and 50% percoll density 
gradient by adding 10 ml DMEM.  
17. Centrifuge it at 350 g (1320 rpm) for 10 minutes to remove any remaining percoll 
solution.  
18. Remove the supernatant.  
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19. Add about 200-500 µl of LSEC medium and resuspend the pellet of cells using a 
pipette. The amount of LSEC medium depends on the cell number and a 
microchannel number.  
20. Wash the microchannel with 200 µl of 1x PBS. 
21. Take 30-40 µl LSEC and plate it into a microchannel.     
22. Put it into an incubator 
23. Replace medium 3-6 hour after plating or overnight.  
24. Replace medium every 24 hours.  
 
 
Figure A1-1. Isolation of PRHs and LSECs 
  
Top 
Bottom 
Percoll gradient 
Primary Rat Hepatocytes (PRHs) 
Rat  Rat Liver  Hepatocytes preparation 
Primary Liver Sinusoidal Endothelial Cells (LSECs) 
PRH Morphology  
(polygonal shape) 
Endothelial cells 
Morphology  
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Appendix 2. Culture of bovine aortic endothelial cells (BAECs) 
 
 
1. Take a BAECs cryo-vial from a liquid nitrogen tank.  
2. Thaw a vial by putting it into 37 ⁰C water bath for 1-3 minutes immediately.   
3. Plate BAECs on the tissue culture dish without collagen-coating and add 10 ml of 
BAEC medium to the culture dish.  
4. Put it into an incubator. 
5. Replace medium every 2–3 days.  
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Appendix 3. Co-culture of PRHs and endothelial cells using a transwell 
 
 
1. Materials 
1.1. PRH medium / LSEC medium / BAEC medium 
1.2. Sterilized 1x PBS 
1.3. Trypsin-EDTA.  
1.4.  6-well/ 6-transwell plates 
1.5. 6x collagen (0.198 mg/ml collagen) 
1.6. Sterilized or autoclaved tools (scissors, tweezers, autoclave indication tapes, 
culture container (200 µl tip box), and supporting rings). 
1.7. Poly-parafilm 
1.8. PRHs, LSECs, and BAECs 
2. Procedure 
2.1. Refer the overall procedure in Figure 3A-1. 
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Figure 3A-1. Overall procedure for co-culture of hepatocytes and endothelial cells using 
a 6-transwell. 
 
2.2. Prepare one new and one used transwell inserts (Figure A3-2).  
2.3. Take 150 µl of 6x Collagen and add it to the new transwell membrane to 
coat a membrane. Preserve it in a clean environment overnight until the 
collagen is dried completely. 
2.4. Remove the membrane from the used one.  
2.5. Clean the used one with water.  
2.6. Prepare a cleaned 500 ml glass beaker.  
2.7. Fill it with 300-400 ml DI water.  
The new transwell insert was coated 
with collagen.   
    
Hepatocytes  
Step 4  
  
Collagen 
Step 2  
  
Step 3  
Parafilm  Remove  
a membrane  
Coat  
a collagen  
Combine  
transwells 
w/ a parafilm 
Remove  
one transwell 
Step 5 
    
  
6-transwell 
 reservoir 
Seed  
endothelial cells 
Seed  
hepatocytes 
    
Endothelial cells  
Step 6  
Support ring 
Used transwell  
insert 
New transwell insert 
Step 1  
Remove the membrane of the used transwell insert. 
Sanitize it using the boiling water. Take it out and dry.  Perform all works in 
a clean bench.  
Combine the used 
transwell insert with 
a new one using 
parafilm (step 3).  
Wrap two combined 
transwell inserts with 
poly-parafilm.  
Use sterilized 
tweezers and new 
gloves with 70 % IPA 
while you work.  
Seed cells.  
Put the combined 
transwell inserts 
into a sterilized 
container (200 µl 
tip box). 
 Incubate it in the 
incubator for one 
day.  
Take the container out on clean bench at 
day 1. Detach the parafilm by using 
sterilized tweezers.  
Remove the used transwell insert.  
Put the new transwell with cells into 6-well 
plate. Instead of using a support ring, the 
sterilized autoclave tape can be used.  
Seed the other cell 
type. 
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2.8. Boil water in the beaker  
2.9. Put the used transwell insert into the boiling water for about 5-7 minutes.  
2.10. Take it out of the beaker or remove the boiled water from the beaker.  
2.11. Dry the used transwell in a clean bench. Be careful not to be contaminated. 
All works should be performed in a clean bench until cells are cultured. 
Also, use the sterilized tools such as tweezers and replace the used gloves 
with new gloves before you work.  
2.12.  Combine it with new transwell insert using poly-parafilm (ThermoFisher). 
Poly-parafilm should be tightened in order not to leak.   
2.13. Put the combined transwell insert into the sterilized container (200 µl tip 
box). Place the bottom side of new transwell membrane facing up. 
 
 
 
Figure A3-2. Preparation of combined transwell inserts  
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2.14. Take two thirds of the PRHs amount to be seeded on 6-well plate and seed it 
on the bottom side of new transwell membrane. For example, if the seeding 
amount of PRH to be plated on a 6-well plate is 60 µl, you should take two 
thirds of 60 µl and plate it (40 µl) on the 6-transwell membrane.   
2.15. Add 1 ml PRH medium into the combined transwell.   
2.16. Put it into an incubator.  
2.17. Replace 1 ml medium 2-4 hr after plating. 
2.18. Incubate it at 37 ⁰C and 5 % CO2 
2.19. Bring the sterilized autoclave indicator tape, a tweezer, a scissor, and 6-well 
plate in a clean bench (Figure 3A-3).   
 
 
Figure 3A-3. Preparation of the sterilized autoclave indicator tape. 
 
2.20. Cut the autoclave indicator tape into the width size of 6-well plate.  
2.21. Paste it on the wall between wells in the 6-well plate by crossing a well and 
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overlapping about 2-3 mm with a well (Figure 3A-4). You can use the 
fabricated support ring or the autoclaved aluminum foil that are cut into a 
proper size instead of the autoclave indicator tape.  
 
 
Figure 3A-4. Setting up a culture platform in 6-well plate after disassembly 
of the combined transwell inserts. 
 
2.22. Take out the cell culture container into a clean bench at day 1.  
2.23. Remove medium.  
2.24. Detach the parafilm. You can use the sterilized tools such as tweezers and 
scissors when you detach the parafilm.  
2.25. Remove the used transwell insert without a membrane.  
2.26. Put the new transwell with cells into the prepared 6-well plate. 
2.27. Cut the autoclave indicator tape into the width size of 6-well plate.  
2.28. Paste it on the wall between the transwells in the 6-well plate by crossing a 
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transwell and overlapping about 2-3 mm with a transwell (Figure 3A-4).  
2.29. Feed 1.8 ml PRH medium into the bottom chamber.  
2.30. Seed endothelial cells on the top chamber.  
2.31. Feed 1 ml EC medium into the top chamber. 
2.32. Put it into an incubator.  
2.33. Change medium 2-4 hrs after plating EC. 
2.34. Put it into an incubator.  
2.35. Replace medium every 24 hrs.    
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Appendix 4. Fabrication of microchannel 
 
 
1. Fabricate the template for rectangular microchannels (15 mm long, 1 mm wide 
and 600-800 μm high) by stereolithography technique such as PhotoSilver 100 
(EnvisionTEC GmbH) resin and Envision Tec® Perfectory SXGA+ Standard UV 
Stereolithography system. The overall template dimension is 40 mm long, 40 mm 
wide, and 5-7 mm high. 
2. For implanting an inlet and outlet, include the design for pillars on the template to 
hold an implanted inlet/outlet tube (0.125” OD and 12-14 mm long) when you 
design the microchannel template by using the Creo software or Solidworks. For 
example, four pillars are required to hold inlet tube and outlet tube. The 
dimension of each pillar is 10 mm long, 5 mm wide and 5 mm high. The gap 
between each two pillars is designed as 4 mm. Each of the two pillars is located at 
10 mm away from the inlet/outlet of a microchannel.  
3. Make a reservoir of the template by wrapping its sides and bottom with an 
aluminum foil in order to keep the mixed PDMS solution. 
4. Mix PDMS solution with PDMS curing reagent in 10:1 mass ratio. For example, 
5g of PDMS curing reagent is added to 50 g of PDMS solution for 10 
microchannel templates. It is mixed manually using a stirrer bar. 
5. Pour 4-7 g of the mixed PDMS solution into a template with reservoir.   
6. Put it into a desiccator.  
7. Turn on the vacuum pump. 
8. Degas the mixed PDMS solution in the desiccator for about 30 min. 
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9. Prepare a larger silicone tube (0.0625” ID x 0.125” OD, Dow corning) and a 
smaller silicone tube (0.0625” OD) 
10. Insert the smaller tube into the larger tube.  
11. Cut the combined tube into a proper size (i.e. 12-14 mm) in order to implant an 
inlet/outlet line of each microchannel. For example, twenty cut tubes with 12-
14mm are required for fabrication of 10 microchannels. 
12. Take out the template from the desiccator.  
13. Implant one cut tube between the inlet position of a channel and pillars in the 
template.  
14. Implant the other cut tube between the outlet position of a channel and other 
pillars in the template. 
15. Put the template on hot plate for 2 hrs at 115 ⁰C or into an oven at 70 ⁰C 
overnight. 
16. Take it out and peel off the cured PDMS using sculpture tools (Figure 4A-1). 
 
  
 
Figure 4A-1. Peeling of PDMS channel. 
 
17. Remove the small tube using tools (i.e., a non-sharpen needle) that was inserted 
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into the larger tube.  
18. Make sure whether the medium can flow in and out through the channel and the 
inlet/outlet. 
19. Cut a microporous membrane (polyethyleneterephthalate (PET), 10 μm thick, 0.4 
μm pores) down to the desired size using sculpture tools or a razor blade that can 
cover the microchannel. Normally, one transwell membrane can be used for three 
microchannels.   
20. Place the cut membrane between two PDMS microchannels.  
21. Put them into the air plasma machine.  
22. Turn on the power of the air plasma.  
23. Treat them with air plasma under a condition of 60 mJ for 60 s. 
24. Bond them together with the microporous membrane in the middle after air 
plasma treatment.  
25. Put them into oven 70 ⁰C for 0.5-1 hr to enhance a bonding.  
26. Wrap the bonded dual-channel device with Kapton tape (Micronova) to seal the 
device and prevent leakage.  
27. Expose the assembled microchannel device under ultraviolet (UV) light (Intensity 
~ 20 mJ/cm2) for 30 seconds.  
28. Collagen-coating on membrane in microchannel. 
28.1. Prepare a working solution of 6x collagen by diluting 100x collagen with DI 
water in order to coat both sides of a membrane in microchannel with 0.198 
mg/ml collagen. 
28.2. For example, 9.4 ml DI is added to 600 µl of 100x collagen in a sterile 
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falcon tube. 100x collagen stock solution is stored in the refrigerator at 
medical school laboratory.  
28.3. Take a 30-40 µl of 6x collagen working solution and introduce it into a 
fabricated microchannel. A membrane in the microchannel should be 
covered with 6x collagen solution.  
28.4. In order to dry 6x collagen working solution in the microchannel, the 
microchannel is put on the hot plate (40-45 ⁰C) overnight.  
28.5. After drying 6x collagen solution, 30-40 µl of 6x collagen working solution 
is added into the other side of a microchannel in order to coat the other 
membrane.  
28.6. Dry 6x collagen solution as the same way above.  
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Appendix 5. Cells plating into a microchannel 
 
 
1. Wash a microchannel with 1x PBS 
1.1. Place a microchannel, sterilized 1x PBS, PRH medium, 1.5 ml tubes and 
pipettes (20 µl and 200 µl) into a sterile clean bench in order to plate PRHs 
in the microchannel. PRH medium should be warm before use by putting it 
in the water bath (37 ⁰C) for about 10 min. 
1.2. Take 200 µl of 1x PBS and wash a microchannel with it gently. Remove it 
from a microchannel.  
1.3.Take 50 µl of PRH medium and introduce it into an opposite side of a 
microchannel where endothelial cells will be plated. 
2. Plating PRHs in a microchannel 
2.1. PRHs are isolated from 6-12 weeks old Sprague-Dawley rats by a student in 
Medical school laboratory. Obtain PRHs (4x10
5
 cells/ a microchannel) with 
70-100 % cell viability. For example, Obtain 100 µl PRHs in 1.5 ml tube. 
Add 100 µl of PRH medium to it. Mix it with pipetting. Take 100 µl from 
the diluted PRHs and put it into the second 1.5 ml tube. Add 100 µl of PRH 
medium to it. Mix it with pipetting. 
2.2. Take 40 µl of the diluted PRHs and plated it into a microchannel.   
2.3. Observe a distance between cells using a microscope. If there is no gap 
between cells and it does not look overplated much but a little bit, then put it 
into a tissue culture dish. Incubate it in a CO2 incubator for 3-6 hrs by 
placing the PRH channel to be faced up.  
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2.4. If the gap between cells is observed, it is under plated. Take 100 µl PRHs 
from the second diluted PRHs and put into the third 1.5 ml tube. Add 50 µl 
of PRH medium to it. Mix it with pipetting. Repeat step 2.1-2.4.  
2.5. If there is no gap between cells and looks overplated too much, PRHs will 
grow with lots of dead cells that are attached to living cells. In order to plate 
cells properly, take 100 µl PRHs from the second diluted PRHs and put into 
the third 1.5 ml tube. Add 200 µl of PRH medium to it. Mix it with pipetting. 
Repeat step 2.1-2.5.  
2.6. Take out a microchannel from an incubator and put it into a clean bench. 
PRH medium should be warm before use by putting it in the water bath (37 
⁰C) for about 10 min. 
2.7. Remove medium from the microchannel using a pipette. Take 50 µl of PRH 
medium and feed it into the microchannel very slowly. Be careful that the 
attached cells on the membrane should not be washed. Incubate it in the 
incubator.  
2.8. Replace the medium every 24 hours.  
3. Co-culture of PRHs and endothelial cells 
3.1. For a layered co-culture of PRHs with LSECs or BAECs, obtain endothelial 
cells according to Appendix 1 and 2.  
3.2. Flip over a microchannel in order that the opposite side of a PRH channel is 
faced up.  
3.3. Remove medium from the opposite side of a PRH channel.  
3.4. Take 40 µl of endothelial cells and plate them into the opposite side of a 
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PRH channel.  
3.5. Put it into a tissue culture dish. 
3.6. Incubate it in an incubator by placing the microchannel side with endothelial 
cells to be faced up.    
3.7. Replace medium 3-6 hrs after plating. 
3.8. Replace medium in both sides of the microchannel every 24 hrs. Normally, 
the PRH side of a microchannel is faced up from 24 hrs after plating 
endothelial cells.  
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Appendix 6. Installation of perfusion system of a microchannel 
 
 
1. Materials  
1.1. PRH/LSEC/BAEC medium 
1.2. Microchannel 
1.3. Syringe pump 
1.4. Tools (tweezers and scissors) 
1.5. 200 µl filtered tips 
1.6. 10 ml Syringes 
1.7. Glass bottles for waste collection 
1.8. Connectors and tubing 
Item Information  
 
1/16 Female Luer  
Ark-plas item #: AP15FL006N  
Barb Size: 1/16, Luer Type: Female Lug  
Material: Nylon 
 
1/16 x 1/16 Commercial Grade Barbed Elbow Connector  
Ark-plas item #: AP0906ELBN  
Barb Size: 1/16, Material: Nylon 
 
Locking Male x Female x Locking Male 4-Way Stopcock  
Ark-plas item #: AP13SRL3MFMRL  
Luer Type: Female Threaded, Luer Type: Locking  
Material: Polycarbonate 
  
2. Procedure 
2.1. Place luer connectors (Ark-plas), stopcocks (Ark-plas), valves (Ark-plas), a 
silicone tube (0.0625” ID x 0.125” OD, Dow corning), 10 ml sterile syringes, 
PRH medium, a sterilized tools (tweezers and scissors) into a clean bench.  
2.2. Take about 10 ml PRH medium into a syringe. Prepare two syringes filled 
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with medium for two inlets.  
2.3. Cut a silicone tube into 30 cm for inlet line and into 15-20 cm for outlet line. 
Each microchannel requires two inlet silicone tubes and four outlet silicone 
tubes.  
2.4. Assemble a syringe to the female luer (Ark-Plas, AP15FL006N, size: 1/16).  
2.5. Assemble the female luer to a 30 cm silicone tube.  
2.6. Assemble a 30 cm silicone tube to the barbed elbow connector.  
2.7. Connect the barbed elbow connector to the microchannel inlet.  
2.8. Assemble the microchannel outlet to the other barbed elbow connector that 
is connected to15-20 cm silicone tube.  
2.9. Connect a 15-20 cm silicone tube to the female luer.  
2.10. Connect the female luer to a 4-way stopcock if you consider a sample taking 
from the outlet of channel. If not, you can skip this step.  
2.11. Connect a 4-way stopcock to the other 15-20 cm silicone tube.  
2.12. Connect the other 15-20 cm silicone tube to the female luer.  
2.13. Connect the female luer to a waste bottle.  
2.14. Mount the syringes of overall assembled microchannel to the syringe pump.  
2.15. Put them into an incubator (Figure 6A-1).  
2.16. Turn on the syringe pump.  
2.17. Operate the pump with a flow rate of 30-40 µl/hr. 
2.18. Replace a syringe filled with new medium when a medium runs out. Take a 
sample from the 4-way stopcock of a channel outlet.  
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Figure 6A-1. Perfusion system of microchannels 
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